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Abstract
The cytosolic Mu-class glutathione S-transferases (GST) present in human liver, skeletal
muscle and testis comprise three distinct neutral-type subunits (N,, N2 and N3) which
hybridize to form homodimers or heterodimers. The two N^type subunits, which represent
allelic variants encoded by the hepatic Mu-class GST locus, have been designated N,a
and N,b. Three isoenzymes containing Nrtype subunits have been purified from one liver
specimen by sequential affinity chromatography, hydroxyapatite chromatography and
chromatofocusing. The skeletal muscle GST N^N.,, N^NL,, N2N2 and N2N3 were purified by
a combination of affinity chromatography and anion-exchange f.p.l.c. followed by either
chromatofocusing f.p.l.c. or hydroxyapatite h.p.l.c. In muscle the expression of the N^type
subunit, but not of the N2 and N3 subunits, was found to differ from specimen to specimen.
The N,-type subunits were absent from about 50% of samples analyzed, and the
purification results from four different specimens is presented to illustrate the phenotypic
variation of skeletal muscle GST. The isolation of a homodimeric Mu-class isoenzyme,
called GST N3N3, from human testicular tissue was achieved in two chromatographic
steps; namely affinity chromatography followed by anion-exchange f.p.l.c.
The neutral-type GST subunits have been defined by the decreasing isoelectric points of
the homodimeric enzymes; GST N^N,3, N^N,", N2N2 and N3N3 have pi values of 6.1, 5.5,
5.3 and 5.0. SDS/PAGE showed that N,, N2 and N3 have Mr values of 26700, 26000 and
26300 respectively. The Nv N2 and N3 subunits are catalytically distinct, with the Nrtype
subunits possessing high activity for frans-4-phenyl-3-buten-2-one and N2 having high
activity towards 1,2-dichloro-4-nitrobenzene. The N-type subunits may also be
distinguished immunochemically; antisera raised against the testicular GST N3N3 cross-
reacted with the N3 subunit, and showed no reactivity towards either the N,-type or the N2
subunit. N-terminal amino acid sequence analysis supported the electrophoretic evidence
that the N2 subunit in GST N^Nj, N,bN2, N2N2 and N2N3 represents the same polypeptide.
The peptides obtained from CNBr digests of N2 were subjected separately to automated
amino acid sequencing, and the results indicate that N2 is distinct but closely related to
the protein encoded by the human Mu-class cDNA clone GTH4 [DeJong, Chang, Whang-
Peng, Knutsen & Tu (1988) Nucleic Acids Res. 16, 8541-8554], GST N2N2 is probably
identical with GST4 [Board, Suzuki & Shaw (1988) Biochim. Biophys. Acta 953, 214-217],
as over the 24 N-terminal residues of GST4 there is complete identity between the two
enzymes. The N3 subunit, which is expressed in skeletal muscle and testis possesses a
blocked N-terminus. Automated amino acid sequencing of a CNBr-derived peptide
vii
allowed 14 residues of the N3 subunit to be identified. This data indicated that testicular
GST N3N3 is likely to be identical to brain/testis [Campbell, Takahashi, Abramovitz,
Peretz & Listowsky (1990) J Biol. Chem. 265, 9188-9195].
Purification schemes are described for GST's from human and murine liver that catalyse
the conjugation of 1-menaphthyl sulphate (1-MS) with reduced glutathione. The human
enzyme which metabolises 1-MS is a homodimer comprising subunits of Mr 25100.
Immunochemical experiments have shown that this enzyme and related murine forms are
members of the class Theta GST. Automated amino acid sequence analysis of the human
isoenzyme have confirmed the immunochemical data and shown that it is related to
human GST 6 described previously [Meyer, Coles, Pemble, Gilmore, Fraser & Ketterer
(1991) Biochem. J. 274, 409-414], However, the human enzyme which catalyses the
conjugation of 1 -MS with glutathione is distinct from GST 6 and has been designated GST
T2T2. The various data which indicate GST 6 and GST T2T2 represent distinct isoenzymes
are discussed.
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Chapter 1 Enzymology of the glutathione
S-transferases
1.01 General introduction
The glutathione S-transferases (GST) are a complex group of detoxification enzymes that
catalyse the conjugation of glutathione to various xenobiotic and endogenous
electrophiles (Mannervik and Danielson, 1988; Ketterer, 1988). This reaction is the first
step in the formation of mercapturic acids, a pathway that is important as a means of
rendering these hydrophobic compounds water soluble and thereby aiding their
elimination from the body (Smith ef a/., 1977; Chasseaud, 1979). In addition to their
conjugation activity, some of these enzymes bind certain non-substrate ligands and this
has led to the suggestion that they may also serve a function as intracellular carrier
proteins (Litwack etal., 1971; Listowsky et at., 1988). These multifunctional proteins are
widely distributed in both the animal and the plant kingdom and in all species are
represented by a number of isoenzymes.
The mammalian GST, which are present as soluble and membrane bound forms, can be
subdivided into classes which share structural and functional homology. Three multigene
families, commonly referred to as Alpha, Mu and Pi, encode the major cytosolic forms of
GST (Alin ef a/., 1985a, Mannervik ef a/., 1985, Hayes and Mantle, 1986a). Recently,
however, soluble isoenzymes which do not belong to these three classes have been
isolated, and a fourth class of GST, designated Theta, has been recognised (Hiratsuka
etal., 1990; Meyer ef a/., 1991). Microsomal GST, which are unrelated to the cytosolic
forms, have also been purified from various sources (Morgenstern etal., 1982, 1985;
McLellan ef a/., 1989).
The GST isoenzymes of the rat have been the most extensively studied. The initial
investigations into the structure, function and tissue distribution of the rat GST have
provided a foundation for subsequent research into the expression of these enzymes in
humans and other species.
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1.02 Historical background
GST activity was first identified in rat liver extracts, in the early 1960's, by two independent
groups of workers. These groups reported that hepatic fractions catalysed the
conjugation of glutathione with 1,2-dichloro-4-nitrobenzene (Booth et al., 1961) and
bromosulphophthalein (Combes and Stakelum, 1961). Subsequent reports demonstrated
the existence of several different types of GST activity in rat liver and initially these
enzymes were described according to the type of reaction they catalysed. The GST
recognised by Booth et al. (1961), which was active with halogenated aromatic hydro¬
carbons was, therefore, named glutathione S-aryltransferase (Grover and Sims, 1964).
During the first five years following their discovery, many other GST substrates were
reported and other types of GST-catalysed reactions identified: glutathione S-epoxide-
transferase, catalysing the reaction of glutathione with many epoxides; glutathione S-
alkyltransferase, which catalysed the S-alkylation of various alkylhalides; glutathione S-
aralkyltransferase, which utilised aralkylhalides and esters as substrates; and glutathione
S-alkenetransferase which catalysed the reaction of glutathione with a/S-unsaturated
compounds (Boyland and Chasseaud, 1969).
Later reports, which described the purification of some of these rat liver GST to
homogeneity, confirmed that multiple forms existed, however, they also demonstrated that
the individual isoenzymes had broad and overlapping substrate specificities (Fjellstedt et
al., 1973; Pabst et al., 1973; Habig et al., 1974a; Habig etal., 1976). Therefore, rather
than using a classification based upon, the structure of the substrate, these purified
enzymes were named according to their chromatographic properties. Jakoby and co¬
workers identified six rat liver GST which were termed AA, A, B, C, D and E in reverse
order of their elution from CM-cellulose columns (Habig et al., 1976). Glutathione S-
epoxidetransferase, later referred to as transferase E, was the first of these enzymes to be
purified from rat liver (Fjellstedt et al., 1973). In the same year Gillham (1973) partially
purified an additional GST from a rat hepatic fraction that was active towards the substrate
1-menaphthyl sulphate and was later designated transferase M.
An organic-anion-binding protein called ligandin was also purified at this time (Litwack et
al., 1971). Subsequent reports demonstrated that ligandin possessed glutathione
conjugating activity towards bromosulphophthalein (Kaplowitz etal., 1973) and provided
evidence that it was identical to GST B (Habig et al., 1974b). However, it was later shown
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that the different preparations of ligandin obtained from various laboratories contained
different or heterogeneous GST mixtures (Hayes etal., 1979; Hayes and Clarkson, 1982).
Bass eta/., (1977) used SDS/polyacrylamide-gel electrophoresis to resolve the three major
subunits which comprise the cytosolic GST of rat liver. These polypeptides which were
isolated as a bromosulphophthalein-binding Y-fraction were described as Ya, Yb and Yc;
a classification which provides a basis for one of the currently used systems of rat GST
nomenclature (see section 2.01b).
1.03 Glutathione
1,03a Structure, function and metabolism of glutathione
Glutathione, a characteristic and essential component of all eukaryotic cells, is a tripeptide
with the sequence/glutamic acid-cysteine-glycine (Figure 1.01). This small molecule, the
most abundant low-molecular-mass thiol in nature, has an involvement in many biological
processes, including protein synthesis, amino acid transport and enzyme activity (Kowsner
and Kowsner, 1976; Meister and Anderson, 1983). Glutathione is also a powerful
antioxidant which affords the cell protection against the toxic products of oxygen
metabolism (Mannervik, 1986; Deneke and Fanburg, 1989).
Within mammalian cells a critical balance is maintained between the readily
interconvertible reduced (GSH) and oxidised (GSSG) forms of glutathione. High
intracellular levels of GSH are generally found with concentrations which vary between
0.5-10.0 mM depending on the tissue, and the growth, nutritional state and hormonal
balance of the organism (Meister and Anderson, 1983). Whereas, significantly lower
concentrations of glutathione disulphide (4-50 ^M) are essential for protein synthesis to
occur and the action of certain enzymes (Kowsner, 1976).
Intracellular GSH levels are dependant on the balance between the rate of its utilization,
in terms of oxidation, conjugation and degradation, and the rates of its synthesis and
of GSSG
reductiog/ The oxidation of GSH and the reduction of GSSG are mediated by the actions
of glutathione peroxidase and glutathione reductase respectively. Glutathione is
synthesised intracellularly, from its constituent amino acids, by a two step ATP requiring
process. The first reaction involves the formation of the /glutamyl peptide link with
cysteine, catalysed by /glutamylcysteine synthetase and this is followed by the formation
4
Figure 1.01 The structure of glutathione
The structure of reduced glutathione (GSH), yglutamylcysteinylglycine.
(1) The glutamic acid residue is joined to the cysteine residue with an unusual peptide
linkage which involves the y-carboxyl group rather than the a-carboxyl group.

























of a peptide bond between the cysteine moiety of /glutamylcysteine and glycine,
catalysed by glutathione synthetase. The breakdown of GSH, on the other hand, occurs
extracelluarly and is catalysed by /glutamyl transpeptidase. This membrane bound
enzyme transfers the /glutamyl moiety from GSH to an amino acid. The resulting
/glutamyl amino acid and cysteinylglycine may then be transported into the cell where
they become available as substrates for glutathione synthesis (Meister and Anderson,
1983).
Glutathione possesses a number of hydrophillic functional groups and is highly water
soluble. The nucleophilic thiol group, however, is the most important chemically reactive
group allowing GSH to react readily with compounds containing an electrophilic carbon,
nitrogen, sulphur or oxygen atom. These reactions are generally catalysed by glutathione
S-transferases, however in many instances they may also proceed non-enzymatically
(Chasseaud,1979). The conjugation of glutathione with electrophilic xenobiotics generally
results in the formation of less toxic compounds prior to their elimination from the body.
Recently, a glutathione S-conjugate efflux pump, which actively transports both foreign
and endogenous compounds out of cells, has been identified (Ishikawa, 1989; Ishikawa
etal., 1989). The glutathione S-conjugate may be excreted directly into bile or, following
conversion to an N-acetyl cysteine conjugate (or mercapturic acid), may be excreted into
urine (Chasseaud,1979).
1,03b Mercapturic acid biosynthesis
Mercapturic acids are the classical excretion products of xenobiotics (Boyland and
Chasseaud,1969; Mannervik, 1985). These compounds are the end product of a series
of reactions which take place in the liver and kidneys of most species and involve the
stepwise degradation of the glutathione moiety, of the GSH-electrophile conjugate,
followed by acetylation.
The first step in this detoxification pathway, depicted in Figure 1.02, is the conjugation of
glutathione with electrophilic compounds catalysed by the glutathione S-transferases.
In a reaction catalysed by /glutamyl transpeptidase, the membrane bound enzyme which
is also involved in GSH degradation (see section 1.03a), the /glutamyl moiety of the GSH
conjugate may then be removed and transferred to amino acid acceptors. The resulting
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Figure 1.02 The mercapturic acid pathway
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derivative and glycine. The final stage in the formation of the mercapturic acid is the N-
acetylation of the cysteine conjugate catalysed by an acetylase.
An alternative metabolic pathway for the biotransformation of the cysteine conjugate
involves the cleavage of the cysteine moiety by yS-lyase resulting in the elimination of
pyruvate and ammonia and the formation of a mercaptan. The thiol group of the
mercaptan may be blocked by either glucuronydation or methylation and the resulting
glucuronide or methylthio derivative can be excreted (Pickett and Lu, 1989).
1.04 Model substrates
The cytosolic GST are dimeric proteins which posses two catalytically independent
subunits (Danielson and Mannervik, 1985). Each subunit contains an active centre
composed of two binding sites; one with a high affinity for glutathione (G-site) and a
second hydrophobic site for the electrophilic substrate (H-site) (Jakobson et a/., 1977;
Mannervik, 1985). It is thought that GST act as catalysts by bringing the two substrates
into close juxtaposition (the "proximity effect") and promoting the ionization of GSH by
lowering the pl^ of the thiol moiety (Jakoby, 1978).
Whereas, the requirement of the glutathione S-transferases for GSH is highly specific, with
only homoglutathione (yglutamylcysteinylalanine) and yglutamylcysteine serving as
possible alternatives (Habig eta/., 1974a; Sugimoto eta/., 1985), the requirements for the
second substrate, hydrophobicity and a sufficiently electrophilic centre, are such that an
extremely wide variety of compounds may serve as substrates for these enzymes. Most
of the compounds which were originally used by researchers for the analysis of GST
enzymic activity were products of the chemical industry chosen because their conjugation
with GSH results in an optical density change which could be followed spectro-
photometricaly. The compound which is often considered as the "universal substrate" for
the GST is 1-chloro-2,4-dinitrobenzene (CDNB). It is apparent, however, that certain GST
forms express either low or undetectable activity towards this compound (Meyer et a/.,
1984, 1991; Hiratsuka et al., 1990), and as a consequence there is a danger that new
forms may be overlooked unless a suitable substrate is chosen.
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1.04a Types of reaction catalysed by GST
The nucleophilic attack of the glutathione thiolate ion (GS") may be directed against
sufficiently electrophilic carbon, oxygen, sulphur and nitrogen atoms, thereby producing
a variety of reaction types. These reactions include not only those which result in
glutathione conjugation but also reactions which involve hydroperoxide reduction and
isomerization.
The conjugation reactions, with a resultant thioether product, involve either substitution
or addition reactions. The nucleophilic attack of GS" on the aromatic carbon of 1-chloro-
2,4-dinitrobenzene, results in the nucleophilic displacement of a chloro substituent, and
is an example of the former type of reaction. The conjugation of glutathione with the afi-
unsaturated carbonyl compound ethacrynic acid, on the other hand, is an example of an
addition reaction. In this case the glutathione reacts additively with the yS-carbon atom of
an activated a/3 double bond (Boyland and Chasseaud, 1969). These two reactions are
depicted in Figure 1.03. Various epoxides also undergo addition reactions in which the
nucleophilic attack of glutathione results in the opening of an oxirane ring (Fjellstedt ef a/.,
1973).
GST-mediated hydroperoxide reduction involves a nucleophilic attack at an electrophilic
oxygen. This reaction is believed to occur in two stages involving the enzymatic formation
of an unstable sulphenic acid intermediate (GSOH), followed by the non-enzymatic
nucleophilic attack of a second molecule of GSH to form glutathione disulphide (GSSG)
and water (Prohaska et al., 1980). The conversion of the GST substrate cumene
hydroperoxide to the corresponding cumyl alcohol is shown in Figure 1.03. GSH may be
regenerated from GSSG by the action of glutathione reductase:
GSSG + NADPH + H+ -» 2GSH + NADP+
The GST catalysed reduction of hydroperoxides represents selenium-independent
glutathione peroxidase activity. The enzymes responsible for this activity will only act
upon organic hydroperoxides, unlike selenium-dependant glutathione peroxidase which
also utilizes H202 as a substrate (Laurence and Burk, 1976).
10
Figure 1.03 Examples of GST catalysed reactions
Panels a, b, c and d depict various types of reaction catalysed by GST:
a) The conjugation of glutathione to 1-chloro-2,4-dinitrobenzene involving a substitution
reaction at an electrophiiic carbon atom.
b) The conjugation of glutathione to ethacrynic acid involving an addition reaction at an
electrophiiic carbon.
c) Glutathione-mediated reduction of cumene hydroperoxide following an attack at an
electrophiiic oxygen.


































Certain GST also catalyse the isomerization of a double bond system as in the conversion
of A5 androstene-3,17-dione to A4 androstene-3,17-dione (Figure 1.03). In this type of
reaction GSH acts as a co-enzyme and is not consumed; it is thought that an unstable
GSH adduct is formed which, upon decomposition, releases GSH and the more stable
isomer (Habig, 1983). Compounds which contain electrophilic nitrogen (eg. organic
nitrate esters) and sulphur atoms (eg. organic thiocyanates and disulphides) are also
targets for GST catalysed reactions (Keen et al., 1976).
1.04b Characterization of enzymes using different substrates
Individual GST forms have distinct catalytic properties and those enzymes which are
structurally related often posses characteristically high specific activities with particular
compounds (Mannervik eta!., 1985). For example, both rat and human Alpha-class GST
demonstrate high peroxidase activity towards cumene hydroperoxide (Hayes efa/., 1987a;
Stockman et a!., 1987). Steroid isomerase activity, with the model substrate A5
androstene-3,17-dione, is also a characteristic of certain rat and human Alpha-class GST
(Benson efa/., 1977; Hayes efa/., 1987a). In general, Mu-class enzymes have been found
to be the most active of the GST towards epoxides (Mannervik efa/., 1985). Styrene oxide,
a metabolite of the chemical industry product styrene, has been shown to be a good
substrate for human hepatic Mu-class GST (Warholm efa/., 1983). Pi-class GST, on the
other hand, are distinguished by their relatively high activity towards ethacrynic acid
(Mannervik et a!., 1985; Stockman et al., 1987). Compounds used recently for the
identification of Theta-class GST include 1-menaphthyl sulphate (Hiratsuka et al., 1990)
and 1,2-epoxy-3-(p-nitrophenoxy)propane (Meyerefa/., 1984, 1991).
Information on substrate specificities may also be useful in distinguishing between GST
isoenzyme forms within a class. Substrates which have been found to discriminate
between individual members of the rat Mu-class GST include frans-4-phenyl-3-buten-2-
one, 1,2-dichloro-4-nitrobenzene and bromosulphophthalein (Hayes, 1986). The structures
of the compounds which are characteristic for Mu- and Theta-class GST are shown in
Figure 1.04.
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Many xenobiotic electrophiles have the potential to react with cellular macromolecules and
thereby cause a variety of toxic effects including mutations and cancer. Complex drug
metabolizing enzyme systems exist, within the cell, in order to combat this challenge.
These enzymes, which catalyse the activation and detoxification of xenobiotics, are
generally described as phase I and phase II. Phase I metabolism includes oxidation,
reduction, hydrolysis and hydration reactions, whereas phase II enzymes catalyse various
types of conjugation reactions. It is thought that phase I reactions create a reactive
functional group on the molecule which may subsequently be attacked by the phase II
enzymes (Gibson and Skett, 1986). The microsomal mixed function oxidase (MFO)
system performs many different phase I "functionalization" reactions and the reactive
intermediates formed by this oxidative metabolism may then be detoxified by conjugation
reactions which include glucuronidation, sulphation, methylation and acetylation as well
as glutathione conjugation. The xenobiotic compounds which are present in the
environment arise as products of the chemical industry, pollutants, natural products and
therapeutic drugs.
1,05a The detoxification of mutagens and carcinogens by GST
The polycyclic aromatic hydrocarbons (PAH) are common environmental pollutants which
have been implicated as aeteological factors in human chemical carcinogenesis (IARC,
1983, 1984). One such PAH which has been studied extensively is benzo(a)pyrene
(Gelboin, 1980). The metabolic activation of this compound to various reactive
intermediates, including epoxides, phenols and quinones, is performed by the
cytochrome-P450-containing mixed function oxidase (MFO) system. Subsequent
metabolic steps may involve the hydration of epoxides to dihydrodiols, mediated by the
enzyme epoxide hydrolase, which may be followed by further oxygenation of these
compounds to form diol epoxides.
Several of the reactive intermediates arising during the metabolism of benzo(a)pyrene
have been shown to be Mu-class GST substrates (Figure 1.05). A human hepatic Mu-
class enzyme , identified first in 1980 (Warholm etal., 1980), was subsequently shown to
have a high specific activity, in comparison with Alpha- and Pi-class enzymes, towards
benzo(a)pyrene 4,5-oxide (Warholm et al., 1981, 1983). This compound and other K-
region epoxides yield positive results in bacterial mutagenicity tests although they have
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Figure 1.05 Metabolism of benzo(a)pyrene
The metabolic activation of the polycyclic aromatic hydrocarbon benzo(a)pyrene (BP) may
involve the formation of the mutagenic compounds BP-4,5-oxide and/or BP-7,8-diol-9,10-
epoxide (BPDE). Both of these reactive intermediates have been shown to be substrates
for GST enzymes. Microsomal mixed function oxidases (MFO) catalyse the initial
epoxidation reactions to form either BP-7,8-oxide or BP-4,5-oxide. Hydration of BP-7,8-
epoxide, mediated by epoxide hydrolase (EH), results in the formation of BP-7,8-diol. This
compound may then be reactivated by the MFO to form BPDE. GST catalysed





not been directly implicated in carcinogenesis (Coles and Ketterer, 1990). The "Bay
region" epoxides, on the other hand, are responsible for the carcinogenic effect of PAH
(Jerina and Lehr, 1977). Glutathione conjugation has been shown to be an important
protection mechanism against the DNA binding of the "Bay region" diol epoxide
benzo(a)pyrene-7,8-diol-9,10-oxide (BPDE) (Hesse et al., 1982). The GST which have
high activity towards this metabolite include a rat Mu-class enzyme (Jernstrom et al.,
1985), and human Mu- and Pi-class enzymes (Robertson etal., 1986). It is of interest that
the nucleophilic attack of GSH on both K-region and "Bay region" epoxides occurs
stereoselectively. For instance the conjugation of GSH with BPDE catalysed by rat Mu-
class GST Yb2Yb2 is selective towards the biologically most active (-t-)-enantiomer
(Robertson and Jernstrom, 1986).
Although the formation of epoxide metabolites of PAH's is regarded as a major metabolic
pathway yielding carcinogenic compounds the existence of an alternative activation
mechanism, involving the formation of reactive sulphate esters, has recently been
demonstrated (Watabe et al., 1986; Okuda et al., 1989). The bioactivation of
benz(a)anthracene and chrysene, PAH which are regarded as weak carcinogens, involves
methylation followed by enzymic oxidation at the methyl carbon, mediated by microsomal
monooxygenases, to yield the corresponding hydroxymethylarenes. These potent
carcinogens may then be further activated by hydroxysteriod sulphotransferase to the
corresponding reactive sulphate esters (Watabe et al., 1987; Okuda et al., 1989). The
metabolically formed sulphate esters react with purine bases on both calf thymus and
preweanling rat DNA (Watabe etal., 1985; Surh etal., 1987). GSH conjugation, mediated
by GST present in rat hepatic cytosol, has been shown to inactivate both 5-hydroxymethyl-
chrysene sulphate and 7,12-dihydroxymethylbenz(a)anthracene sulphate and inhibit the
formation of DNA adducts (Okuda et al., 1986; Watabe et al., 1987). The metabolic
activation and inactivation of 5-methylchrysene, an environmental pollutant found in
tobacco smoke, is depicted in Figure 1.06.
Sato and colleagues have recently used GST activity towards 5-hydroxymethylchrysene
sulphate to identify at least three hepatic cytosolic isoenzymes in the rat (Hiratsuka etal.,
1990). The major form which is active with this substrate has been purified and
designated GST YrsYrs. It was found to posses enzymic activity towards a number of
reactive sulphate esters including 1-menaphthyl sulphate, a compound which had been
used earlier for the identification of rat liver GST M (Gillham, 1973).
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Figure 1.06 Metabolic activation and inactivation of 5-methylchrysene
5-Hydroxymethylchrysene (5-HCR) is a major metabolite of 5-methylchrysene in rat liver.
In the presence of a S'-phosphoadenosine s'-phosphosulphate (PAPS)-generating system
this compound may be activated to the highly mutagenic sulphate conjugate, 5-HCR
sulphate, by rat liver sulphotransferase. The conjugation of GSH to 5-HCR sulphate























1.05b The conjugation of glutathione with therapeutic drugs
A number of alkylating agents, used as chemotherapeutic drugs, have been shown to
serve as GST substrates. These include the nitrogen mustards melphalan (Dulik and
Fenselau, 1987), chlorambucil and cyclophosphamide (Colvin and Hilton, 1988) and the
nitrosourea 1,3-bis(2-chloroethyl)-1 -nitrosourea (Smith et al., 1989). The emergence of
drug resistant cell populations following treatment with these and other agents is often a
major obstacle to effective cancer chemotherapy. The cytotoxic effect of many of the anti¬
cancer drugs is mediated by the action of drug metabolising enzymes, which include the
GST. Changes in the levels of expression of these enzymes are likely, therefore, to be an
important mechanism which leads to alterations in the sensitivity of cells to cytotoxic
chemicals.
Many mammalian cell models have been studied where an increased resistance to
cytotoxic insult is accompanied by the over-expression of GST enzymes (for a review see
Hayes and Wolf, 1988). In one such study rat Mu-class GST were shown to be elevated
in a rat brain tumour cell line which was resistant to 1,3-bis(2-chloroethyl)-1 -nitrosourea
(BCNU). When purified rat Alpha-, Mu- and Pi-class GST were analysed for their ability
to detoxify BCNU, Mu-class isoenzymes were found to be the best catalysts of the
denitrosation reaction (Smith eta/., 1989). Recently, in an attempt to obtain more direct
evidence on the involvement of GST in drug resistance, some workers have performed
cDNA transfection experiments. One of these studies showed that the transfection of
cDNA's encoding human Alpha- and Pi-class GST confers resistance to both chlorambucil
and the anthracycline adriamycin to yeast cells (Black et al., 1990). A similar approach
has also demonstrated that mammalian cells transfected with full length cDNA's for human
Pi-class and rat Alpha- and Mu-class GST provide a decrease in sensitivity to the nitrogen
mustards chlorambucil and melphalan (Puchalski and Fahl, 1990).
1.06 Endogenous substrates
Oxidative metabolism in aerobic organisms results in the production of a number of highly
reactive molecular species. It has, therefore, been proposed that glutathione and
glutathione-dependant enzymes originally evolved in order to deal with the inactivation of
the toxic products of oxygen metabolism (Mannervik, 1986). Some of the endogenous
electrophiles which have been investigated as potential natural substrates for the GST are
discussed below.
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1.06a GST and protection against lipid and DNA peroxidation
The peroxidation of lipid biomembranes occurs following the attack of free radicals upon
the polyunsaturated fatty acyl moieties. In the presence of oxygen this can lead to chain
propagation reactions involving lipid peroxy radicals and hydroperoxides. If this process
is unimpeded the consequences include the release of toxic breakdown products and the
eventual destruction of the lipid component of biological membranes (Slater, 1984). This
process can be prevented by the intervention, at various points, of a number of different
enzymes, including selenium-dependant glutathione peroxidase, catalaseand superoxide
dismutase.
A possible protective role of GST isoenzymes, that involves their selenium-independent
glutathione peroxidase activity, has been investigated. Some workers have demonstrated
that the consecutive action of the enzyme phospholipase Aa, which releases fatty acyl
hydroperoxides from peroxidized phospholipids, and certain rat Alpha-class GST, which
reduce these free fatty acid hydroperoxides, is sufficient for the inhibition, in vitro, of
microsomal lipid peroxidation (Tan et a!., 1984). It was subsequently reported that a
number of purified rat GST had activity towards hydroperoxides of linoleic acid and
arachidonic acid, two polyunsaturated fatty acids which are abundant in biological
membranes (Ketterer etal., 1987). Rat Alpha- and Pi-class GST and an isoenzyme called
GST 5-5, which has recently been ascribed to the Theta-class, were shown to have the
highest specific activities towards these fatty acid hydroperoxides.
One class of highly toxic compounds which are by-products of lipid peroxidation are the
4-hydroxy unsaturated aldehydes or 4-hydroxyalkenals (Esterbauer et al., 1982). A
number of mammalian GST isoenzymes are highly efficient in the detoxification of these
compounds (Danielson etal., 1987). The most active of the GST towards the biologically
active compound 4-hydroxynonenal is a rat Alpha-class GST called YkYk (Jensson etal.,
1986). However, certain rat and human Mu-class GST have also been shown to express
a significant amount of activity towards this substrate (Alin et al., 1985b; Danielson et al.,
1987). Cholesterol a epoxide is a further example of a by-product of lipid peroxidation
which is a possible natural substrate for the GST. The conjugation of glutathione to this
weakly mutagenic compound, is catalysed by rat Alpha-class GST (Meyer and Ketterer,
1982).
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Figure 1.07 Endogenous GST substrates
Panels a, b and c depict the following GST catalysed reactions:
a) Reduction of 9-hydroperoxy-linoleic acid
b) Glutathione conjugation of 4-hydroxyalkenal
c) Reduction of 5-hydroperoxymethyl uracil
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DNA is also susceptible to free radical attack during oxidative stress. The participation
of GST isoenzymes in the detoxification and repair of the potentially mutagenic radical
damage to DNA has been studied by a number of workers. Both thymine hydroperoxides
and DNA peroxidized by exposure to ionising radiation in the presence of oxygen have
been shown to be GST substrates (Tan ef a/., 1986, 1988). However, these workers
reported that the specificity of rat GST isoenzymes for the peroxidized DNA was different
from that towards the free thymine hydroperoxide 5-hydroxymethyl uracil. Certain rat
Alpha- Mu- and Pi-class enzymes had a high activity towards 5-hydroxymethyl uracil
whereas, two different Mu-class GST and the Theta-class GST 5-5 demonstrated activity
towards DNA hydroperoxide (Tan ef a/., 1988). Some of the GST catalysed reactions
described above are depicted in Figure 1.07.
1.06b Other endogenous reactions catalysed by GST
GST isoenzymes have been shown to catalyse in vitro a number of reactions which are
of physiological importance. For example the product of the GST-mediated isomerization
reaction involving A5 androstene-3,17-dione (see Figure 1.03d) is a precursor for
testosterone.
The biologically active cysteine-containing leukotriene C4, D4 and E4 are presumed to
mediate anaphalactic and allergic reactions. Leukotriene C4 is formed from leukotriene
A4 following the conjugation of glutathione to an epoxy group on the parent compound.
The identity of the GST responsible for this leukotriene C synthase activity has not been
fully established. A rat microsomal GST present in basophilic leukaemia cells and purified
human cytosolic GST from classes Alpha, Mu and Pi have all been shown to posses
catalytic activity towards leukotriene A4 (Bach efa/., 1984; Soderstrom ef a/., 1985). More
recently, however, evidence for the existence of a distinct microsomal enzyme, with a high
leukotriene C synthase activity, in mastocytoma cells from the mouse has also been
presented (Soderstrom efa/., 1988).
The hydroxy endoperoxide prostaglandin (PG) H2 may undergo three different glutathione-
dependant conversions in order to form biologically active compounds. The precursor
molecule can be reduced to PGF2a or isomerized to PGD2 or PGE2. All three reactions
are catalysed by rat cytosolic GST in vitro (Christ-Hazelhof ef a/., 1976; Chang efa/., 1987;
Meyer and Ketterer, 1987).
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Chapter 2 Glutathione S-transferase isoenzymes
2.01 Multiple GST forms
2.01a Cytosolic classes of GST
In all of the mammalian species examined to date the GST are represented by a large
number of isoenzymes. Historically, the multiple forms of GST which are present in rat
and human cytosol were each assigned to several different groups or classes. The rat
enzymes have been classified, according to their immunochemical properties, as
belonging to groups I, II and III (Hayes and Mantle, 1986a), whereas, the human GST were
originally subdivided, on the basis of their charge, into the basic, near-neutral and acidic
forms (Mannervik, 1985).
Mannervik and co-workers undertook a comparison of the catalytic properties, immuno¬
chemical cross-reactivities and N-terminal amino acid sequences of the major cytosolic
enzymes from several mammalian species (Mannervik ef a/., 1985). This work clearly
demonstrated the existence of relationships between the groups of isoenzymes previously
identified in rodents and humans, and led to the general acceptance of a species-
independent classification system. Three evolutionary classes of GST, designated Alpha,
Mu and Pi, were identified, and these represent the rat group I, II and III enzymes and the
human basic, near-neutral and acidic GST, respectively. Recently, several rat isoenzymes
have been described which belong to a fourth cytosolic class of GST, which has been
called Theta by some workers (Meyer etal., 1991). Detailed information on the existence
of Theta-class GST in species other than the rat has yet to be obtained.
2.01b Rat GST nomenclature
The cytosolic GST exist as homodimeric and heterodimeric proteins which have physical
and enzymatic properties which reflect their subunit composition. Therefore, the systems
of nomenclature which have been favoured by most workers in this field are those which
take account of the quaternary structure of the enzymes. Two classification systems are
currently used to describe the rat cytosolic GST, one based on the relative mobilities of
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the individual subunits on SDS/PAGE (Bass et al., 1977), and a second in which the
subunits have been assigned Arabic numerals in chronological order of their isolation and
characterization (Jakoby et al., 1984).
Bass et al. (1977) originally identified three types of GST subunit present in rat liver
cytosol, which were termed Ya, Yb and Yc in the order of their relative mobilities on
SDS/PAGE. Subsequent studies into the GST content of rat liver and other tissues have
revealed the existence of other subunit types, including Yf, Yk, Yn, Yl, Yo and Yrs (Hayes,
1986, 1988; Hayes and Mantle, 1986a, 1986b; Ishikawa et al., 1988; Hiratsuka et al.,
1990). Improvements in protein purification and the application of molecular cloning
techniques has also revealed the existence ofmultiplicity within certain GST subunit types.
This multiplicity has been documented for the Ya-type subunits (Rothkopf et al., 1986;
Hayes etal., 1990), Yc-type subunits (Hayes etal., 1991), Yb-type subunits (Hayes, 1984;
Ding etal., 1986) and Yn-type subunits (Ishikawa etal., 1988). In addition, several rat GST
have been described which have not, as yet, received a "Y1 designation. These include
the Theta-class GST 5-5 and GST 12-12, which were previously co-purified and
designated GST E (Meyer et al., 1984, 1991).
The inter-relationship between the "Y1 designations and the numerical designations of the
multiple GST subunits, together with their species-independent class designations, are
shown in Table 2.01. The system of nomenclature used when discussing rat GST in this
thesis will be that which describes the subunit types according to their mobility on
SDS/PAGE (Hayes, 1986; Hayes and Mantle, 1986a, 1986b).
2.01c Human GST nomenclature
Several systems of nomenclature have been adopted by workers in different laboratories
for the classification of the human GST isoenzymes. Kamisaka et al. (1975) originally
described five basic (Alpha-class) forms of GST in human liver which were assigned
Greek alphabetical symbols {a, /3, y, <5 and e). Following the identification of near-neutral
(Mu-class) GST in liver, and acidic (Pi-class) GST in placenta, the additional forms were
also designated by the Greek symbols n, y>, 0 and n (Guthenberg et al., 1979; Warholm
etal., 1981; Singh etal., 1987a; Stockman and Hayes, 1987; Hayes, 1989).
Further studies on the hepatic basic GST determined the subunit composition of these
enzymes (Stockman etal., 1985). This allowed a system of nomenclature, which is based
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Table 2.01 Nomenclatures for the rat cytosolic GST subunits
Class Subunit1"6 Subunit Mr1"7 Numerical
Designation714






Mu Yb, 26300 3
Yb2 26300 4
Yn, or Yb3 26000 6
Yn2 26000 9
Yo 26500 11
Pi Yf or Yp 24800 7




1. Hayes ef al., 1990
2. Hayes and Mantle, 1986a
3. Hayes ef a/., 1991a
4. Hayes, 1988
5. Ishikawa et al., 1988
6. Hiratsuka ef al., 1990
7. Meyer ef a/., 1984
8. Jakoby ef al., 1984
9. Meyer ef a/., 1985
10. Guthenberg ef al., 1985
11. Jensson ef al., 1986
12. Ketterer ef al., 1988
13. Kispert ef a/., 1989
14. Meyer ef a/., 1991
Abbreviations: N.I., not included
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upon the quaternary structure of the proteins, to be proposed for the human Alpha-class
GST. This system describes three enzymes formed by the combination of two structurally
and immunologically distinct subunits called B, and B2 (Stockman et al., 1985, 1987;
Hayes et al., 1989). The homodimeric enzyme GST B^, represents GST e, and the
heterodimer 6,62 is equivalent to GST <3. However, the relationship of B2B2 to the
enzymes described by Kamisaka etal. (1975) is less clear; this homodimeric enzyme is
probably equivalent to GST a, /S and 7, three forms which may have arisen following the
autoxidation of a single gene product.
The human GST have also been named according to their pi value. Del Boccio et al.
(1987) have described a very basic enzyme, called GST 9.9, purified from human skin
which has an identical N-terminal amino acid sequence to that of the rat Alpha-class
enzyme GST Yc,Yc,.
Other workers, who have taken a genetic approach to the classification of the human GST
have numbered the enzymes, according to their gene loci, using evidence obtained from
zymogram analysis (Board, 1981; Strange et al., 1984). This approach has given rise to
the designation GST1, GST2 and GST3 , which are the loci encoding enzymes of the Mu-
class, Alpha-class and Pi-class GST respectively. Similar investigations into a number of
different human tissues indicated the existence of at least three more gene loci termed
GST4, GST5 and GST6 (Laisney et al., 1984; Suzuki et al., 1987). Later reports have
shown that GST4 and GST6 encode enzymes that belong to the Mu evolutionary class
(Board etal., 1988; Suzuki etal., 1991).
A list of the major human cytosolic GST described in the literature is given in Table 2.02.
2.02 Human Alpha-class GST
The expression of human GST isoenzymes is subject to both inter-organ and inter-
individual variation (Laisney ef al., 1984; Strange etal., 1984; Suzuki etal., 1987; Corrigal
and Kirsch, 1988). The highest levels of Alpha-class GST are found in liver, however,
significant amounts of the basic enzymes are also present in human testis, kidney and
adrenal glands (Tateoka etal., 1987; Singh etal., 1987b; Aceto et al., 1989; Meikle et al.,
1992).
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Table 2.02 Nomenclatures for the human cytosolic GST Isoenzymes
Class Isoenzyme1"7 Locus7"9










1. Stockman et al., 1985
2. Del Boccio et al., 1987
3. Warholm et al., 1983
4. Hayes, 1989
5. Stockman and Hayes, 1987
6. Guthenberg et al., 1979
7. Board ef a/., 1988
8. Board, 1981
9. Strange ef al., 1984
A number of workers have purified the hepatic Alpha-class GST and shown that they are
represented by multiple isoenzymes. Kamisaka etal. (1975) originally observed five basic
forms of GST (a-e) which had different pi values but were indistinguishable by other
criteria. It was, therefore, proposed that these enzymes were charge isomers formed as
a result of deamination in vivo of a single gene product. Subsequent studies have shown,
however, that the basic forms of GST present in human liver comprise two immuno-
chemically and catalytically distinct subunits (Stockman et al., 1985, 1987; Soma et al.,
1986). These subunits may combine to form two homodimeric enzymes, which have been
designated GST B,B, and GST B2B2, and one heterodimeric enzyme, called 6,62
(Stockman etal., 1985, 1987). In contrast to these reports, Vander Jagt etal. (1987) have
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described the isolation of 13 Alpha-class enzymes from a number of different liver
specimens. However, it is likely that these forms do not represent separate enzymes but
are multiple forms generated by the purification strategy (see Hayes et al., 1989).
Several groups of workers have investigated the GST isoenzyme content of different
tissues using starch-gel electrophoresis combined with an activity stain. This type of
zymogram analysis also revealed the existence of three electrophoretically distinct cationic
GST enzymes in human liver (Board, 1981; Strange etal., 1984). These three forms were
originally thought to be the product of one gene locus which was designated GST2. The
reports published at this time, however, presented conflicting evidence as to whether the
separate enzymes which were observed had arisen following the post-translational
modification of a single gene product (Laisney et al., 1984; Strange et al., 1984) or as to
whether they were formed from the combination of two allelic products (Board, 1981).
Molecular cloning studies, which allowed the investigation of human Alpha-class GST at
a nucleic acid level, were also undertaken during this period. Tu and his colleagues
described two separate full-length cDNA clones, called GTH, and GTH2, which both
encoded human Alpha-class GST subunits (Tu and Quain, 1986; Rhoads et al., 1987).
Independently, Board and Webb (1987) cloned a cDNA which encoded the same GST
subunit as the cDNA clone described by Tu and Quain (1986). An analysis of the
deduced amino acid sequences from these two human Alpha-class genes indicates that
they encode two highly homologous subunits which differ in only 11 amino acids. A direct
molecular relationship between the human Alpha-class cDNA clones described in the
literature and the basic isoenzymes which may be purified from human liver was
established following protein sequencing experiments. Hayes et al. (1989) showed that
the amino acid sequences obtained from CNBr-derived peptides from GST subunits B,
and B2 were virtually identical to the deduced amino acid sequences of the cDNA clones
GTH, and GTH2 (Rhoads et al., 1987), respectively.
At the present time it is unambiguous that there are at least two Alpha-class GST subunits
which are the products of two separate gene loci (Board and Peirce, 1987; Hayes et al.,
1989). The chromosomal location of the genes which encode these human Alpha-class
enzymes has been investigated using in situ hybridization techniques. Separate studies
have indicated that the genes are clustered on the short arm of chromosome 6 at band
p12 (Board and Webb, 1987; Chow et al., 1988).
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The possibility that there are additional human Alpha-class GST has also been the subject
of investigation. One group of workers have documented the existence of an Alpha-class
isoenzyme which is distinct from the hepatic GST. Del Boccio et al. (1987) purified a very
basic GST from human skin which has a close relationship to the rat GST Yc,Yc, (or 2-2).
It is also of interest that the polymorphic expression of a similar GST has been observed
in human prostate (Di lllio et al., 1990). At a nucleic acid level, Southern blotting
experiments, using a cDNA encoding the GST B, subunit, have revealed hybridization
patterns that indicate that there may be multiple Alpha-class genes in the human genome
(Board and Webb, 1987).
2.03 Human Mu-class GST
In man, the GST which comprise the Mu evolutionary class have been the subject of
particular interest due to the polymorphic expression of certain of the isoenzyme forms.
However, the multiplicity of the Mu-class GST, together with the variability in their
expression has given rise to some confusion in the literature. Workers in this field have
used a number of different approaches in order to analyze these isoenzymes. Some have
studied the levels of GST expression in various human tissue extracts obtained from large
populations using zymogram analysis, whereas others have attempted to purify and
characterize the individual isoenzymes. A more recent approach has involved the
application of molecular cloning techniques to the study of the Mu-class genes.
2.03a Genetic population studies
In an early investigation into the genetic basis of the expression of multiple GST
isoenzymes in man, Board (1981) used zymogram analysis to examine the enzyme levels
in liver cytosol extracts from a large number of individuals. This electrophoretic analysis
indicated that the hepatic GST were the products of three separate gene loci, termed
GST1, GST2 and GST3. Subsequent studies have demonstrated that the GST1 enzymes
fall within the Mu-class (Suzuki et al., 1987; Board et al., 1988).
The initial electrophoretic study undertaken by Board (1981) showed that the products of
the GST1 locus were represented by three activity bands which were subject to
phenotypic variation. The most acidic of these enzymes was termed GST1 type 1 and the
least acidic was termed GST1 type 2. These workers proposed that the isoenzyme with
an intermediate mobility was a heterodimeric protein formed by the combination of GST1
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type 1 and type 2 subunits. This type of analysis also revealed that a large number of
individuals did not express any of the GST1 isoenzymes. A statistical analysis of the data
obtained indicated that the different phenotypes observed were attributable to different
combinations of three autosomal alleles, including a null, at a single gene locus.
Other workers subsequently confirmed this genetic model and extended this type of
investigation to include the analysis of GST activity in tissues other than liver (Strange et
al., 1984; Laisney et a!., 1984). These studies showed that the GST1 phenotype was a
constant individual characteristic which was observed in all of the tissues which had
detectable levels of these enzymes. The report by Laisney et al. (1984) also included a
description of two additional GST forms, called GST4 and GST5, which were present in
certain extra-hepatic tissues. Both of these forms were thought to be the products of an
independent gene locus. GST4 was shown to be abundant in skeletal muscle, but was
also observed in a number of other tissues. GST5 was present in brain and also weakly
observed in lung. No phenotypic variation in the expression of these two GST enzymes
was reported by these investigators. This study also provided evidence for the existence
of a molecular relationship between the GST1 and GST4 isoenzymes. These workers
described electrophoretic bands which apparently represented heterodimeric proteins
formed by the combination of GST1 subunits and GST4 subunits.
In a later study, which also incorporated the use of starch-gel electrophoresis, Suzuki et
al. (1987) described enzymes which were similar to the GST4 and GST5 forms observed
earlier, together with an additional form, termed GST6. A number of differences were
apparent, however, between the results of this study and those of the previous report.
Unlike Laisney et al. (1984), these workers did not detect heterodimeric GST formed as
a result of the combination of GST1 and GST4 subunits. This investigation also provided
evidence for an association between the expression of GST5 and GST1 type 1, which had
not been observed by Laisney et al. (1984).
2.03b The polymorphic expression of Mu-class GST: An association with susceptibility
to cancer?
A characteristic feature of human hepatic Mu-class GST is their high glutathione
conjugating activity towards certain mutagenic epoxides, including benzo(a)pyrene-4,5-
oxide and styrene 7,8-oxide. This has led to the suggestion that an enzyme responsible
for this activity may play an important role in the protection against carcinogenic
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compounds (Warholm et al., 1983). The genetic polymorphism associated with human
Mu-class isoenzymes has been well documented (Warholm et al., 1980; Board, 1981;
Strange etal., 1984; Laisney etal., 1984; Seidegard and Pero, 1985; Hussey etal., 1987).
The influence that this deficiency may have on an individuals susceptibility to the toxic
effect of various xenobiotics has also been the subject of intense investigation.
A number of different workers have quantitated the expression of Mu-class GST using
several different methods of analysis, including the starch-gel electrophoresis (Board,
1981; Strange etal., 1984; Laisney etal., 1984) and specific radioimmunoassay (Hussey
etal., 1987). A wide variation in the frequency of the nulled phenotype has been reported
both within and between different racial groups (Table 2.03). One method which has
been introduced for the detection of certain Mu-class enzymes is the measurement of GST
activity towards frans-stilbene oxide in mononuclear leukocytes (Seidegard and Pero,
1985; Seidegard et al., 1987). Seidegard and co-workers used this activity assay to asses
the degree of protection afforded by the expression of Mu-class GST against the chemical
carcinogens present in cigarette smoke. In two separate studies, these workers
demonstrated significant differences between the distribution of trans-stilbene oxide
activity in populations of control smokers and populations of lung cancer patients
(Seidegard etal., 1986,1990). These investigators concluded that the expression of Mu-
class GST may be used as a marker for susceptibility of an individual to lung cancer.
Recently, Strange et al. (1991) used a starch-gel zymogram approach to compare the
frequency of the Mu-class GST null allele in controls and a group of patients with
adenocarcinoma of the stomach or colon. In support of the findings of Seidegard et al.
(1986, 1990), these workers also observed an increase in the frequency of the null
phenotype in patients with carcinoma. However, there are several reports in the literature
which contain contradictory evidence about the expression of Mu-class GST in patients
with cancer. Peters et al. (1990) used an immunochemical detection method for the
measurement of GST in mononuclear blood cells, and demonstrated that their were no
significant differences in the distribution of Mu-class enzymes in patients with breast or
colon cancer, as compared to controls.
The polymorphism associated with human Mu-class GST has also been investigated at
a genomic level using Southern blotting analysis. Seidegard etal. (1988) showed that the
null phenotype correlated with the absence of a hybridization to a cDNA probe encoding
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Table 2.03 The frequency of the Mu-class GST null phenotype




Caucasian 23 40 Warholm et al., 1980
Caucasian 40 65 Board, 1981
Caucasian 49 41 Strange et al., 1984
Caucasian 56 43 Laisney et al., 1984
Caucasian 248 54 Seidegard and Pero, 1985
Caucasian 42 45 Hussey et al., 1987
Chinese 96 58 Board, 1981
Indian 43 35 Board, 1981
Japanese 168 49 Harada et al., 1987
a hepatic Mu-class GST. In a recent study, one group of workers have used a genotyping
assay, which involved this kind of analysis, to investigate the association between Mu-
class GST polymorphism and the susceptibility of an individual to lung cancer (Zhong et
a/., 1991). In contrast to the findings of Seidegard et al. (1986,1990), these workers saw
similar distributions of the null allele in both a control population and a large group of lung
cancer patients.
The data obtained from the investigations mentioned above are summarised in Table 2.04.
The differences observed between the findings of these studies means that the
consequences of the Mu-class GST polymorphism remain ill-defined.
2.03c Mu-class isoenzymes
A neutral GST that was distinct from the five basic forms (GST a-e) purified earlier
(Kamisaka et al., 1975) was first identified in human liver in 1980 (Warholm et al., 1980).
This isoenzyme was characterized by its high activity towards the substrate frans-4-phenyl-
3-buten-2-one and the fact that it was only present in the livers of some individuals.
Warholm etal. (1981,1983) subsequently purified and characterized this new form, called
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Table 2.04 The frequency of the Mu-class GST null phenotype in carcinoma
patients




Control smokers 192 42 Seidegard et al.,
Lung cancer patients 191 62 1986,1990
Controls 49 41 Strange et al.,
Adenocarcinoma patients 45 67 1984,1991
Controls 64 38 Peters et al., 1990
Carcinoma patients 106 31
Control smokers 225 42 Zhong et al., 1991
Lung cancer patients 228 43
GST p, and showed that it had both chemical and physical properties that distinguish it
from hepatic GST a-e and a placental form called GST n. The neutral enzyme was also
found to be highly efficient at catalysing the conjugation of glutathione with the epoxides
benzo(a)pyrene-4,5-oxide and styrene 7,8-oxide.
A number of isoenzymes which are related to GST p have since been identified. A
hepatic enzyme, called GST \p, has been purified in several laboratories (Singh et al.,
1987a; Hayes etal., 1987b), and it has been shown that this homodimeric protein has an
identical N-terminal amino acid sequence to that of GST p (Alin et al.t 1985a; Hayes,
1989). The expression of this additional Mu-class form in human liver is also subject to
variation (Hussey et a/., 1986). It is now generally accepted that GST p and GST ip
represent allelic variants encoded by the GST1 locus which was earlier identified by Board
(1981) and Strange et at. (1984). Less information is available on the heterodimeric
enzyme formed by the combination of "p-type" and >-type" subunits. The existence of
this isoenzyme has been demonstrated by means of starch-gel electrophoresis and
chromatofocusing (Strange et a/., 1984; Faulder et al., 1987), however, so far, it has not
been fully characterized. A third hepatic Mu-class enzyme, named GST <p, was identified
by Stockman and Hayes (1987). This isoenzyme, which was present in only one of 20
livers examined by these workers, was shown to be immunologically related to GST p and
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GST y. It was, however, distinguished from these forms by its lower isoelectric point and
the fact that, unlike GST p and GST q>, it has a blocked N-terminus (Stockman and Hayes
unpublished information).
Several extra-hepatic GST, which were initially identified using starch-gel electrophoresis
(see section 2.03a), were purified and characterized to a limited extent by Board and co¬
workers (Suzuki efa/., 1987). An enzyme, called GST4, was isolated from human skeletal
muscle and shown to be immunologically related to GST p, and to have N-terminal amino
acid sequence homology with GST p (Board et al., 1988). Two further forms, termed
GST5 and GST6, were purified from brain by this group of workers (Suzuki efa/., 1987).
GST5 was shown to be a homodimeric enzyme that is structurally similar to the products
of the GST1 locus. GST6, on the other hand, was an immunochemically distinct protein
which contained two dissimilar subunits.
Others (Singh efa/., 1988) have isolated novel GST from skeletal muscle with N-terminal
sequences which are similar to those of GST p. However, a major muscle form identified
by these investigators, and called GST £ ,was unrelated to Alpha-, Mu- or Pi-class GST
and possessed a blocked N-terminus.
2.03d Mu-class GST genes
Human Mu-class genes have been located on both chromosome 1 and chromosome 3.
DeJong et al. (1988) carried out in situ hybridization using a cDNA encoding a human
hepatic Mu-class GST and showed that the human Mu-class genes were clustered in
region p31 of chromosome 1. In contrast, using a panel of human-rodent somatic cell
hybrids and two different rat Mu-class cDNA probes, Islam etal. (1989) assigned Mu-class
genes to chromosome 3. The second group of workers postulated that they had mapped
the Mu-class loci, GST4 and GST5, which had been previously identified by Laisney etal.
(1984) and Suzuki etal. (1987).
Two cDNA clones encoding hepatic Mu-class isoenzymes have been isolated and
sequenced by Seidegard etal. (1988) and DeJong etal. (1988). The deduced amino acid
sequences from these two clones differ at one residue as a result of a single base
substitution (C_+G) in the coding region of the cDNA. At amino acid residue 172 the
protein encoded by the clone isolated by DeJong efa/. (1988) contains lysine, whereas,
the cDNA described by Seidegard et al. (1988) specifies asparagine at this position. The
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difference between these two protein sequences produces a variation in charge that is
compatible with the difference observed between GST \i and GST y>. Conformation that
the proteins encoded by these two clones do in fact represent the allelic variants encoded
by the GST1 locus was obtained recently following the heterologous expression of both
of these cDNA sequences in E.Coli (Widersten et al., 1991).
Following the hybridization of specific cDNA probes to human genomic DNA, two groups
of workers have shown that the Mu-class GST null phenotype is associated with the
absence of certain restriction fragments (Seidegard et al., 1988; DeJong and Tu, 1990).
This has led to the conclusion that the null allele at the polymorphic Mu-class GST locus
is due to a gene deletion. Southern blotting analysis has also revealed a high level of
complexity in the genomic organization of the human Mu-class genes. This type of
analysis has indicated that there are at least six Mu-class genes present in the human
genome (DeJong and Tu, 1990).
2.04 Human Pi-class GST
In man the Pi-class isoenzyme is widely distributed and represents the most thoroughly
characterized extra-hepatic GST. Pi-class GST have been purified from a number of
sources including placenta (Guthenberg eta!., 1979), lung (Koskeloefa/., 1981; Partridge
etal., 1984) and erythrocytes (Marcus et al., 1978). Although the human Pi-class enzyme
is now commonly referred to as GST n, the forms isolated from placenta, lung and
erythrocytes were originally named GSTyr, GSTX and GST/j, respectively.
Some controversy has existed in the literature regarding the possible existence of more
than one Pi-class GST. The acidic isoenzymes isolated from erythrocytes, lung and
placenta have been shown to share immunological identity and have the same subunit
Mr value and isoelectric point (Koskelo, 1983; Howie et al., 1988). However, using non-
denaturing starch-gel electrophoresis Laisney etal. (1984) and Suzuki etal. (1987) have
shown that an acidic isoenzyme present in erythrocytes has a different mobility to that of
the GST3 enzyme observed in other tissues. Other workers have described two Pi-class
isoenzymes present in skeletal muscle tissue which have minor differences in their
isoelectric point (Singh et al., 1988). It worth noting, however, that GST n, the skeletal
muscle forms and the erythrocyte GST all share an identical N-terminal amino acid
sequence (Alin et al., 1985a; Suzuki et al., 1987; Singh et al., 1988).
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At a nucleic acid level, a number of investigators have isolated cDNA clones encoding a
human Pi-class GST (Kano et al., 1987; Moscow et al., 1988; Board et al., 1989). A
comparison between the deduced amino acid sequence of a human GST n cDNA and
that of the rat GST YfYf shows a very high level of homology (86%) and indicates that they
represent corresponding enzymes in these species (Kano et al., 1987).
The genomic GST n gene has also been cloned and characterized by several workers
(Cowell et al., 1988; Morrow et al., 1989). The chromosomal location of this gene was
originally mapped to chromosome 11 by zymogram analysis of the GST isoenzymes
expressed in somatic cell hybrids (Laisney et al., 1984; Suzuki and Board, 1984).
Subsequently, in situ hybridization experiments confirmed these earlier results and
assigned the GST3 locus to 11 q13 (Moscow et al., 1988; Board et al., 1989). The report
published by Board et al. (1989), however, also contained evidence for the existence of
a second human Pi-class gene in region q13-14 of chromosome 12. In this context, it is
interesting that the amino acid sequence of a fatty acid ethyl ester (FAEE)-synthetase from
human myocardium has been reported to be highly similar to, but not identical with, that
of GST n (Bora ef al., 1989a). This enzyme and a second related FAEE-synthetase from
human heart have also been shown to have activity towards 1-chloro-2,4-dinitrobenzene
(Bora et al., 1989b). These results, therefore, suggest that additional Pi-class GST exist
which may have an involvement in ethanol metabolism.
2.05 Theta-class GST
The existence of a fourth class of cytosolic GST has recently been recognised following
the purification of several novel rat GST. Hiratsuka et al. (1990) identified at least three
hepatic isoenzymes which were shown to posses catalytic activity towards reactive
sulphate esters. These investigators purified one of these forms, designated GST YrsYrs,
and demonstrated that it has structural, immunological and catalytic properties that
distinguish it from Alpha- Mu- and Pi-class GST. In a subsequent study, Meyer et al.
(1991) purified two enzymes from rat liver which are structurally related to GST YrsYrs.
These two forms, designated GST 5-5 and GST 12-12, were previously isolated within a
preparation called GST E (Fjellstedt et al., 1973; Meyer et al., 1984).
A human hepatic Theta-class isoenzyme, called GST 8, was also purified and partially
characterized by Meyer et al. (1991). This isoenzyme was particularly labile and
represented only 0.003% of the soluble liver protein. The N-terminal amino acid sequence
40
of GST 9 was shown to be highly homologous to those of the rat Theta-class isoenzymes
GST 5-5 and GST 12-12. It is of interest, however, that electrophoretic analysis of the
human enzyme indicated that this preparation contained two dissimilar subunits.
Therefore, the quaternary structure of the protein remains to be elucidated.
2.06 Aims of the thesis
The major aims of the work described in this thesis were as follows:
i) To investigate the expression of extra-hepatic Mu-class GST in man.
ii) To purify and characterise the human Mu-class GST from skeletal muscle, testis
and liver in order to establish the molecular relationships between the multiple Mu-
class forms.
iii) To investigate the existence of Theta-class GST, with activity towards the substrate
1-menaphthyl sulphate, in human and mouse liver.





Chapter 3 Routine and analytical methods
3.01 Materials
3.01a Chemicals
Aldrich Chemical Co., Gillingham, Dorset, UK
trans-4-Phenyl-3-buten-2-one.
BDH Chemicals Ltd., Poole, Dorset, UK
Acetic acid; acrylamide; 2-amino-2-(hydroxymethyl)propane-1,3-diol(Tris); ammonium
persulphate; ammonium sulphate; bromophenol blue; butan-1-ol; calcium chloride; 1-
chloro-2,4-dinitrobenzene; Coomassie brilliant blue R250; disodium hydrogen
orthophosphate; ethanol; glycerol; glycine; hydrochloric acid; hydrogen peroxide; 2-
mercaptoethanol; methanol; N.N'-methylenebisacrylamide; orthophosphoric acid;
potassium chloride; sodium azide; sodium chloride; sodium dodecyl sulphate; sodium
hydroxide; 5-sulphosalicylic acid; N.N.N/N'-tetramethyl ethylenediamide (TEMED);
trichloroacetic acid.
Bio-Rad Laboratories, Hemel Hempstead, Herts., UK
Immuno-blot assay kit.
Koch-Light Laboratories Ltd., Colinbrook, Berks., UK
Cumene hydroperoxide; 1,2-dichloro-4-nitrobenzene.
Pharmacia Limited, Milton Keynes, Bucks., UK
Ampholine solutions; protein pi standards for isoelectric focusing.
Rathburn Chemicals Ltd., Peeblesshire, Scotland, UK
Acetonitrile; trifluoroacetic acid.
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Sigma Chemical Co. (London) Ltd., Poole, Dorset, UK
Bis-tris; bromosulphophthalein; Coomassie brilliant blue G-250; cyanogen bromide; 1,2-
epoxy-3-(p-nitrophenoxy)propane; ethacrynic acid; ethanolamine; ethylenediamine-
tetraacetic acid (EDTA); Freunds adjuvant (complete and incomplete); gelatin; glutathione
(reduced form); glutathione reductase; iminodiacetic acid; nicotinamide adenine di-
nucleotide phosphate (reduced form, type X); p-nitrobenzyl chloride; Tween-20.
3.01b Equipment
Anderman and Company Ltd., Kingston-upon-Thames, Surrey, UK
Nitrocellulose paper.
Elkay Laboratory Products (UK) Ltd., Basingstoke, Hants., UK
Flow-rated pump tubing.
Millipore (UK) Ltd., Harrow, Middlesex, UK
Ultrafiltration membranes.
Scientific Instruments Centre Ltd., London, UK
Visking dialysis tubing.
3.01c Materials for chromatography
Amicon Ltd., Stonehouse, Glos., UK
Matrex™ Gel Orange A.
Bio-Rad Laboratories, Hemel Hempstead, Herts., UK
Bio-Gel HT-grade Hydroxyapatite; Bio-Gel HPHT h.p.l.c. grade hydroxyapatite column.
Chromatography Services Ltd.,Merseyside, Cheshire, UK
DEAE-Cellulose.
Millipore, Harrow, Middlesex, UK
H Bondapak C18 reverse-phase h.p.l.c. column.
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Pharmacia (Laboratory Separation Division), Milton Keynes, Bucks, UK
Mono P HR 5/20 f.p.l.c. chromatofocusing column; Mono Q 5/5 f.p.l.c. anion exchange
column; Polybuffer exchanger (PBE) 94.
Sigma Chemical Co., (London) Ltd., Poole, Dorset, UK
Epoxy-activated Sepharose 6B; Polybuffer 74 and 96; Sephadex G-100.
3.01 d Reagents obtained from non-commercial sources
Materials for chromatography
The S-hexylglutathione was provided by Dr JD Hayes; S-hexylglutathione-Sepharose 6B
affinity matrix was made, according to the method of Mannervik and Guthenburg, (1981),
by coupling the /-glutamyl moiety of S-hexylglutathione to epoxy-activated Sepharose 6B.
GST substrates
The GST substrate 1-menaphthyl sulphate was a gift from Dr F Oesch (Section on
Biochemical Pharmacology, University of Mainz, Germany); the substrates 4-hydroxy-
nonenal and 4-hydroxydecinal were generously provided by Dr H Esterbauer (Insitute of
Biochemistry, University of Graz, Austria).
Standards for electrophoresis
Purified human GST isoenzymes 6,62 and p. and rat isoenzymes Y0Y0, YnYn and Yb,Yb,,
which were used as standards during electrophoresis and Western blotting, were from Dr
JD Hayes; human GST n standard was a gift from Dr AF Howie.
Antisera
Antisera raised in rabbits against the human GST enzymes B^,, n and n were provided
by Drs GJ Beckett, JD Hayes and AF Howie (all of Department of Clinical Biochemistry,
University of Edinburgh); rabbit antisera against the rat enzymes Y0Y0, YnYn and Yb,Yb,
were from Dr JD Hayes; antiserum raised in sheep against rat GST E was generously
provided by Dr WB Jakoby (The National Institutes of Health, Bethesda, Maryland, USA).
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3.01 e Animals
Inbred C57BL6 mice were obtained from the Animal House, Department of Bacteriology,
University of Edinburgh, where the animals were bred "in house". New Zealand White
rabbits were obtained from Charles River Breeding Laboratories, UK.
3.02 General methods
3.02a Protein determination
Protein concentrations were measured using the method of Bradford (1976) adapted for
use on the Cobas Fara (Roche Diagnostics, Welwyn Garden City, UK) centrifugal analyzer
as described in detail by Howie, (1990).
3.02b Sodium determination
Sodium concentrations in the fractions obtained following column chromatography were
estimated using flame photometry with a IL 343 photometer (Instrumentation Laboratory
(UK) Ltd., Warrington, Cheshire, UK).
3.02c Enzvmic activity assays
Enzymic activity assays for all substrates were carried out at 37 °C. In each case a non¬
enzyme rate was determined and subtracted from the rates measured in samples.
The measurement of enzymic activity with four substrates, 1-chloro-2,4-dinitrobenzene
(CDNB), 1-menaphthyl sulphate (1-MS), 1,2-epoxy-3-(p-nitrophenoxy)propane(EPNP) and
cumene hydroperoxide were carried out using methods adapted for use on a Cobas Fara
centrifugal analyzer.
GST activity with CDNB as substrate was determined using the method described by
Hayes and Clarkson (1982). Samples were pre-incubated with GSH and the reaction was
started by the addition of CDNB. The reaction rates, calculated as AA/min/ml, were
determined by an integral kinetic data program, which performed a linear regression
analysis on 8 absorbance readings taken over 45 sec at 340nm.
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The method of Gillham (1971) was used for the measurement of GST activity with the
substrate 1-MS. Samples were also pre-incubated with GSH and the reaction initiated by
the addition of the electrophilic substrate. Reaction rates were calculated using the data
obtained from twenty absorbance measurements, at 298nm, taken at 30 sec intervals over
10 min. A pre-programmed conversion factor allowed the enzyme activity to be expressed
as nmol 1-MS conjugated to GSH/min/ml.
GST activity towards the substrate EPNP was measured using the method of Habig and
Jakoby (1981). The reaction was started by the addition of EPNP following an incubation
of the sample with GSH. Fifty absorbance readings at 360nm were taken at 5 sec
intervals over 250 sec. Enzyme activity was expressed as ^mol GSH conjugated/min/ml.
Peroxidase activity, towards the substrate cumene hydroperoxide, was measured using
an adaptation of the method of Wendel (1981). The first step involved a 5 min pre¬
incubation with NAPDH, glutathione reductase and GSH which was carried out in 60 mM
Tris/HCI buffer pH 7.6 containing 0.12 mM EDTA and 1.0mM NaN3. The reaction was
initiated by the addition of cumene hydroperoxide. Absorbance readings, at 340 nm, were
taken at 10 sec intervals for 1 min 40 sec allowing reaction rates to be calculated and
expressed as ,«mol substrate reduced/min/L.
GSTactivitywith the substrates frans-4-phenyl-3-buten-2-one, 1,2-dichloro-4-nitrobenzene,
p-nitrobenzyl chloride and ethacrynic acid were all performed manually as described by
Habig and Jakoby (1981). The assay for GST activity with bromosulphophthalein was
also carried out manually using the method detailed by Habig et al. (1974a).
The substrates 4-hydroxynonenal and 4-hydroxydecinal were supplied at a concentration
of 10 mg/ml in chloroform, and were stored at -20 °C. Prior to use, the chloroform solvent
was removed by evaporation under nitrogen and the compounds were dissolved in
distilled water. The concentration of the resulting solution was calculated using the molar
extinction coefficient following an estimation of the maximum absorbance reading in the
UV spectrum 200-300 nm. GST activities with these two substrates were determined
manually using the method of Alin et al. (1985b).
The assay conditions and extinction coefficients for each of the enzyme assays described







































































SDS/Polyacrylamide-gel electrophoresis (SDS/PAGE) was performed, at room temperature,
using the discontinuous buffer system of Laemmli (1970), in slab gels (0.01 cm x 16.5 cm
x 18.0 cm) on a PROTEAN II electrophoresis system (Bio-Rad Laboratories, Hemel
Hempstead, Herts UK) in the presence of 0.1% (w/v) SDS. The electrophoretic gels were
made up of a "stacking gel" which was 2.5 cm long and a "resolving gel" which was 15
cm long. The "stacking gel" contained 3.6% (w/v) polyacrylamide and 0.01% (w/v) N,N7-
methylenebisacrylamide in 0.125 M Tris/HCI buffer pH 6.8 and the "resolving gel"
contained 12% (w/v) polyacrylamide and 0.32% (w/v) N.N'-methylenebisacrylamide (CBis
2.6%) in 0.375 M Tris/HCI buffer pH 8.8.
Protein samples for electrophoresis were heated for 10 min at 90 °C in a solution
containing 1% (w/v) SDS, 1% (v/v) 2-mercaptoethanol, 0.002% (w/v) bromophenol blue
and 10% (v/v) glycerol. Samples were applied to wells within the "stacking gel" and
subjected to electrophoresis at 50 mA (100 V) per gel through the "stacking gel", the
current was then re-set to 50 mA (150 V) per gel before the sample entered the "resolving
gel". Electrophoresis was terminated when the bromophenol blue marker reached 0.5 cm
from the bottom of the "resolving gel". Gels were stained, for 20 min, using Coomassie
brilliant blue R, 0.2% (w/v), in a solution of water: methanol: acetic acid (50: 50: 7 by vol)
and de-stained by several changes of a solution containing water: methanol: acetic acid
(88:7:5 by vol).
The molecular mass values for the novel GST subunits studied in this thesis were
estimated using either rat or human GST enzymes for which the subunit Mr values have
been determined previously (Hayes and Mantle, 1986b; Hayes, 1989).
3.03b Isoelectric focusing
Analytical isoelectric focusing was performed using an LKB 2117 Multiphore with an LKB
2103 power supply as described by the manufacturer (Pharmacia LKB Biotechnology AB,
Bromma, Sweden). Electrofocusing was carried out in 5% (w/v) polyacrylamide slab gels
(24 cm x 11.5 cm x 0.2 cm) containing 10% (v/v) glycerol and 5% Carrier Ampholine
mixture covering the pH range 3.5-9.5. The electrode solutions were 1M NaOH (cathode)
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and 1M H3P04 (anode). Protein samples (5-10/ig) were applied to strips (1.0 cm x 1.0-2.0
cm) ofWhatman No 1 filter paper positioned approximately 3.0 cm from the cathode. The
gels were calibrated with protein pi standards which comprised trypsinogen (pi 9.30); lentil
lectin (pi 8.65, 8.45, 8.15); horse myoglobin (pi 7.35, 6.85) human carbonic anhydrase B
(pi 6.55); bovine carbonic anhydrase B (pi 5.85); /S-lactoglobin A (pi 5.20); soybean
trypsin inhibitor (pi 4.55); amyloglucosidase (pi 3.50).
Isoelectric focusing was carried out for 3.5 h at a constant power of 25 W; the sample
application strips were removed after 1 h. The proteins were fixed in an aqueous solution
of 3.5% (w/v) sulfosalicylic acid and 11.5% (w/v) trichloroacetic acid for 30 min and the
gels were then washed in a de-staining solution of water: ethanol: acetic acid (67: 25: 8
by vol) for 30-60 min. Staining was achieved by immersing the gel in 0.2% (w/v)
Coomassie brilliant blue R, dissolved in the de-staining solution, for 10 min at 60 °C
followed by frequent changes of the de-staining solution.
3.03c Immunoblottinq
Western blotting was performed by the method of Towbin et al. (1979) as described in
detail by Hayes and Mantle (1986a). Protein samples, resolved by SDS/PAGE, were
transferred to nitrocellulose paper using a Bio-Rad Trans-blot cell and Bio-Rad model
250/25 power supply (Bio-Rad Laboratories, Hemel Hempstead, Herts, UK). The
polyacrylamide gels were first equilibrated, for 20 min, in 25 mM Tris/192 mM glycine
buffer pH 8.3 followed by electrophoretic transfer, in the same buffer, performed at 0.25
A for 4 h at 10 °C. The nitrocellulose paper was then immersed in a blocking solution,
containing 3% (w/v) gelatin and 500 mM NaCI in 20 mM Tris/HCI buffer pH 7.5, for 16 h
at 20 °C.
After the blocking procedure, performed to reduce non-specific antibody binding, the
nitrocellulose paper was incubated, for 3 h at 20 °C, in the primary antibody solution which
comprised either a specific rabbit or sheep antiserum diluted, between 1:200-1:3000,
depending on the titre of the antibody used, in 1% (w/v) gelatin in 20 mM Tris/HCI buffer
pH 7.5 containing 500 mM NaCI and 0.05% (v/v) Tween 20. Visualisation of the proteins
which cross-reacted with the specific antisera used was achieved, following extensive
washing in the above buffer, using either a goat anti-(rabbit IgG) or a rabbit anti-(sheep
IgG) antibody-horseradish-peroxidase conjugate immunoblot assay kit, as described by
the manufacturer (Bio-Rad Laboratories, Hemel Hempstead, Herts., UK).
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The immunogen, for the particular primary antibody used, was run alongside the other




Portions of GST N2N2 (1.0 mg) and GST N3N3 (0.7 mg), purified under reducing conditions,
were dialysed extensively against 10 mM ammonium acetate buffer pH 7.0 before freeze-
drying. The lyophilised protein was then dissolved in 2.0 ml of aq. 70% (v/v) formic acid
before the addition of a crystal of CNBr (approx. 25 mg). Incubation with CNBr was
allowed to proceed in the dark for 20 h at room temperature (20 °C) before the reaction
mixture was diluted with 15 volumes of distilled/deionised water (to terminate the cleavage
process) before being freeze-dried.
A portion of GST T2T2 (60 fig), which had been purified under reducing conditions, was
subjected to reverse-phase h.p.l.c. as described in section 4.05b. The protein in the peak
recovered from the \i Bondapak C18 column was freeze-dried before being dissolved in
0.15 ml of aq. 70% (v/v) formic acid containing approx. 2.0 mg of CNBr. Digestion was
left to proceed in the dark for 20 h before the reaction mixture was diluted with 10 volumes
of water and freeze-dried.
3.04b Separation of peptides by reverse-phase h.p.l.c.
A Waters h.p.l.c. system (Waters Associates (Instruments), Northwich, Cheshire, UK) with
a ii Bondapak C1B column (10 /urn particle size; 0.39 cm x 30.0 cm; Millipore, Harrow,
Middlesex, UK) was employed for the separation of CNBr-cleaved peptides obtained from
the Mu-class GST N2N2 and N3N3. The h.p.l.c. system comprised two model 510 pumps,
a model 680 automated gradient controller, a model 481 Lambda-Max absorbance
detector and a model U6K universal detector. The freeze-dried peptides were dissolved
in 1.5 ml of aq. 0.1% (v/v) trifluoroacetic acid and centrifuged at 10,000 g for 5 min in a
microcentrifuge, to remove particulate material, before application to the reverse-phase
column. The gradient controller was programmed to allow the samples to be loaded
isocratically onto the column over a period of 5 min. During this time the flow rate was
increased linearly from 0.1-1.0 ml/min. A linear gradient of 0-70% (v/v) acetonitrile in aq.
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0.1% (v/v) trifluoroacetic acid over 60 min was used to develop the column and resolve
the peptide fragments. The of the eluate was monitored continuously allowing the
peptide-containing peaks to be collected manually.
The separation of CNBr-cleaved peptides from GST subunit T2 was performed by Margaret
Daniel and Stephen D Peacock at the WELMET Protein Sequencing Laboratory,
Department of Biochemistry, University of Edinburgh. The freeze-dried cleaved protein
was re-dissolved in 0.2 ml of aq. 0.1% (v/v) trifluoroacetic acid and the peptides were
resolved using a Applied Biosystems 130A Microbore Separation System with an
Aquapore RP300 reverse-phase column (7 /<m particle size; 2.1 mm x 30 mm; Applied
Biosystems, Warrington, Cheshire, UK). The column was developed with a linear 0-70%
acetonitrile gradient in aq. 0.1% (v/v) trifluoroacetic acid formed over 45 min.
3.04c Amino acid sequencing
Amino acid sequencing of either purified GST subunits or CNBr-cleaved peptides was
performed by Andrew D Cronshaw, Margaret Daniel, Linda A Kerr and Stephen D Peacock
at the WELMET Protein Sequencing Laboratory. Samples were first checked for purity on
an Aquapore RP300 column (7 pm particle size; 2.1 mm x 30 mm). The column was
developed with a linear 8-80% (v/v) acetonitrile gradient in aq. 0.1% trifluoroacetic acid
and monitored at 220 nm.
Automated amino acid sequencing of the GST subunits and CNBr-cleaved peptides was
performed on an Applied Biosystems 477A instrument with a 120A on-line phenyl-
thiohydantoin analyzer. A glass-fibre filter disc was first loaded with polybrene (2 mg)
which was pre-cycled three times before the protein sample to be analysed was loaded
(approx. 1.5 nmol). Edman degradation of the N-terminus resulted in the cleavage of
anilinothiazolinone derivatives from the peptide which were converted automatically to the
more stable phenylthiohydantoin (PTH) forms. Separation of the PTH derivatives was
achieved on an Applied Biosystems PTH C18 (5 pm particle size; 2.1 mm x 220 mm)
column developed, at 55 °C, with a linear 0-100% (v/v) acetonitrile gradient. The eluate
from the column was monitored at 269 nm. Cysteine residues in the peptides were
detected following vapour-phase pyridylation. This procedure is described in detail
elsewhere (Hayes eta!., 1989).
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3.05 Antibody production
Antisera against purified human GST N2N2 and N3N3 were produced in one and two female
New Zealand White rabbits respectively. An aqueous solution of the purified GST was
emulsified in an equal volume of Freunds complete adjuvant using a polytron homo-
genizer (Kinematica, Switzerland). Rabbits were injected subcutaneously, at multiple sites
on the back, with the emulsion so that each animal received approx. 100 fig of protein.
A booster injection, also containing 100 fig of purified GST, was prepared in Freunds in¬
complete adjuvant and given after six weeks. Rabbits were sacrificed after a further 10
days and blood was recovered by cardiac puncture. Serum was separated from the clot
by centrifugation, at 3000 g for 15 min, and stored, in the presence of 0.1% (w/v) sodium
azide, at -20 °C.
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Chapter 4 Purification methods
4.01 Tissue source
4.01a Human tissue
Human skeletal muscle, from both right and left psoas muscle, testis, cerebrum and liver
were obtained post mortem by Dr DJ Harrison, Department of Pathology, University of
Edinburgh, and stored at -80 °C before use. A macroscopic examination was performed
at autopsy to establish that there was no abnormality in the tissue samples collected. Full
details on the tissue samples used for the purification of GST isoenzymes are presented
in Table 4.01.
4.01b Murine tissue
Male C57BL6 mice were killed at between 10-13 weeks old. The livers were removed and
stored at -80 °C until used.
4.02 Preparation of cytosolic fractions
Tissue samples were allowed to thaw at room temperature and 25% (w/v) homogenates
were then prepared in ice-cold buffer. The buffer used for homogenization was that used
in the first chromatographic step of the purification procedure (see sections 4.07-4.11).
All subsequent steps were performed either on ice or at 4 °C. Homogenates were
centrifuged at 10,000 g, for 30 min, and the resulting supernatants were centrifuged at
100,000 g for 60 min. The supernatants obtained following centrifugation at 100,000 g
were filtered through plugs of glass wool, to remove lipid material, and from this point are
referred to as cytosol.
4.03 Ammonium sulphate precipitation
The precipitation of proteins by ammonium sulphate was performed at 4 °C (Dixon and
Webb, 1979). Samples were taken gradually to 30% saturation with ammonium sulphate
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and then incubated for 1.5 h. After centrifugation, at 10,000 g for 30 min, the resulting
supernatant was taken to 90% saturation with ammonium sulphate and incubated for a
further 1.5 h. The protein which precipitated between 30-90% saturation was recovered
by centrifugation (10,000 g for 30 min) and resuspended in the appropriate buffer.
4.04 Conventional "open-column11 chromatographic techniques
The chromatographic techniques described bellow were all performed at 4 °C.
4.04a Affinity chromatography
Affinity purification of GST isoenzyme pools from cytosol was achieved using the S-
hexylglutathione-Sepharose 6B affinity matrix described by Mannervik and Guthenberg
(1981). Cytosolic fractions, which had been dialysed extensively against 20 mM Tris/HCI
buffer, pH 7.8 containing 200 mM NaCI and 0.5 mM dithiothreitol, were applied to columns
(1.6 cm x 30 cm) of S-hexylglutatione-Sepharose 6B which had been equilibrated in the
same buffer. After washing with about 800 ml of the equilibration buffer the bound
material was eluted by 5 mM S-hexylglutathione in the same buffer. The protein containing
fractions, established by absorbance at 280 nm, were pooled prior to either analysis or
further purification steps.
4.04b Dve-liaand chromatography
Chromatography on Matrex™ Gel Orange A was used during the purification of a human
Theta-class GST. The sample was dialysed against two changes, each of two litres, of
20 mM sodium phosphate buffer, pH 6.8, containing 1 mM EDTA and 0.5 mM dithiothreitol
before application to a pre-equilibrated column (1.6 cm x 26 cm) at a flow rate of 34 ml/h.
Following a wash of approx. 200 ml of the equilibration buffer the column was developed
with a non-linear gradient of 0-1.0 M KCI in the sodium phosphate buffer. GST activity
towards the substrates CDNB and 1 -MS as well as glutathione peroxidase activity towards
the substrate cumene hydroperoxide and absorbance at 280 nm were measured in each




Hydroxyapatite chromatography, used during the purification of human Mu-class GST, was
performed on a column of Bio-Rad HT grade hydroxyapatite (1.6 cm x 20 cm) which had
been equilibrated with 10 mM sodium phosphate buffer pH 7.0, containing 0.5 mM
dithiothreitol. The sample, previously dialysed against the same buffer, was applied to the
column at a flow rate of 14 ml/h. Following washing, with approx. three column volumes
of the equilibration buffer, the column was developed with a linear gradient (350 ml) of 10-
250 mM sodium phosphate buffer, containing 0.5 mM dithiothreitol throughout. The
fractions collected (2.3 ml) were monitored for GST activity towards CDNB and
absorbance at 280 nm.
Human Theta-class GST were purified using a larger column (3.3 cm x 45 cm) of Bio-Rad
HT grade hydroxyapatite which had been equilibrated in 10 mM sodium phosphate buffer,
pH 7.0, containing 1 mM EDTA and 0.5 mM dithiothreitol. The sample was applied as
described above and the column developed using a non-linear 10-250 mM sodium
phosphate gradient. The fractions obtained (4.7 ml) were examined for activity towards
CDNB, 1-MS and cumene hydroperoxide as well as absorbance at 280 nm.
Murine GST
Chromatography of murine Theta-class GST on hydroxyapatite was carried out using a
column of Bio-Rad HT grade hydroxyapatite (1.6 cm x 30 cm) which had been equilibrated
in 10 mM sodium phosphate buffer pH 7.0, containing 1 mM EDTA and 2 mM 2-
mercaptoethanol. The sample, which had been previously dialysed against the same
buffer, was applied at a flow rate of 14 ml/h and the column was developed using a linear
gradient (350 ml) of 10-250 mM sodium phosphate, containing 1 mM EDTA and 2 mM 2-
mercaptoethanol. The fractions collected (2.3 ml) were monitored for activity towards
CDNB, 1-MS, cumene hydroperoxide and absorbance at 280 nm.
4.04d Chromatofocusinq
Conventional chromatofocusing of human Mu-class GST isoenzymes was performed,
within the pH range 8.5-5.5, using a column (1.6 cm x 32 cm) containing polybuffer
exchanger PBE 94, pre-equilibrated in 25 mM Tris/CH3COOH buffer pH 8.9. The pH
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gradient was formed using polybuffer 96 diluted 1:10 (v/v) in water and adjusted to pH 5.5
with acetic acid. Immediately before chromatofocusing of the sample, 5 ml of the pH 5.5
eluant buffer was applied to the column to initiate the formation of the pH gradient. The
sample, dialysed extensively against the equilibration buffer, was then applied at a flow
rate of 34 ml/h and the column developed using the polybuffer pH 5.5 eluant. Fractions
(3.4 ml) were collected and protein concentrations and GST activity, with CDNB as
substrate, were measured. The pH was determined, at 4 °C, in every fifth fraction.
Murine Theta-class GST were subjected to chromatofocusing in the pH range 9.5-6.5
using a column (1.6 cm x 30 cm) of polybuffer exchanger PBE 94, equilibrated in 25 mM
ethanolamine/HCI buffer, pH 9.5, containing 2 mM 2-mercaptoethanol. The partially
purified GST were dialysed against two changes, each of two litres, of 25 mM
ethanolamine/HCI buffer, pH 8.5, containing 2 mM 2-mercaptoethanol, before application
to the column at a flow rate of 34 ml/h. A pH gradient was developed using polybuffer
96 diluted 1 in 10 (v/v) with water and adjusted to pH 6.5 with HCI, containing 2 mM 2-
mercaptoethanol. The GST activity towards CDNB and 1-MS, protein concentrations and
the pH at 4 °C were measured in the fractions collected.
4.04e Ion-exchange chromatography
Anion-exchange chromatography, using DEAE-cellulose, of murine and human Theta-class
GST, was performed on columns of DE-52 (4.4 cm x 90 cm) equilibrated in 10 mM
Tris/HCI buffer pH 8.25, containing 1 mM EDTA and either 2 mM 2-mercaptoethanol or 0.5
mM dithiothreitol respectively. Following application of sample, at a flow rate of 46 ml/h,
the column was washed with the equilibration buffer before being developed with a non¬
linear gradient (400 ml mixing reservoir) of 0-300 mM NaCI in the same buffer. Fractions
(11.5 ml) were collected and the GST activity, with 1-MS and CDNB as substrates, and
the absorbance at 280 nm were measured.
4.04f Gel filtration
Gel filtration of GST enzymes was carried out on a Sephadex G-100 column (4.4 cm x 90
cm) equilibrated with 10 mM sodium phosphate buffer pH 7.0, containing 1 mM EDTA and
2 mM 2-mercaptoethanol. The sample, reduced to a suitable volume by ammonium
sulphate precipitation, was applied to the column at a flow rate of 34 ml/h. Following
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elution, with the equilibration buffer, fractions (6.8 ml) were collected and GST activity and
absorbance at 280 nm were measured.
4.05 High pressure liquid chromatography (h.p.l.c)
This was performed at room temperature on a twin-pump Waters h.p.l.c. system (Waters
Associates, Northwich, Cheshire, UK; see section 3.04b).
4.05a Hvdroxvapatite h.p.l.c.
Separation of human Pi- and Mu-class GST enzymes was achieved on a Bio-Gel HPHT
h.p.l.c. grade hydroxyapatite column (Bio-Rad Laboratories, Hemel Hempstead, Herts, UK).
Samples were first dialysed, against two changes, each of two litres, of 10 mM sodium
phosphate buffer pH 7.0, containing 0.5 mM dithiothreitol, before application to the column
at a flow rate of 0.5 ml/min. A linear gradient of 10-350 mM sodium phosphate buffer pH
7.0, containing 0.5 mM dithiothreitol and 0.4 mM CaCI2 was employed to develop the
column over 60 min. The A^ of the eluate was monitored continuously and the GST
activity was measured to allow identification of the isoenzyme-containing fractions.
4.05b Reverse-phase h.p.l.c.
Reverse-phase h.p.l.c. on a ji Bondapak C18 column (Millipore, Harrow, Middlesex, UK)
was used to separate and isolate individual GST subunits, a method first described by
Ostlund Farrants et al (1987). Samples, containing 0.1% (v/v) trifluoroacetic acid, were
injected onto the column and the flow rate increased linearly, over 5 min, from 0.1 ml/min
to 1.0 ml/min (see section 3.04b). The column was developed, over 60 min, with a linear
40-55% (v/v) acetonitrile gradient in aq. 0.1% (v/v) trifluoroacetic acid. The absorbance
at 220 nm was monitored continuously to facilitate collection, by hand, of the protein
containing peaks.
4.06 Fast protein liquid chromatography (f.p.l.c.)
This was performed, at room temperature, using a Pharmacia integrated f.p.l.c. system
(Pharmacia, Laboratory Separation Division, Milton Keynes, Bucks., UK). The system
comprised a model GP-250 gradient programmer, two model P-500 pumps, a UV-1 UV
monitor, a pH monitor and a flow-through electrode.
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4.06a Anion-exchanqe f.p.l.c.
Affinity purified human GST isoenzyme pools and a partially purified human Theta-class
GST were further resolved on a Mono Q HR 5/5 column (Pharmacia) equilibrated with 20
mM Tris/HCI buffer pH 8.0, containing 0.5 mM dithiothreitol at a flow rate of 0.75 ml/min.
Following extensive dialysis, at 4 °C, against the equilibration buffer, samples were applied
to the column which was developed with a 0-1.0 M NaCI gradient in the same buffer. The
gradient was established in two linear stages; 0-0.15 M NaCI in 60 min followed
immediately by 0.15-1.0 M NaCI in either 10 or 25 min. Fractions (0.75 ml) were collected
and analysed for protein concentration and GST activity.
4.06b Chromatofocusing f.p.l.c.
Chromatofocusing of human Mu-class GST isoenzymes, in the pH range 7-4, was
performed on a Mono P HR 5/20 f.p.l.c. column (Pharmacia) pre-equilibrated in 25 mM
Bistris/iminodiacetic acid buffer pH 7.1. Material to be subjected to chromatofocusing was
first dialysed against two changes, each of 2 litres, of the same buffer before application
to the column at a flow rate of 0.75 ml/h. The pH gradient was formed using Polybuffer
74 (diluted 1:30 (v/v) in water) adjusted to pH 4.0 with iminodiacetic acid, as the eluant.
The pH was monitored continuously and the protein concentration and GST activity in the
fractions (0.75 ml) collected were measured.
4.07 Purification of Mu-class isoenzymes from human skeletal muscle
Data on the purification and analysis of Mu-class isoenzymes from skeletal muscle tissue
from three individuals (specimens 1,2 and 3; Table 4.01) will be presented. Cytosolic
fractions from samples M1 (375 g), M2 (247 g) and M3 (354 g) were prepared separately
(see section 4.02) in 20 mM Tris/HCI buffer pH 7.8, containing 200 mM NaCI and 0.5 mM
dithiothreitol.
4.07a Affinity purification and resolution of GST isoenzyme forms
GST isoenzyme mixtures were isolated from the three skeletal muscle cytosolic fractions
by affinity chromatography on columns of S-hexylglutathione-Sepharose 6B (see section
4.04a). Partial resolution of the affinity purified GST was then achieved by the use of
anion-exchange chromatography, at pH 8.0, on a Mono Q HR 5/5 column with the
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Pharmacia f.p.l.c. system (see section 4.06a). The samples were applied to the column
in 5.0 ml portions (between 5-10 mg protein) which were then eluted separately at a flow
rate of 0.75 ml/min. The column was developed in two stages with a linear salt gradient
of 0-0.15 M NaCI over 60 min, followed immediately by 0.15-1.0 M NaCI over 10 min.
Protein concentrations and GST activity, with CDNB as substrate, were measured in the
fractions collected.
The chromatographic profiles obtained from Mono Q f.p.l.c. were different for each of the
three individuals studied. However, a maximum of seven protein containing peaks (P1-P7)
were resolved by this method. The protein containing fractions were pooled and analysed
by SDS/PAGE before further purification. Three of the seven peaks (P1, P3 and P6)
contained the major GST forms.
4.07b Purification of Mu-class isoenzymes
Anion-exchange on Mono Q f.p.l.c. of the affinity purified-material resulted in the isolation
and purification of a Mu-class isoenzyme, which was present in peak P6 obtained from
muscle samples M1 and M2. The other major GST forms, present in protein containing
peaks P1 and P3, required further purification.
Peak P1 from skeletal muscle preparation M2 and peak P1 from skeletal muscle sample
M3 each contained a different Mu-class enzyme. These GST were purified following
chromatofocusing on Mono P f.p.l.c. in the pH range 7-4 (see section 4.06b). The Mu-
class GST present in peak P1 from specimen M2 eluted from the chromatofocusing
column at pH 5.9 and was recovered as peak P1-A, whereas the Mu-class GST present
in peak P1 from specimen M3 eluted from the chromatofocusing column at pH 5.25 and
was recovered as peak P1-A'.
The material in peak P3, from all three skeletal muscle preparations (M1, M2 and M3), was
subjected to chromatography on hydroxyapatite h.p.l.c. (see section 4.05a). A10-350 mM
sodium phosphate gradient resolved the GST activity present in this pool into two peaks,
one containing a Pi-class enzyme (peak P3-A) and one containing a Mu-class enzyme
(peak P3-B).
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4.08 Purification of a Mu-class enzyme from human testicular tissue
A human testicular Mu-class GST was purified from testis tissue from one individual
(specimen T3; see table 4.01).
A cytosolic fraction was prepared from 71 g of testicular tissue as described previously
in section 4.02. Following dialysis, against two changes each of 5 litres of 20 mM Tris/HCI
buffer, pH 7.8, containing 200 mM NaCI and 0.5 mM dithiothreitol, the cytosol was
subjected to affinity chromatography on S-hexylglutathione-Sepharose 6B (see section
4.04a).
The affinity-purified GST pool was dialysed extensively against 20 mM Tris/HCI buffer pH
8.0, containing 0.5 mM dithiothreitol before being subjected to anion-exchange
chromatography on a Mono Q HR 5/5 f.p.l.c. column (see section 4.06a). The GST
isoenzyme mixture was applied to the column in 5.0 ml portions (containing 5-10 mg
protein) which were then chromatographed separately. A two step salt gradient was used
to develop the column, this involved a linear 0-0.15 M NaCI gradient, established over 60
min, followed immediately by a linear 0.15-1.0 M NaCI gradient over 25 min. Following
measurement of protein concentrations and GST activity in the fractions collected those
containing protein were pooled and analysed by SDS/PAGE.
The protein peak (Pvii) resolved by the second stage of the salt gradient, eluting at
approx. 400 mM NaCI, was found to contain a Mu-class enzyme. The purification of this
GST was, therefore, possible using two chromatographic steps.
4.09 Purification of human hepatic Mu-class enzymes
Hepatic Mu-class isoenzymes were purified from one individual (specimen L4; Table 4.01)
and the isoenzyme profile in the skeletal muscle and cerebrum from the same individual
were also analysed.
4.09a Affinity purification and separation of hepatic Mu-class GST
Cytosol was prepared from human liver tissue (411 g), as described in section 4.02. A
GST isoenzyme pool was isolated from the cytosolic fraction following affinity chromato¬
graphy on two columns (1.6 cm x 20 cm) of S-hexylglutathione-Sepharose (see section
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4.04a) which were run in parallel. Chromatography on a column (1.6 cm x 20 cm) of Bio-
Rad HT grade hydroxyapatite was used to separate the GST isoenzymes present in the
affinity-purified pool according to their class. This procedure is described in detail in
section 4.04c. A linear gradient of 10-250 mM sodium phosphate buffer pH 7.0,
containing 0.5 mM dithiothreitol, resolved the GST activity present into two peaks. Those
fractions containing GST activity were combined into two pools. The GST activity which
eluted in a peak between 80-140 mM sodium phosphate (PI) contained isoenzymes of the
Mu-class and was, therefore, retained for further purification.
4.09b Resolution of multiple hepatic Mu-class isoenzymes
Conventional chromatofocusing, described in section 4.04d, in the pH range 8.5-5.5, was
used to resolve the hepatic Mu-class isoenzymes expressed by this individual into three
protein containing peaks each containing a distinct Mu-class enzyme.
4.09c Analysis of isoenzyme profiles in skeletal muscle and cerebrum
Skeletal muscle (240g; sample M4) and cerebrum (540 g; sample C4) were homogenized
1:4 in 20 mM Tris/HCI buffer pH 7.8, containing 200 mM NaCI and 0.5 mM dithiothreitol,
and cytosols were prepared as described in section 4.02. Following affinity chromatograp¬
hy, on S-hexylglutathione-Sepharose 6B (see section 4.04a), the samples were subjected
to anion-exchange chromatography, at pH 8.0, on a Mono Q column. The Mono Q
column was developed with linear salt gradients established in two stages as described
in section 4.06a. Chromatography of the sample purified from skeletal muscle involved the
use of a 0-0.15 M NaCI gradient, developed over 60 min, followed immediately by a 0.15-
1.0 M NaCI gradient over 10 min. By contrast, chromatography of the cerebrum sample
involved the use of a 60 min 0-0.15 M NaCI gradient which was followed by a 0.15-1.0 M
gradient established over 25 min. GST activity, with CDNB as substrate, and protein
concentrations were measured in the fractions collected and those fractions containing
protein were further analysed by SDS/PAGE.
4.10 Purification of a Theta-class GST from human liver
A human hepatic GST with high activity towards 1-menaphthyl sulphate (1-MS) and no
apparent activity towards CDNB was purified from a liver sample from one individual.
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Immediately following the preparation of a cytosolic fraction from 624 g of human liver
(sample L5; Table 4.01), as described in section 4.02, the cytosol was applied to two
columns (4.4 cm x 90 cm) of DE-52, equilibrated with 10 mM Tris/HCI buffer, pH 8.25,
containing 1 mM EDTA and 0.5 mM dithiothreitol (see section 4.04e). The two columns,
which were run in parallel, were washed with approx. one column volume of the
equilibration buffer before each was developed with a 0-300 mM NaCI gradient in the
same buffer. The fractions (11.5 ml) collected were analysed for GST activity towards
CDNB and 1-MS as well as absorbance at 280 nm. A single peak of activity towards 1-
MS eluted, between 110-160 mM NaCI on the gradient, from each of the columns.
Those fractions which contained activity towards 1-MS following DEAE-cellulose
chromatography were pooled and applied immediately to a column (3.3 cm x 45 cm) of
Bio-Rad HT grade hydroxyapatite equilibrated in 10 mM sodium phosphate buffer, pH 7.0,
containing 1 mM EDTA and 0.5 mM dithiothreitol (see section 4.04c). A 10-250 mM
sodium phosphate gradient was used to develop the column and the eluate was
monitored for enzyme activity. The fractions (4.7 ml) containing activity towards 1 -MS, that
eluted between 80-120 mM sodium phosphate, were pooled for further purification.
Dye-ligand chromatography on Matrex™ Gel Orange A was performed on the hydroxy¬
apatite purified material. The sample, which had been dialysed extensively against 10 mM
sodium phosphate buffer pH 6.8, containing 1 mM EDTA and 0.5 mM dithiothreitol, was
applied to a pre-equilibrated column (1.6 cm x 26 cm) as described in section 4.04b.
Following the formation of a non-linear 0-1.0 M KCI the fractions collected were measured
for GST activity.
The final stage in the purification involved anion-exchange chromatography on Mono Q
f.p.l.c. (see section 4.06a). Those fractions which contained activity towards 1 -MS, which
had been retained by the Matrex™ Gel Orange A column, were pooled and dialysed
extensively against 20 mM Tris/HCI buffer pH 8.0, containing 0.5 mM dithiothreitol, before
application to Mono Q f.p.l.c. The sample was loaded onto the column in 5.0 ml portions
(approx. 0.75 mg) which were each chromatographed separately. The gradient was
formed in two linear stages consisting of 0-0.15 M NaCI formed over 60 min followed
immediately by 0.15-1.0 M NaCI formed over 10 min. Protein concentration, GST activity
with 1-MS as substrate and GSH peroxidase activity with cumene hydroperoxide as
substrate were measured in the fractions collected.
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4.11 Purification of a Theta-class GST from mouse liver
A murine hepatic GST with activity towards 1-MS was purified from the livers of adult
C57BL6 male mice.
Cytosol, from 134 g of mouse liver, was prepared in 10 mM Tris/HCI buffer pH 8.25,
containing 1 mM EDTA and 2 mM 2-mercaptoethanol as described in section 4.02.
Following dialysis, for 18 h at 4 °C, against two changes each of 5 litres of the same
buffer, the sample was applied to a pre-equilibrated DE-52 column (4.4 cm x 90 cm) at
a flow rate of 46 ml/h (see section 4.04e). A 0-300 mM NaCI gradient, in the running
buffer, was used to develop the column. The fractions (11.5 ml) containing GST activity
with the substrate 1-MS, which eluted between 20 mM and 60 mM NaCI on the gradient,
were pooled for further purification.
Ammonium sulphate precipitation of protein between 30-90% saturation was performed
on the material which was obtained following anion-exchange chromatography as
described in section 4.03. The protein precipitated between 30-90% (NH4)2S04 saturation
was resuspended in 10 mM sodium phosphate buffer pH 7.0, containing 1 mM EDTA and
2 mM 2-mercaptoethanol. Chromatography on a Sephadex G-100 gel filtration column
(4.4 cm x 90 cm) was then used to further purify the Theta-class GST. See section 4.04f
for details of this procedure.
The fractions obtained from the gel filtration column which contained GST activity were
pooled prior to further chromatography on a column (1.6 cm x 30 cm) of Bio-Rad HT
grade hydroxyapatite pre-equilibrated with 10 mM sodium phosphate buffer pH 7.0,
containing 1 mM EDTA and 2 mM 2-mercaptoethanol (see section 4.04c). This column
was developed with a 10-250 mM sodium phosphate gradient and the fractions collected
were analysed for absorbance at 280 nm, GST activity with CDNB and 1 -MS as substrates
and glutathione peroxidase activity with cumene hydroperoxide as substrate. A single
peak of GST activity with 1-MS as substrate eluted between 80-120 mM sodium
phosphate. The final chromatographic step involved conventional chromatofocusing in





Chapter 5 Purification of Mu-class GST from human
skeletal muscle
5.01 Human skeletal muscle GST
The existence of a GST in skeletal muscle tissue, that was distinct from the hepatic GST,
was first described by Laisney et al. (1984), who used starch gel electrophoresis to
analyze GST activity in various human tissues. Subsequently, other workers (Suzuki et
al., 1987; Board et al., 1988) purified a transferase expressed in skeletal muscle, called
GST4, which is structurally related to the Mu evolutionary class. The reports of Laisney
et al. (1984) and Board et al. (1988), however, present conflicting evidence as to the
existence of heterodimeric Mu-class GST. Singh et al. (1988) have isolated several
skeletal muscle GST; two of the minor forms, which were not observed in all of the
samples examined, had sequence homology with the hepatic Mu-class enzymes.
However, the major muscle isoenzyme described by these workers, which was present
in all of the samples analysed, was distinct, both immunologically and catalytically, from
any of the known Alpha-, Mu- or Pi-class GST.
In this thesis the skeletal muscle GST from a number of individuals have been purified in
order to clarify the discrepancies which exist in the literature and to examine the possibility
of inter-individual variation in the expression of these isoenzymes.
5.02 A purification strategy for skeletal muscle GST isoenzymes
Skeletal muscle GST have been isolated from a number of individuals. The results of the
purification of GST from three of the tissue samples will be presented in detail in this
chapter.
A combination of f.p.l.c and h.p.l.c. techniques were used to resolve affinity-purified GST
isoenzymes. Initially, a partial separation of the GST forms present in S-hexylglutathione
affinity-purified pools was achieved on Mono Q anion-exchange f.p.l.c. Further purification
was carried out by either chromatofocusing on Mono P f.p.l.c. or hydroxyapatite h.p.l.c.
These procedures allowed the isolation of four separate Mu-class GST and a Pi-class GST
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from skeletal muscle. The steps involved in the purification of the Mu-class GST are
described in detail in section 4.07 and summarized in Scheme 5.01.
5.03 Variation in the expression of GST isoenzymes in human skeletal muscle
5.03a Analysis of GST isoenzyme pools from different individuals
S-Hexylglutathione affinity-purification of skeletal muscle cytosol from specimens M1, M2
and M3 resulted in isoenzyme mixtures which accounted for 0.22, 0.20 and 0.19% of the
total cytosolic protein from each of the muscle samples respectively. When the isoenzyme
profiles of two of these pools (from specimens M1 and M2) were examined by analytical
isoelectric focusing (Figure 5.01) it was apparent that one band, of pi 5.65, was present
in the pool obtained from skeletal muscle M2, whereas it was absent in the M1 pool.
Isoelectric focusing also revealed the existence of two other predominant proteins,
expressed by both individuals, which focused at pH 5.3 and pH 4.7.
5.03b Isolation of GST forms
Separation of the affinity-purified GST isoenzyme mixtures, from the seven skeletal muscle
samples studied, on anion-exchange f.p.l.c. resulted in profiles which differed from
specimen to specimen. The elution profiles obtained from samples M1, M2 and M3 are
presented in Figure 5.02, together with SDS/PAGE analysis of the protein containing
fractions.
Material from skeletal muscle M1 was resolved by Mono Q into seven protein-containing
pools, two of which (P3 and P6) contained the major GST forms (Figure 5.02a).
SDS/PAGE showed that peaks P1 and P2, which did not have GST activity towards 1-
chloro-2,4-dinitrobenzene, both contained a single band with a subunit Mr of 28500
(Figure 5.02b). P3 the first major peak, contained the 28500-M, polypeptide together with
bands which co-migrated with the human placental 24800-M, GST n standard and with
a 26000-M, standard. The minor peaks P4 and P5 contained polypeptides of the same
electrophoretic mobility as that of peak P3; however, P5 contained an additional band with
an estimated subunit Mr of 22500, which probably represents glyoxylase I (Hayes, 1988).




























Scheme 5.01 Purification of Mu-class GST from human skeletal muscle
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Figure 5.01 Isoelectric focusing of affinity-purified GST pools from human skel
muscle
Isoelectric focusing of S-hexylglutathione-affinity-purified cytosolic GST from hui
skeletal muscle samples M1 and M2 (20 //g of protein) was performed using a broac
range gel (pH 3.5-9.5) in thin-layer 5% (w/v) polyacrylamide. The pi values of the pre




Figure 5.02 Resolution of human skeletal muscle GST by anion-excha
chromatography and SDS/PAGE analysis of individual peaks
Anion-exchange f.p.l.c. on Mono Q of S-hexylglutathione-affinity-purified GST from hui
skeletal muscle samples M1, M2 and M3 was performed as described in section 4.i
Panels a, c and e show the elution profiles obtained following chromatography of mat
purified from specimens M1, M2 and M3 respectively. A 0-1.0 M NaCI gradient, in 20
Tris/HCI pH 8.0 containing 0.5 mM dithiothreitol, was established in two steps as shi
by the straight lines. GST activity with 1-chloro-2,4-dinitrobenzene (*) and pro
concentrations (o) were measured. The protein containing fractions, from preparat
M1, M2 and M3 were pooled, as indicated by the horizontal bars, and subjecte-
SDS/PAGE as shown in panels b, d and f respectively. The resolving gel contained
(w/v) polyacrylamide and 0.32% (w/v) N.N'-methylenebisacrylamide. The positions o-
human GST markers (i (Mr 26700) and n (Mr 24800), which were run in parallel,
indicated. The first lane on each gel contained the total S-hexylglutathione-affinity-pur
material (TOT; 6 /ig of protein) from each muscle specimen. The following la
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with the 26000-M, standard and a second band with a subunit Mr of 26300. This 26300-Mr
band was also observed in peak P7, as was the 22500-Mr polypeptide tentatively identified
as glyoxylase I.
By contrast, when the affinity-purified GST pool from skeletal muscle sample M2 was
subjected to the same anion-exchange chromatography step only five peaks were
resolved by f.p.l.c. on Mono Q (Figure 5.02c). The most significant difference between
the elution profile of specimen M2 and that of M1 was the increased size of the first peak,
P1, and the fact that unlike P1 from M1, this pool contained GST activity towards 1 -chloro-
2,4-dinitrobenzene. When this peak from M2 was examined by SDS/PAGE (Figure 5.02d),
three subunit bands were observed; the one with the slowest mobility was the 28500-Mr
polypeptide, the second band co-migrated with the human hepatic GST ^ standard, of
subunit M, 26700, and a third band co-migrated with the 26000-M, standard. Apart from
virtual
the^absence of the 28500-M, polypeptide, peaks P3, P5, P6 and P7 appeared to have the
same subunit compositions as the corresponding peaks on the elution profile obtained
from sample M1.
The elution profile obtained following chromatography of the affinity-purified material from
specimen M3 was similar to that of specimen M2. Five protein containing peaks were
observed (Figure 5.02e), however, only two major GST forms were obtained and these
were recovered in peaks P1 and P3. Electrophoretic analysis of peaks P1 and P3 (Figure
5.020 revealed that they contained subunits with the same mobility as those present in
peaks P1 and P3 from skeletal muscle M2.
Hence, specimen M1 expressed GST subunits of M, 24800, 26000 and 26300, whereas
both specimens M2 and M3 expressed not only these three polypeptides but an additional
GST subunit of M, 26700.
5.04 Purification of skeletal muscle GST
5.04a Resolution of muscle GST by chromatofocusinq f.p.l.c.
The GST that were eluted from Mono Q in peak P1 were purified further by chromato-
focusing on Mono P. The material recovered in peak P1 from skeletal muscle specimen
M2 was resolved on this column into one major peak P1-A and three minor peaks, P1-B,
P1-C and P1-D (Figure 5.03a). The protein-containing fractions were combined and their
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Figure 5.03 Chromatofocusing of partially purified skeletal muscle GST isoenz)
and SDS/PAGE of resulting peaks
Skeletal muscle GST activity, from specimens M2 and M3, purified by S-hexylglutath
affinity chromatography and anion-exchange chromatography on Mono Q (P1),
resolved by chromatofocusing on Mono P f.p.l.c. as described in section 4.06b (pa
and panel c respectively). Transferase activity with 1-chloro-2,4-dinitrobenzen
substrate (*) and protein concentration (o) were measured, and the pH was monil
( ). Fractions were combined, as indicated by the horizontal bars, and the su-
composition was analysed by SDS/PAGE (panel b and panel d). The first lane on
gel was loaded with the material applied to the chromatofocusing column (P1; A fig)
shown, the following lanes contained the pools obtained from Mono P; P1-A (4//g),
(1.5 jug), P1-C (4 jug) and P1-D (3 fig) from specimen M2 and P1-A' (2.5 fig)
specimen M3. The mobility of the marker protein human GST (Mr 26700) which


























subunit compositions examined by SDS/PAGE (Figure 5.03b). Peak P1-A, which was
eluted from the chromatofocusing column at pH 5.9, contained the two subunits that co-
migrated during SDS/PAGE with the liver GST standards of Mr 26000 and 26700.
Electrophoresis showed that peak P1-B also contained these two subunits of Mr 26000
and 26700 as well as the polypeptide of Mr 28500. P1 -C, the only peak which did not have
GST activity with 1-chloro-2,4-dinitrobenzene as substrate, contained the contaminant
polypeptide of Mr 28500. Peak P1 -D contained trace amounts of the contaminant and the
GST subunit with Mr 26000. When the GST present in peak P1 from skeletal muscle M3
were subjected to the same chromatofocusing step only one protein peak, which eluted
at pH 5.25, was recovered from the column (Figure 5.03c). SDS/PAGE showed that this
peak (P1-A') also contained two subunits of Mr 26000 and 26700 (Figure 5.03d).
5.04b Separation of a Mu-class and a Pi-class skeletal muscle GST
Hydroxyapatite h.p.l.c., a technique that resolves the different classes of human hepatic
GST (Hussey et a/.,1986), was employed to separate the subunit forms present in peak
P3 obtained from all three muscle specimens. The profile obtained when material from
specimen M2 was applied to this column is illustrated in Figure 5.04a. The first peak,
which was eluted on the early part of the phosphate gradient, indicated the presence of
Pi-class GST, and the second peak, which was eluted in the middle part of the gradient,
indicated the presence of Mu-class subunits. Analysis by SDS/PAGE (Figure 5.04b)
confirmed that the first peak (P3-A) contained the subunit with the same mobility as GST
71, whereas the second peak (P3-B) contained the subunit with an estimated Mr of 26000.
Similar results were obtained when the GST present in peak P3 from skeletal muscle
specimens M1 and M3 were separated by chromatography on hydroxyapatite h.p.l.c.
5.04c Characteristics of isoenzymes purified
The results of the purification of GST from skeletal muscle specimens M1, M2 and M3 are
summarized in Table 5.01. A different profile of GST isoenzymes was obtained from the
skeletal muscle tissue of each of the three individuals studied.
Each of the muscle samples from the three individuals expressed two Mu-class
isoenzymes and a Pi-class isoenzyme. The two Mu-class, which were designated GST
N2N3 and GST N2N2, were recovered respectively in peak P6 from Mono Q, and in peak
P3-B obtained following hydroxyapatite h.p.l.c. The GST N2N3 from specimen M3 was not
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Figure 5.04 Hydroxyapatite chromatography of partially purified skeletal m
GST isoenzymes and SDS/PAGE analysis of pooled fractions
Enzymes purified from skeletal muscle specimen M1 by S-hexylglutathione-a
chromatography and anion-exchange chromatography on Mono Q (P3) were fi
resolved by chromatography on Bio-Gel HPHT as described in section 4.05a (par
The column was developed with a linear 10-350 mM sodium phosphate gra
indicated by the straight line, and the A,80 was monitored ( ). SDS/PAGE analysis
combined fractions, indicated by the horizontal bars, is shown in panel b. The mot
of the human GST markers n (Mr 26700) and n (Mr 24800) are indicated. The firs!
contained the material applied to the hydroxyapatite h.p.l.c. column (P3; 4 fig).
















Cytosol Affinity-chromatography pool MonoQf.p.l.c.ols: P1 P3 P6(N2N3) MonoPf.p.l.c.ool: P1-A(N,aN2) P1-A'(N,bN2) HPHTh.p.l.c.pools: P3-A(Pi) P3-B(N2N2)
900774212533 19.8423 3 3.9 2.7 0.66 0.593.1 4.1 0.9 1.12 0.73 1.14
1.3 7.2 1.09 1.44 1.75
5419 2245 933.0 253.0 74.0 100.8
4817 3817 631.2 1160 1630 152.0 87.6 243.0
6063 4746 361.4 2108 221.8 149.3 486.5
0.60498 77.8196.7203 201.082 3 240.583 692 8 92.3187.4 135.7
203.5
112.520 003 7 171.12138 0
100 41.479 28.3 13.16.0 17.224 13 8 4.73 4 1.4 1.93.2 1.8 5.0
3.7 2.4 8.0
purified due to the very low level of its expression in this tissue, as indicated by the size
of peak P6 on Mono Q. The Pi-class GST was resolved on hydroxyapatite h.p.l.c. in peak
P3-A.
Specimens M2 and M3, however, each expressed a different, additional Mu-class GST to
those described above which was isolated, in each case, using chromatofocusing f.p.l.c.
GST N/Nj was recovered from specimen M2 in peak P1 -A, which eluted at pH 5.9 from
Mono P, and GST N,bN2 was purified from specimen M3 as peak P1-A' which eluted from
the chromatofocusing column at pH 5.25.
The characterization of the Mu-class GST N^Ng, N^Nj, N2N2, and N2N3 will be presented
in detail in Chapter 8.
5.05 Isolation of skeletal muscle Mu-class GST subunits
Reverse-phase h.p.l.c. was used in an attempt to prepare separately the individual
subunits present in the skeletal muscle GST isoenzymes (section 4.05b). This technique
successfully resolved the N2 and N3 subunit and could also be used to purify further GST
N2N2 (P3-B) by removing small quantities of the 28500-Mr polypeptide that contaminated
certain preparations. Figure 5.05a shows the elution profiles obtained when GST N2N2
(P3-B) and GST N2N3 (P6) , purified from skeletal muscle specimen M1, were applied to
the n Bondapak column. Electrophoretic analysis (Figure 5.05b) revealed that the major
peak, which was present on both profiles eluting between 37 and 41 min, contained the
N2 subunit of Mr 26000. The N3 subunit, of Mr 26300, was recovered in two peaks which
eluted at 50 min and 56 min. The N,a and N2 subunits present in GST isolated from
skeletal muscle sample M2, were not resolved by this technique; both subunits eluted as
a single peak at 40 min.
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Figure 5.05 Preparative reverse-phase h.p.l.c. of human skeletal muscle
subunits and SDS/PAGE analysis of resulting peaks
The GST pools P3-B, containing isoenzyme N2N2, and P6, containing isoenzyme
from skeletal muscle sample M1 were each subjected to reverse-phase h.p.l.c. (pa
on a Waters n Bondapak C18 column (10/im particle size; 0.39 cm x 30 cm). The ci
was developed with a 40-70% (v/v) acetonitrile gradient in aq. 0.1% (v/v) trifluoro
acid in two stages as shown by the straight lines. The A^ of the eluate was mon
continuously ( ). The GST N2 and N3 subunits which were resolved by this methoc
collected and freeze-dried prior to analysis by SDS/PAGE (panel b). The first track s
contained P3, the GST pool obtained after anion-exchange chromatography on M<
of total S-hexylglutathione affinity purified material (4//g). The second track conl
pool P3-B purified on hydroxyapatite h.p.l.c. (4 /ug). The N2 subunit, purified frorr
P3-B on reverse-phase h.p.l.c., was loaded into the third track shown. The fourth
contained pool P6, purified by affinity chromatography and anion-exchange chroma
phy on Mono Q (4 //g). The N2 and N3 subunits resolved by reverse-phase h.p.l.c
pool P6 were loaded into the final three tracts as shown. The mobilities of the
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Figure 5.05
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Chapter 6 Purification of human testicular GST
6.01 Human testis GST
High concentrations of Basic (Alpha-class) and Near-neutral (Mu-class) GST have been
found in human testis using radial immunodiffusion (Corrigall and Kirsch, 1988). Others
(Aceto et al., 1989), who attempted to characterize the GST isoenzymes present in
testicular tissue, described preparations that they were unable to related to any of the GST
characterized previously.
The purification of Alpha-class GST B,B, and a distinct Mu-class GST from a human testis
sample from one individual is presented in this chapter.
6.02 Purification protocol for human testis GST
To allow comparisons between the GST isoenzyme profile of human testis and that of
skeletal muscle an identical purification strategy, to that described in the previous chapter,
was used. Anion-exchange f.p.l.c. of an affinity-purified isoenzyme mixture resulted in the
purification, in two chromatographic steps, of an Alpha-class and a Mu-class GST.
Scheme 6.01 outlines the stages involved in the isolation of human testis GST; a more
detailed account is given in section 4.08.
6.03 Resolution of testicular GST isoenzymes
Human testis cytosol was found to be a comparatively rich source of GST. The S-
hexylglutathione-affinity-purified isoenzyme pool from specimen T3 accounted for 0.7% of
the total cytosolic protein. When this isoenzyme mixture was subjected to anion-exchange
f.p.l.c. 62.8% of the affinity-purified protein failed to be retained by the Mono Q column.
The remainder of the affinity-purified pool was resolved on the salt gradient into seven
peaks, P(i)-P(vii), all of which contained activity towards 1-chloro-2,4-dinitrobenzene
(Figure 6.01a). In terms of protein recovered, however, the major GST forms were present
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Scheme 6.01 Purification of human testicular GST
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Figure 6.01 Anion-exchange f.p.l.c. of affinity-purified GST isoenzymes from hu
testis and SDS/PAGE of combined fractions
S-Hexylglutathione-affinity-purified GST activity from human testis sample T3 was resc
by anion-exchange chromatography on Mono Q (panel a) as described in section 4
The column was developed with a two-step linear 0-1.0 M NaCI gradient as shown b
straight lines and the resulting fractions were assayed for protein concentration (o)
GST activity with 1-chloro-2,4-dinitrobenzene as a substrate (a). Those frac
containing GST activity were pooled, as indicated by the horizontal bars, and subje
to electrophoretic analysis (panel b). The first track on the SDS/PAGE gel shows the
S-hexylglutathione-affinity-purified material (TOT; 6 //g). The second track was lo<
with the GST activity which was not retained by the Mono Q column (FT; 6 /vg), anc
following seven tracts contained the peaks of activity resolved by the salt gradient (Pi
4 /jg). The positions of the human GST subunit markers p (Mr 26700) and n (Mr 241
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Figure 6.01
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Electrophoretic analysis (Figure 6.01b) of the fractions eluting from the anion-exchange
column revealed the presence of a single 26000-Mr polypeptide in the flow-through
material. The first peak, P(i), resolved on the gradient also contained a single band of
subunit Mr 26000. Peaks P(ii) and P(iii) contained polypeptides which co-migrated with
the hepatic subunit standards of Mr 26000 and 26700, but also contained additional high
molecular weight subunits of Mr 31500, in the case of P(ii), and 28500 in the case of P(iii).
SDS/PAGE of peak P(vi) showed the presence of two bands; the predominant subunit co-
migrated with the GST n standard (Mr 24800) and a second subunit which had an Mr of
26000. Although the minor peaks P(v) and P(vi) were not well resolved they each
appeared to have a different subunit composition; a single polypeptide of Mr 26500 was
present in P(v), whereas P(vi) contained bands of M, 26000 and 26300.
At least five cytosolic GST subunits (Mr 26000, 26700, 24800, 26500 and 26300) were,
therefore, expressed in testis sample T3. Details of the purification of the testicular GST
enzymes are presented in Table 6.01.
6.04 Identification of human testis GST
6.04a Comparison of testicular GST with skeletal muscle isoenzymes
If one compares the elution positions of the testis GST subunits, following Mono Q,
together with their subunit compositions, as determined by SDS/PAGE, with those
resulting from Mono Q of affinity purified pools from skeletal muscle (see Figure 5.02), it
is possible to make a tentative identification of some of the GST forms present. The major
testis GST, however, which was not retained by the Mono Q column and possessed a
subunit M, of 26000 (FT), was not present in any of the skeletal muscle samples analysed.
A further electrophoretic characterization of this isoenzyme is presented in the following
section.
The subunit size and elution position of testis peaks P(ii) and P(iii) indicate the presence
of N, (Mr 26700) and N2 (Mr 26000) subunits; peak P(iv), which eluted in the same position
from Mono Q as peak P3 from skeletal muscle (60-75 mM NaCI), appears to contain a Pi-
class enzyme (M, 24800) together with GST N2N2 (Mr 26000); peak P(vi), represented by
peak P6from skeletal muscle, contains GST N2N3; and peak P(vii) contained a major testis
Mu-class GST N3N3 (Mr 26300). Details on the characterization of GST N3N3 are included
in chapter 8. Unfortunately, due to paucity of material it was not possible to further
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characterize the GST subunits of Mr 26000 and 26500 present in peaks P(i) and P(v)
respectively.
6.04b Isoelectric focusing of testis Alpha-class GST
Analytical isoelectric focusing of a portion of the affinity purified isoenzyme mixture from
testis sample T3 revealed the presence of two bands which focused in the basic region
of the gel, at pi's of 8.9 and 8.73, and three minor bands in the acidic region at pi's of
5.25, 5.1 and 4.9 (Figure 6.02). The Mono Q flow-through material, which was analysed
at the same time, contained the GST which focused at a pi of 8.9. The pi and subunit Mr
of this testis GST are identical to those of the hepatic GST 13,6, described by Stockman
et al. (1985). The second basic band of pi 8.73, visible in the affinity purified pool,
probably represents GST B,B2; this isoenzyme has been described as having a pi of 8.75
(Stockman etal., 1985). If this is the case it is possible that peak P(i), resolved on Mono
Q, which has the same subunit size as the human hepatic Alpha-class GST, also
represents B,B2.
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Figure 6.02 Isoelectric focusing of human testicular GST isoenzymes
GST pools obtained by S-hexylglutathione-affinity chromatography of a human 1
cytosolic fraction (TOT; 20//g), followed by anion-exchange chromatography on Mo
f.p.l.c. (FT; 5 fjg) were each analysed by isoelectric focusing. The electrophoresis
carried out using a broad range gel (pH 3.5-9.5) in thin-layer 5% (w/v) polyacrylar
The first track contained protein pi calibration standards, the pi values of whicf
indicated.
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Chapter 7 Purification of the allelic variants of the
human hepatic Mu-class GST
7.01 Human liver Mu-class GST
The Mu-class GST of human liver are represented by two well characterized isoenzymes
termed p. (Warholm eta/., 1983) and xp (Hussey eta/., 1986; Singh eta/., 1987a; Hayes,
1989). These homodimeric proteins are highly homologous (Hayes, 1989), and it has
been suggested that they represent allelic variants coded at a single locus (Board, 1981;
Strange eta/., 1984). The heterodimeric form of these enzymes was purified recently (Van
Ommen eta/.,1990), however the characterization of this GST was not described in detail.
Between 40 and 45% of individuals fail to express either of these Mu-class GST (Strange
et a/., 1984; Hussey et a/., 1987) and there is evidence to suggest that the hepatic Mu-
class GST may provide a susceptibility marker for chemical carcinogenesis (Seidegard et
al., 1986, 1990)). A third hepatic Mu-class GST was identified by Stockman and Hayes,
(1987); this homodimeric enzyme, called <p, was found in only one of 20 human livers
examined.
7.02 Strategy for the analysis of N,-type subunits
In this thesis the subunits which comprise GST n and xp have been designated N,a and
N,b respectively. The purification of two homodimeric and one heterodimeric Mu-class
GST from the liver of an individual (specimen L4; see Table 4.01) who expressed both N,a
and N," subunits is presented in this chapter. The abundance of GST in human liver
cytosol permitted the isolation of these isoenzymes using conventional chromatographic
procedures; affinity-purified material was resolved by hydroxyapatite chromatography
followed by chromatofocusing in the pH range 9-6. The purification steps involved are
described both in detail in section 4.09, and summarized in Scheme 7.01.
In an attempt to further establish the relationship between the N,-type subunits and the
N2 and N3 subunits, described in the preceding chapters, the GST present in skeletal
muscle and cerebrum from the individual who expressed the two kinds of N, subunit were
























Scheme 7.01 Purification of Mu-class GST from human liver
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purified material to anion-exchange f.p.i.c. and performing SDS/PAGE on the protein
containing fractions.
7.03 Purification of three hepatic Mu-class GST
The GST isoenzyme mixture, isolated by S-hexylglutathione affinity-chromatography of
cytosol from human liver specimen L4, accounted for 1.1% of the total cytosolic protein.
Hydroxyapatite chromatography was used to separate the GST forms present in the
affinity-purified material into two pools; one of which contained Alpha-class enzymes and
a second which contained Mu-class GST. These pools were separately recovered as two
protein peaks, named PI and Pll, which eluted from the hydroxyapatite column between
50-65 mM and 100-125 mM sodium phosphate respectively (Figure 7.01a). Electro-
phoretic analysis of the fractions (Figure 7.01b) confirmed that peak PI contained a
subunit which co-migrated with the hepatic GST p standard (Mr 26700), together with a
minor 28500-M, contaminant, whereas Pll contained a single band of Mr 26000, which co-
migrated with the human hepatic Alpha-class standard GST B^g.
The hepatic Mu-class GST from specimen L4 (peak PI) were resolved by chromato-
focusing into three protein-containing peaks, PI/A, Pl/B and Pl/C, which eluted from the
column at pH 7.75, 7.45 and 7.15 respectively (Figure 7.02). Each of these peaks
contained a distinct Mu-class GST; PI/A represented N,aN,a (or |x), Pl/B represented
(a heterodimer composed of subunits from p and xp), and Pl/C represented (or xp).
Table 7.01 shows details on the purification of these hepatic Mu-class GST.
The electrophoretic, immunological and enzymatic characterization of the hepatic Mu-class
isoenzymes in comparison with the Mu-class GST isolated from skeletal muscle (Chapter
5) and testis (Chapter 6) are presented in Chapter 8.
7.04 Expression of N^type subunits in extra-hepatic tissue
An affinity-purified pool from the skeletal muscle of the individual who expressed both the
Mu-class GST N,a and N," subunits was resolved by anion-exchange f.p.i.c. into six
protein-containing peaks (Figure 7.03a). Subunit analysis of these peaks was achieved
using SDS/PAGE (Figure 7.03b); peaks 1 and 2, which were poorly resolved, each
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Figure 7.01 Hydroxyapatite chromatography of affinity-purified GST isoenz
from human liver and SDS/PAGE analysis of pooled fractions
Affinity-purified GST isoenzymes from a human liver cytosolic fraction (specimen L4)
subject to chromatography on a column of Bio-Rad HT grade hydroxyapatite as desc
in section 4.04c (panel a). The column was developed with a linear 10-250 mM sc
phosphate gradient (■), and GST activity, with 1-chloro-2,4-dinitrobenzene as sub
(*), and protein concentrations (o) were measured in each of the fractions collected
two peaks of activity (PI and Pll), resolved by the sodium phosphate gradient,
pooled, as indicated by the horizontal bars, and analysed by SDS/PAGE (panel b)
first track shown contained the total S-hexylglutathione-affinity-purified material (T
fxg) and the following two tracks were loaded with the pooled fractions (PI and Pll;
from hydroxyapatite chromatography. The mobilities of the human GST subunit mt
p (Mr 26700) and B^ (Mr 26000) are indicated.
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Figure 7.01
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Figure 7.02 Resolution of human hepatic Mu-class GST by chromatofocusii
Total hepatic Mu-class GST (from specimen L4), purified by affinity-chromatograpt
hydroxyapatite chromatography, were resolved by chromatofocusing as descrit
section 4.04d. The column (1.6 cm x 32 cm), containing polybuffer exchanger PE
was pre-equilibrated in 25 mM Tris/CH3COOH buffer pH 8.9 and following the appli
of protein sample, a pH gradient was formed using polybuffer 96 at pH 5.5. The p
determined at 4 °C (■) in every fifth fraction collected. GST activity, with 1-chloi
dinitrobenzene as substrate (a), and protein concentrations were measured (o).
fractions which were combined are indicated by the horizontal bars.
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Table7.01Purificationofhumaep ticM - l ssGSTis enzymes Forexperimentald tailssect on4.09.GSTa ivitywam asuredith1-chlor -2,4-dinit ob nzene37°C FractionTotalprotein (mg)Totalactivity (i/mol/min)
Specificactivity (wmol/minperg)
Recovery
Cytosol Affinity-chromatography pool Hydroxyapatite chromatographyp ols: PI Pll Chromatofocusing.pH range8.5-5.5,pools: PI/A(N,aN,a) Pl/B(N,aN,b) Pl/C(N,bN,b)
25620 273.6 28.1 162.0 1.5 4.1 3.6
19156±80.0 13440±65. 4119±36.8 6356 285.2±3.9 667.4±15.2 619.3±9.8
0.75±01 49.1±0.24 146.4±.3 39.2 190.1±2.6 162.8±3.7 172.0±2.7
100 70.2 21.5 33.2 1.49 3.48 3.23
Figure 7.03 Analysis by Mono Q f.p.l.c. and SDS/PAGE of human GST isoen
pools purified from skeletal muscle and cerebrum samples fro<
same individual
Anion-exchange chromatography on Mono Q f.p.l.c. of S-hexylglutathione-affinity-pi
GST from a skeletal muscle sample (M4) and a cerebrum sample (C4), obtained fro
same individual (see Table 4.01) was performed as described in section 4.06a. P
a and c show the elution profiles resulting from chromatography of material purifier
samples M4 and C4 respectively. The Mono Q columns were each developed wit
1.0 M NaCI gradient, established in two stages, as shown by the straight lines,
activity, with 1 -chloro-2,4-dinitrobenzene as substrate (*), and protein concentration*
measured (o). The protein-containing fractions which are indicated by arrows-
analysed by SDS/PAGE (panels b and d). The first lane on each gel contains the t<-
hexylglutathione-affinity-purified material from each tissue specimen (TOT; 6 jug), ai-
following lanes contain the fractions resulting from Mono Q f.p.l.c. as shown. The h-
GST markers ji (Mr 26700) and n (Mr 24800) were run in parallel and the mobili
























contained bands of subunit Mr 26700 and 26000, together with a 28500-Mr polypeptide;
peak 3, which had no GST activity towards CDNB, contained the high molecular weight
28500-Mr subunit; peak 4 contained three bands of Mr 28500, 26000 and 24800; peak 5
contained two subunits of Mr 26300 and 26000; and peak 6 contained the polypeptide
bands of Mr 26300 and 22500. The GST forms present in the peaks analysed can be
identified from their electrophoretic and chromatographic properties. Hence, peaks 1 and
2 both contain Nrtype (Mr 26700) and N2 (Mr 26000) subunits; peak 4 contains N2 and Pi-
class GST subunits (Mr 24800); and peak 5 contains N2 and N3 (Mr 26300) subunits.
When a cerebrum sample from the same individual was subjected to the same analytical
procedure a more complex pattern of isoenzyme expression was observed (Figure 7.03c).
Nine protein-containing fractions from the Mono Q column, seven of which had GST
activity towards CDNB, were analysed by SDS/PAGE (Figure 7.03d). Those fractions
which did not posses GST activity (3 and 5 as indicated) contained the 28500-Mr
polypeptide. Protein peak 1 contained Nrtype subunits (Mr 26700); peaks 2 and 4 both
contained N,-type and N2 (Mr 26000) subunits; peak 6, which contained the major GST
form, yielded a subunit which co-migrated with the GST n (Mr 24800) standard; peak 7
contained a subunit of Mr 25500: peak 8 contained N2 and N3 (Mr 26300) subunits; and
peak 9 contained N3 subunits.
The chromatographic profiles obtained following anion-exchange f.p.l.c. of skeletal muscle
and cerebrum samples from this individual, therefore, both posses two protein peaks (1
and 2 in muscle; 2 and 4 in cerebrum) which contain N,-type and N2 subunits. This
indicates that two heterodimeric proteins formed by the combination of the N2 subunit with
either N,a or N,b subunits are expressed in these extra-hepatic tissues. The heterodimeric
enzyme formed by the combination of Nrtype and N3 subunits was difficult to identify;
however, it may be represented by peak 7, obtained following chromatography of the
cerebrum sample, which contained a Mr 26500 polypeptide.
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Chapter 8 Characterization of human Mu-class GST
Until recently only four homodimeric Mu-class GST had been identified and characterized.
These included the hepatic enzymes \i, xp (Warholm ef a/.,1983; Hayes, 1989) and <p
(Stockman and Hayes, 1987), and a skeletal muscle form called GST4 (Board etal., 1988).
The work presented in this thesis includes the purification of five extra-hepatic (N^Nj,
N1bN2, N2N2, N2N3 and N3N3) and three hepatic (N^N,8, and N^N,") Mu-class GST
isoenzymes which are formed by the association of four N-type subunits. In order to
establish the molecular relationships between these forms the catalytic, immunochemical
and structural properties of the multiple human Mu-class GST have been investigated.
8.01 Physical properties of hepatic and extra-hepatic Mu-class GST
Analytical isoelectric focusing in thin-layer polyacrylamide slab gels was carried out on all
of the purified Mu-class GST (Figure 8.01). All of the isoenzymes focused into single
bands, thereby confirming their purity and allowing a pi value to be assigned to each
GST.
SDS/PAGE analysis of the purified Mu-class isoenzymes is shown in Figure 8.02. In order
to permit the designation of molecular mass values to these enzymes the human subunit
markers (Mr 26000), p. (Mr 26700) and tt (Mr 24800) were used to calibrate the gel.
The homodimeric enzymes N^N,8, N^N,", N2N2 and N3N3 all gave a single band following
electrophoresis. A close examination of the polyacrylamide gel revealed that N,bN,b
migrated slightly faster than N^N,8 and their apparent Mr values were calculated as 26600
and 26700 respectively. The protein bands present in the heterodimeric GST N,8N,b were
not resolved by SDS/PAGE, unlike the subunits which comprised the heterodimers N,bN2
and N2N3 which were clearly separated by this technique. Table 8.01 shows the pi and
Mr values assigned to the purified Mu-class GST.
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Figure 8.01 Isoelectric focusing of human hepatic and extra-hepatic Mu-class
isoenzymes
Isoelectric focusing (IEF) was performed in a broad range gels, pH 3.5-9.5, in 5%
polyacrylamide. Panels a, b and c show the electrophoretic analysis of eight humai
class GST (7-10//g protein loaded). Protein calibration standards (STD) were run on
gel and the pi values of these marker proteins are indicated. Isoenzymes N^N,3, t
and (panel a) were purified from liver sample L4 by S-hexylglutathione-a
chromatography followed by hydroxyapatite chromatography and chromatofocusii
the pH range 8.5-5.5, as described in section 4.09. N^N., and N2N2 (panel a)
isolated from skeletal muscle sample M3 by a combination of affinity chromatograph
anion-exchange chromatography on Mono Q f.p.l.c followed by either chromatofoc
in the case of N1bN2, or hydroxyapatite h.p.l.c. in the case of N2N2. Details o
purification of the skeletal muscle enzymes are described in section 4.07. The purific
of the testicular GST N3N3 (panel a), described in section 4.08, involved a
chromatography followed by Mono Q f.p.l.c. Panel b shows isoelectric focusing of
which was purified from skeletal muscle sample M2 by affinity chromatography, s
exchange chromatography on Mono Q followed by chromatofocusing on Mo-
Isoenzyme N2N3 (panel c) was purified from skeletal muscle sample M1 by a combir
































Figure 8.02 SDS/polyacrylamide-gel electrophoresis of human Mu-class
isoenzymes
SDS/PAGE analysis was performed, according to the method of Laemmli (1970), uj
resolving gel which contained 12% (w/v) polyacrylamide and 0.32% (w/v) N.N'-mettr
bisacrylamide. The human GST subunit markers 6,82 (Mr 26000), jx (Mr 26700) and
24800) were loaded into the first three tracks. The following seven tracks conl
human Mu-class GST purified from liver sample L4 (N,aN,a, N,aN,b and N^N,"), sf
muscle samples M3 (N,bN2 and N2N2) and M4 (N2N3), and testis sample T3 (N3f
indicated. The purification procedures used are described both briefly in the lege
Figure 8.01 and in detail in sections 4.07, 4.08 and 4.09.
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8.02 Immunological properties of human Mu-class GST
Western blot analysis of skeletal muscle GST subunits is shown in Figure 8.03. The
subunits which comprise the isoenzymes N2N2 and N2N3, and those from peak P3-A,
isolated on hydroxyapatite h.p.l.c., were purified on reverse-phase h.p.l.c. before being
probed with antisera raised against the human GST B^,, p and n. GST subunits N2 and
N3 cross-reacted with anti-(p) IgG but not with antisera raised against either Alpha- or Pi-
class GST. By contrast, the component of peak P3-A was found to cross-react with
antibodies to Pi-class GST but not with other antibodies against other GST.
Purified human Mu-class GST were also challenged with antisera raised against both
human and rat Mu-class isoenzymes, in an attempt to differentiate between the N,-type,
N2 and N3 subunits (Figure 8.04). No immunochemical differences were apparent
between GST and N^N,". These hepatic enzymes cross-reacted strongly with
antibodies raised against human GST N^N," (or p) and N2N2, and rat GST Y^Yb,, YnYn
and Y0Y0, however, no cross-reactivity was observed between these enzymes and anti-
(n3n3) IgG. The isoenzyme purified from skeletal muscle, GST N2N2, was immuno¬
chemical^ related to the isoenzymes containing N^type subunits. However, when the Mu-
class GST were probed with anti-(N1aN1a) IgG, differences in the intensity of the peroxidase
staining was observed between the Nrtype and the N2 subunits. The Nrtype subunits
also cross-reacted to a greater extent, than the N2 subunits, with antisera raised against
the various rat Mu-class GST.
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Figure 8.03 Cross-reactivity of skeletal muscle GST subunits with antisera i
against human Alpha, Mu and Pi-class GST
Immunochemical analysis of individual skeletal muscle GST subunits was performed
the Western Blot technique described by Towbin etal. (1979). GSTN2N2, N2N3 and p
purified from skeletal muscle sample M1, as described in section 4.07, and the su
present in these isoenzymes were separated by reverse-phase h.p.l.c. usinc
Bondapak column developed with a 40-55% (v/v) acetonitrile gradient in 0.1 °a
trifluoroacetic acid. SDS/polyacrylamide gels were loaded as follows; tracks 1,2;
human GST standards 6,62, p and tracks 4 and 5, skeletal muscle Pi-class sut
track 6 the N2 subunit obtained following reverse-phase h.p.l.c. of N2N2; track 7
subunit isolated from N2N3 by the same technique; tracks 8 and 9, the N3 subunit re:
following reverse-phase h.p.l.c. of N2N3. The proteins were transferred electrophore
onto nitrocellulose paper and probed for cross-reactivity with specific antisera
against human GST B^, (panel a), GST p, or N^N,®, (panel b) and GST n (pane
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(a) Anti-(B1B1) IgG





Figure 8.04 Immunoblot analysis of human Mu-class GST purified from si
muscle, testis and liver
Purified hepatic and extra-hepatic human Mu-class GST were subjected to immu
analysis (Towbin ef a/., 1979) using antisera raised against human Mu-class GST
(a), N2N2 (b) and N3N3 (c) and rat Mu-class GST Y^Yb, (d), YnYn (e) and YoYo (f). F
(1 /ig/band) was applied to SDS/polyacrylamide gels as follows; track 1, the a
against which the relevant antiserum was raised; tracks 2, 3 and 4, human GST E
and n standards; tracks 5 and 6, the hepatic (L4) GST and N^N,"; track 7, s
muscle (M3) GST N,bN2; track 8, skeletal muscle (M3) GST N2N2; track 9, skeletal r
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The subunit which comprises the testis enzyme GST N3N3 was immunochemical^ distinct
from the other human Mu-class subunits. No cross-reactivity was observed between GST
N3N3 and antisera raised against GST N2N2, and only a very slight cross-reactivity was
apparent when this GST was probed with anti-(N,aN1a) IgG. When the human Mu-class
GST were challenged with antisera raised against GST N3N3 the only apparent cross-
reactivity occurred with the immunogen and the N3 subunit component of GST N2N3. An
immunochemical relationship, however, existed between GST N3N3 and the rat Mu-class
GST Y^Yb,, YnYn and YoYo; the strongest cross-reactivity being apparent between this
enzyme and with antisera raised against GST Yb,Yb, and YoYo.
8.03 Catalytic properties of human Mu-class enzymes
The specific activities of the human Mu-class GST, purified from liver skeletal muscle and
testis, and a Pi-class enzyme, purified from skeletal muscle, with a range of substrates are
shown in Table 8.02. All of the enzymes had activity towards the substrate 1 -chloro-2,4-
dinitrobenzene, however, the activity of the testis enzyme was considerably lower than that
of the other GST. Different patterns of activity were also observed when frans-4-phenyl-3-
buten-2-one, 1,2-dichloro-4-nitrobenzene and para-nitrobenzyl chloride were employed as
substrates for these enzymes. The homodimeric GST N2N2 and the heterodimeric GST
N2N3 both had activity with 1,2-dichloro-4-nitrobenzene but no detectable activity towards
either frans-4-phenyl-3-buten-2-one or para-nitrobenzyl chloride, unlike the hepatic
enzymes, N^N,8, N^N," and N^N,", where the converse was true. The heterodimeric GST
N^Nj, however, had activity towards all three of these substrates. None of the enzymes
examined had activity with bromosulphophthalein as substrate. The hydroxyalkenals, 4-
hydroxynonenal and 4-hydroxydecinal, however, were good substrates for all of the Mu-
class GST. Those isoenzymes which contained N,-type subunits had the highest activity
towards cumene hydroperoxide and the skeletal muscle Pi-class enzyme (P3-A) was the
most active towards ethacrynic acid.
8.04 Structural properties of human Mu-class GST
8.04a N-Terminal amino acid sequence analysis
The GST subunits which comprise the skeletal muscle isoenzymes N^Nj, N2N2 and N2N3
were subjected to N-terminal sequence analysis in order to help establish the molecular
relationship between the muscle enzymes and to provide evidence that the polypeptide
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of Mr 26000, that has been designated N2, is indeed a common subunit. Before sequence
analysis the N2 and N3 subunits, from GST N2N2 and N2N3, were isolated using reverse-
phase h.p.l.c., as described in section 5.05. The results of these analyses are shown in
Figure 8.05.
The subunits of Mr 26000 present in the N2N2 homodimer and the N2N3 heterodimer were
shown to have identical N-terminal sequences over the first ten residues. Although the
subunits in GST N,aN2 could not be separated on the n Bondapak C18 column it was
possible to interpret the sequence data obtained from the heterodimeric protein over most
the residues analysed. The direct sequencing of GST N,aN2 yielded unambiguous
assignments from cycles 1, 2, 4, 5, 6, 7, 9,10 ,11,12,13 and 14, but at residues 3, 8 and
15 the Sequenator identified two amino acids, namely threonine or isoleucine at cycle 3,
asparagine or aspartic acid at cycle 8 and serine or alanine at cycle 15. When these
sequences were compared with those of human Mu-class GST described in the literature,
it was apparent that one sequence could be attributed to that of human liver GST n or xp
(Alin et al., 1985a; Hayes, 1989) and the other was identical with the 24 residues
published for the skeletal muscle enzyme GST4 (Board etal., 1988). These data suggest
that the subunit of Mr 26000, designated N2, in GST N,aN2, N2N2 and N2N3 represents the
same polypeptide. The N3 subunit that was purified by reverse-phase h.p.l.c. was found
to posses a blocked N-terminus and could not be sequenced directly.
8.04b Primary structure of the Mu-class GST NoN., and N,N,
Protein sequencing of the skeletal muscle enzyme GST N2N2 and the testicular GST N3N3
was possible following cleavage of these proteins with cyanogen bromide. When the
resulting peptides, from the two enzymes, were resolved by reverse-phase h.p.l.c. on the
Bondapak C18 column markedly different profiles were obtained (Figures 8.06 and 8.07).
The protein sequence information obtained from the muscle Mu-class GST N2N2 has
enabled the comparison of 52% of its primary structure with that of other human Mu-class
enzymes reported in the literature. Four of the fragments CNBr-2, CNBr-5, CNBr-6 and
CNBr-7, represented by peptide-containing peaks a, b, c and d respectively (Figure 8.06),
were subjected to automated amino acid sequencing. In Figure 8.08 the amino acid
sequences obtained from these peptides, together with the N-terminal sequence of
subunit N2 (CNBr-1), are aligned with the homologous sequences deduced from the
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Figure 8.05 N-terminal amino acid sequences of human N-type GST subunits
Before sequence analysis the individual subunits from purified skeletal muscle isoenzymes
N2N2 and N2N3 (sample M1) were isolated using reverse-phase h.p.l.c. as described in the
legend to Figure 5.05. The subunits present in GST N1aN2 (sample M2) could not be
separated on the ^ Bondapak column, therefore, this heterodimeric protein was analysed
directly. N-terminal amino acid sequences were obtained following automated Edman
degradation as described in section 3.04c. Subunit N3 has a blocked N-terminus. The
N-terminal amino acid sequences of GST p. (or N,aN,a) (Hayes, 1989) and GST4 (Board
et at., 1988) are aligned for comparison.
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Figure 8.06 Preparative peptide map of human GST N2N2
Peptides were obtained following cyanogen bromide digest of GST N2N2 (1.0 mg), p
under reducing conditions, as described in section 3.04a. The CNBr-cleaved frag
were dissolved in 1.5 ml of aq. 0.1% (v/v) trifluoroacetic acid and, after centrifuc
portions (0.5 mg of protein) were applied to a Waters p Bondapak C18 column (
particle size; 0.39 cm x 30 cm) that had been equilibrated with aq. 0.1%
trifluoroacetic acid. A linear gradient of 0-70% (v/v) acetonitrile in aq. 0.1%
trifluoroacetic acid, indicated by the straight line, was used to resolve the peptides





Figure 8.07 Preparative peptide map of human GST N3N3
A CNBr digest of a portion (0.7 mg) of purified testis GST N3N3 was prepared as des
in section 3.04a. The resulting CNBr-cleavage fragments were dissolved in 1.5 ml
0.1% (v/v) trifluoroacetic acid before application of 1.0ml to a reverse phase ji Bon
column, pre-equilibrated in aq. 0.1% (v/v) trifluoroacetic acid. The column was devi
with a 0-70% (v/v) acetonitrile gradient in 0.1% (v/v) trifluoroacetic acid, as indica
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Figure 8.08 Comparison of the primary structure of the N2 subunit with those of
other human Mu-class GST
The N-terminal amino acid sequence (CNBr-1) and the sequences of the CNBr-derived
peptides from subunit N2 are aligned for comparison with the homologous sequences
deduced from the cDNA GTH4 (DeJong et al., 1988) and the available homologous
sequences deduced from the genomic DNA clones GST mu2 and GST mu3 (Taylor et al.,
1990,1991). Putative methionine residues are in parentheses and a dash indicates where
no residue could be identified with confidence. An asterisk (*) indicates amino acid
residues that differ between the sequences.
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human hepatic cDNA clone GTH4, reported by DeJong et al. (1988), and the sequences
deduced from the human Mu-class genomic clones, GST mu2 and GST mu3, described
by Taylor etal. (1990, 1991).
Comparison of the N-terminal sequence of GST N2N2 (peptide CNBr-1) with that of the
GTH4 clone reveals the three amino acid differences found at positions 3, 8 and 15
predicted from the N-terminal sequence analysis of GST p. and GST xp discussed in
section 8.04a. This is followed by a region of complete identity between the two
sequences from residue 16 to residue 38. The peptide CNBr-2, which eluted from the n
Bondapak C18 column at 44.5 min (peak c), was subjected to 45 automated Edman
degradation cycles, allowing identification of residues 34-78. Over this region of the
predicted protein amino acid sequence, information deduced from the genomic clones
GST mu2 and GST mu3 is available for comparison with subunit N2. Amino acid
differences were apparent between the sequence of the N2 subunit peptide CNBr-2 and
those of the proteins encoded by clones GTH4 and GST mu2. At position 66 the N2
subunit contains threonine whereas the proteins encoded by clones GTH4 and GST mu2
contain alanine, and at position 77 the N2 subunit possesses arginine whereas the
proteins encoded by clones GTH4 and GST mu2 both contain cysteine. However, when
the sequence of the N2-subunit peptide CNBr-2 is compared with that of the protein
encoded by clone GST mu3 it is apparent that the two sequences correspond exactly over
the region where sequence data on this genomic clone are available (i.e. residues 37-78).
Residues 133-153 of subunit N2 were identified by sequencing the peptide, CNBr-5, that
was eluted at 51 min from the p. Bondapak C18 column (peak d). Five amino acid
substitutions were present between the sequence of N2-subunit peptide CNBr-5 and that
of the protein encoded by clone GTH4. At position 133 a methionine residue, which has
provided a CNBr-cleavage site, can be assigned to subunit N2, whereas the protein
encoded by clone GTH4 contains a lysine residue. The other four amino acid changes
between the N2-subunit peptide CNBr-5 and the protein encoded by clone GTH„, at
positions 139, 144, 148 and 150, were as follows: glutamine to glutamic acid, glutamine
to arginine, leucine to alanine and aspartic acid to asparagine, respectively. The N2-
subunit peptides CNBr-6 and CNBr-7, which were eluted at 30 min and 23 min from the
reverse-phase column (peaks b and a), contained residues 198-210 and residues 212-217
respectively. No differences were apparent between this C-terminal region of the N2
subunit and the homologous region of the protein encoded by clone GTH4.
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Cyanogen bromide cleavage of GST N3N3 permitted the sequencing of one peptide (CNBr-
6), which eluted at 41.5 min from the jx Bondapak C18 column, represented by peak a on
the chromatogram shown in Figure 8.07. The homologous region of the protein encoded
by clone GTH4 (residues 184-204), together with a sequence deduced from the cDNA
clone HTGT-6 (Campbell et al., 1990) are shown aligned for comparison with the amino
acid sequence of the N3-subunit peptide (Figure 8.09). Of the fourteen residues from the
N3-subunit peptide CNBr-6, which could be identified with confidence, only six were
identical to those of the protein encoded by clone GTH4. The eight amino acid changes
between the N3-subunit peptide CNBr-6 and the protein encoded by clone GTH4 were as
follows: methionine to isoleucine, alanine to serine, leucine to methionine, glutamine to
lysine, aspartic acid to serine, glutamine to arginine, cysteine to leucine and lysine to
proline. However, when the sequence of the N3-subunit peptide CNBr-6 is compared with
that of the protein encoded by clone HTGT-6 it is apparent that the two sequences
correspond exactly.
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Figure 8.09 Comparison of a part of the primary structure of the N3 subunit with the
sequences of other human Mu-class GST
The amino acid sequence of a CNBr-derived peptide (CNBr-6) from subunit N3 is shown
aligned for comparison with the homologous sequences deduced from the cDNA GTH4
(DeJong et al„ 1988) and the cDNA HTGT-6 (Campbell et a/., 1990). Residues are
numbered according to the amino acid sequence deduced from cDNA HTGT-6, which
encodes four more amino acid residues, than cDNA GTH4, at the N-terminus. An asterisk
(*) indicates amino acid residues that differ from those in CNBr-6. The putative
methionine residue is in parentheses and a dash indicates a position where no residue
could be identified with confidence.
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Chapter 9 Purification of human hepatic Theta-ciass
GST
9.01 A fourth cytosolic class of GST
Recent reports have described cytosolic GST isoenzymes which are structurally unrelated
to the Alpha, Mu and Pi classes of GST (Hiratsuka ef al., 1990; Meyer ef a/., 1991).
Following the purification of two isoenzymes from rat liver (GST 5-5 and 12-12) and one
from human liver (GST 6) Meyer et al. (1991) have proposed that these isoenzymes
comprise a fourth class of cytosolic GST which should be designated Theta. The Theta-
class GST differ from the GST of the Alpha-, Mu- and Pi-classes in that they lack catalytic
activity towards the commonly used GST substrate 1 -chloro-2,4-dinitrobenzene and are
not retained by the S-hexylglutathione and glutathione affinity matrixes. Substrates that
have been used to identify Theta-class GST and monitor them during purification include
1,2-epoxy-3-(p-nitrophenoxy)propane and 5-hydroxymethylchrysene sulphate.
Prior to the description of Theta-class GST by Meyer et al. (1991) several novel rat liver
GST which catalyse the inactivation of reactive sulphate esters were identified by
Hiratsuka ef al. (1990). One of these isoenzymes, a homodimeric protein called GST
YrsYrs, was purified from rat liver cytosol and like GST 5-5 and 12-12 it was shown to be
structurally and immunologically distinct from Alpha-, Mu- and Pi-class GST. GST YrsYrs
has N-terminal amino acid sequence homology with the Theta-class GST described by
Meyer ef al. (1991), however, unlike these enzymes, it does not possess GST activity
towards 1,2-epoxy-3-(p-nitrophenoxy)propane. The compound 1-menaphthyl sulphate
was found to be the best substrate for GST YrsYrs among the arylmethyl sulphates
examined by these workers.
In this thesis the expression of Theta-class isoenzymes in human liver have been
investigated using activity with the substrate 1-menaphthyl sulphate as a means of
establishing the identity of these GST. The purification of a human hepatic GST active
towards this sulphate ester will be presented in this chapter.
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9.02 Purification strategy for human hepatic Theta-class GST
The purification protocol adopted for the isolation of a human Theta-class GST,
designated T2T2, is depicted in Scheme 9.01. Preliminary experiments revealed that the
chromatographic behaviour of this human enzyme was distinct from that described for
either rat GST YrsYrs (Hiratsuka et al., 1990) or the Theta-class GST purified by Meyer et
al. (1991). Unlike GST YrsYrs, the GST activity towards 1-menaphthyl sulphate present
in a human liver sample was not retained by the dye-ligand Blue Sepharose. However,
Matrex™ Gel Orange A, a chromatographic gel used during the purification of rat GST 5-5
and 12-12 and human GST d (Meyer et al., 1991), was found to bind GST T2T2. The
behaviour of GST T2T2 on anion-exchange chromatography indicated that it was a more
acidic protein than either GST 5-5, 12-12 or 6 , in that it was retained on Mono Q at pH
8.0, whereas a higher pH (9.55) was necessary to retain these Theta-class GST. The 1-
menaphthyl sulphate activity from a human liver sample was also retained during
chromatofocusing on a column containing polybuffer exchanger PBE 94 at pH 7.0. Thus
indicating that the pi of GST T2T2, as estimated by chromatofocusing, is < 7.0.
The purification of GST T2T2 was achieved in four chromatographic steps. Anion-
exchange on DEAE-cellulose was followed by hydroxyapatite chromatography, a
technique which successfully resolves the human hepatic Alpha-, Mu- and Pi-class GST.
The third step involved chromatography on Matrex™ Gel Orange A, which bound a large
proportion of the GST activity towards 1 -menaphthyl sulphate present in the human liver
sample and resulted in a significant increase in specific activity. Finally, chromatography
on Mono Q yielded a homogeneous preparation of GST T2T2.
9.03 Purification of a Theta-class GST from human liver
A cytosolic fraction was prepared from 624 g of human liver as described above (see
sections 4.02 and 4.10). The specific activity of human liver cytosol with 1-menaphthyl
sulphate as substrate was found to reduce significantly with storage at 4 °C. Immediately
following preparation, the specific activity of the cytosol for 1-menaphthyl sulphate was
1.39 ± 0.08 nmol/min per mg of protein, whereas, after 24 h at 4 °C a specific activity of
0.29 ± 0.04 nmol/min per mg was recorded. Because of this dramatic loss of activity the
sample was applied immediately, without prior dialysis, to two columns containing DEAE-
cellulose. These two columns were developed in parallel and the elution profiles













9.01 Purification of human Theta-ciass GST
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Figure 9.01 Elution of human liver cytosolic GST from DEAE-cellulose
Anion-exchange chromatography on DEAE-cellulose was performed at pH 8.25 in 1
Tris/HCI buffer, containing 1 mM EDTA and 0.5 mM dithiothreitol, as described in s
4.04e. Human liver cytosol (specimen L5) was prepared and immediately appl
columns (4.4 cm x 90 cm), containing DE-52. Following a wash with approx. 1000
the equilibration buffer a 0-0.3M NaCI gradient (■) was used to develop the
exchanger. The resulting fractions (11.5 ml) were assayed for GST activity towa
menaphthyl sulphate (•) and 1-chloro-2,4-dinitrobenzene (*) and the absorbance
nm (o) was measured. Those fractions which were combined for further purificath
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GST activity with 1 -chloro-2,4-dinitrobenzene as substrate was not retained by the column
and the remainder eluted as a peak on the salt gradient between 40-60 mM NaCI. A peak
of GST activity towards 1-menaphthyl sulphate, which did not co-elute with the peak of
activity towards 1-chloro-2,4-dinitrobenzene, was resolved between 110-160 mM NaCI on
the salt gradient. A second minor peak of activity towards 1-menaphthyl sulphate, which
was not retained for further purification, eluted on the gradient at 250-280 mM NaCI.
The fractions collected following hydroxyapatite chromatography of the DEAE-cellulose
purified material were assayed for glutathione peroxidase activity with cumene hydro¬
peroxide as substrate as well as GST activity towards 1-menaphthyl sulphate and 1-
chloro-2,4-dinitrobenzene (Figure 9.02). The GST activity towards 1-menaphthyl sulphate
eluted as two peaks on the sodium phosphate gradient; one between 40-70 mM sodium
phosphate and a second between 130-170 mM sodium phosphate. Both of these peaks
contained glutathione peroxidase activity. Those fractions in the first peak of GST activity
towards 1-menaphthyl sulphate (i.e. which eluted at 40-70 mM sodium phosphate) that
were not coincident with activity towards 1-chloro-2,4-dinitrobenzene were pooled for
further purification, as shown in Figure 9.02.
The third purification step involved chromatography on Matrex™ Gel Orange A (Figure
9.03). Approximately one third of the GST activity towards 1 -menaphthyl sulphate was not
retained by this column. However, the remaining GST activity towards 1-menaphthyl
sulphate eluted as a single peak, between 0.2-0.3 M KCI on the gradient, that was well
resolved from the GST activity towards 1 -chloro-2,4-dinitrobenzene. Those fractions active
towards 1-menaphthyl sulphate were also found to contain glutathione peroxidase activity.
The material which was active toward 1-menaphthyl sulphate, that was resolved on the
KCI gradient following Matrex™ Gel Orange A chromatography was subjected to a final
chromatographic step on Mono Q f.p.l.c. (Figure 9.04a). The GST activity towards 1-
menaphthyl sulphate and the glutathione peroxidase activity towards cumene hydro¬
peroxide eluted as a single peak between 80-90 mM NaCI on the salt gradient.
9.04 Purity and subunit analysis of human Theta-class GST T2T2
SDS/PAGE analysis of the fractions from Mono Q revealed that the peak which was active
with 1-menaphthyl sulphate contained a single polypeptide band of subunit Mr 25100
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Figure 9.02 Hydroxyapatite chromatography of human hepatic GST
Material from the DEAE-cellulose column was subjected to chromatography on a c
(3.3 cm x 45 cm) containing hydroxyapatite equilibrated with 10 mM sodium phos
buffer, pH 7.0, that contained 1 mM EDTA and 0.5 mM dithiothreitol, as descril
section 4.04c. A 10-250 mM sodium phosphate gradient (■) was used to develi
column and the eluate was monitored for GST activity towards 1 -menaphthyl sulphj
and 1-chloro-2,4-dinitrobenzene (*), glutathione peroxidase activity towards ci
hydroperoxide (a) and absorbance at 280 nm (o). The horizontal bar indicates the


















































































Figure 9.03 Dye-ligand chromatography of human hepatic Theta-class GST
The preparation of human Theta-class GST recovered from hydroxyapatite was subj<
to chromatography on a column (1.6 cm x 26 cm) containing Matrex™ Gel Oran
equilibrated with 10 mM sodium phosphate buffer, pH 6.8, containing 1 mM EDTA an
mM dithiothreitol. The sample was dialysed extensively against the equilibration t
before application to the column as described in section 4.04b. Following the form
of a 0-1.0 M KCI gradient (■), in the equilibration buffer, the fractions (3.4 ml) collt
were analysed for GST activity using 1-menaphthyl sulphate (•) and 1-chloro-2,4-di
benzene (*) as substrates, glutathione peroxidase activity using cumene hydroper
(a) as substrate and absorbance at 280 nm (o). The peak of GST activity towar-
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Figure 9.04 Purification of a human hepatic Theta-class GST by anion-exc
f.p.l.c. and SDS/PAGE analysis of combined fractions.
The material purified by DEAE-cellulose, hydroxyapatite and dye-ligand chromatoc
was dialysed extensively against 20 mM Tris/HCI buffer, pH 8.4 at 4 °C, containing C
dithiothreitol, before application to Mono Q f.p.l.c. as described in section 4.06a (pa
The column was eluted at 0.75 ml/min and developed with a 0-1.0 M NaCI gradient
dialysis buffer; this gradient was established in two steps as shown by the straigl
Fractions (0.75 ml) were collected and the absorbance at 280 nm ( ) was mon
Those fractions which contained GST activity towards 1 -menaphthyl sulphate were p
as indicated by the horizontal bar, and subjected to SDS/PAGE analysis (panel b).
1, 2 and 3 were loaded with the human subunit markers GST B,B2 (Mr 26000), GS'
26700) and GST n (Mr 24800), respectively. Track 4 contained the pool ot-
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(Figure 9.04b) indicating that the enzyme comprised subunits of equal size. The results
of the purification of this transferase are shown in Table 9.01.
This GST was judged to be 95% pure when analysed by reverse-phase h.p.l.c. (Figure
9.05). Human Alpha-class GST, which were present in an S-hexylglutathione affinity-
purified pool, were applied to the reverse-phase column as a means of calibration;
subunits B, and B2 eluted from the n Bondapak C18 column at 50 and 56 min respectively.
The GST with activity for 1 -menaphthyl sulphate eluted from the reverse-phase column as
a single symmetrical peak at 62 min. As these data suggest that this Theta-class enzyme
is a homodimeric protein containing a single subunit type it has been designated GST
T2T2.
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Table9.01Purificationofhumanep icTheta-classGST Forexperimentald tailssect on4.10.GSTa ivitywam asuredith1- naphthylsulphate37°C FractionTo alproteinlactivityS ec fict itRe ery (mg)(nmol/min)( ol/min/mg)% CytOSOl3816053136±29881.390. 8 Cytosolfoll wing24h at4°C3816011178±540.290421 DEAE-cellulosepo l40305304±3771. 20 99. Hydroxyapatitepool949.51723.5±23 4.820 03. Matrex™GelOrangeA pool3.6825±7.50.1.040 MonoQf.p.l.C.ool0.19596.9±3 7749 .21 40.1
Figure 9.05 Preparative reverse-phase h.p.l.c. of human Theta-class GST
A portion (60 ,wg) of human hepatic GST T2T2, purified by sequential DEAE-ce
chromatography, hydroxyapatite chromatography, Matrex™Gel Orange A chromatoo
and Mono Q f.p.l.c., was subjected to reverse-phase h.p.l.c. on a Waters \i Bondap
column (10 jum particle size; 0.39 cm x 30 cm). The column was developed by &
40-55% (v/v) acetonitrile gradient in aq. 0.1% (v/v) trifluoroacetic acid formed over
that was followed by a 55-70% (v/v) acetonitrile gradient in aq. 0.1% (v/v) trifluon-





Chapter 10 Purification of Theta-class GST from mouse
liver
The cytosolic fraction from the livers of mice fed normal diets contains GST isoenzymes
which are representative of the Alpha-, Mu- and Pi-classes; GST Ya3Ya3, Yt^Yb, and YfYf
respectively (McLellan and Hayes, 1989). To date, the existence of isoenzymes which are
unrelated to any of these three well characterized cytosolic classes of GST has not been
documented in the mouse.
In this thesis, the expression of hepatic murine GST active towards the substrate 1-
menaphthyl sulphate has been investigated, to enable a comparison between rodent
Theta-class forms and the human liver Theta-class GST designated T2T2.
10.01 Strategy for the purification of murine Theta-class GST
An adaptation of the protocol by Hiratsuka et al. (1990), for the isolation of rat GST YrsYrs,
was used for the purification of mouse GST (Scheme 10.01). Murine GST, active towards
1 -menaphthyl sulphate, behaved in a similar manner to GST YrsYrs during DEAE-cellulose
chromatography and chromatofocusing. The mouse GST, like GST YrsYrs, was retained
by the dye-ligand Blue Sepharose. However, this step was omitted from the purification
scheme because a substantial loss of 1 -menaphthyl sulphate conjugating activity (approx.
85%) was observed when it was used in a preliminary study.
10.02 Purification of mouse Theta-class GST
A cytosolic fraction was prepared from the livers of male C57BL6 mice. Following dialysis,
at 4 °C for 24 h, the specific activity of the cytosol, towards 1-menaphthyl sulphate, was
1.56 ± 0.02 nmol/min per mg of protein. All of this activity was retained on DEAE-
cellulose at pH 8.25 and eluted as a single peak between 30-70 mM NaCI on the gradient
(Figure 10.01). The majority of the GST activity towards 1-chloro-2,4-dinitrobenzene, on













Chromatofocusing, pH range 9.5-6.5
Pool... ABC
Scheme 10.01 Purification of murine Theta-class GST
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Figure 10.01 DEAE-cellulose chromatography of murine hepatic GST
Hepatic cytosol, prepared from the livers of C57BL6 adult male mice, was dialysed agi
two changes, each of 5 litres, of 10 mM Tris/HCI buffer, pH 8.25, containing 1 mM E
and 2 mM 2-mercaptoethanol, before application to a column (4.4 cm x 90 cm) contai
DE-52 equilibrated in the same buffer. A non-linear 0-0.3 M NaCI gradient (■), ir
dialysis buffer, was used to develop the column and the fractions (11.5 ml) collected
analysed for GST activity towards 1-menaphthyl sulphate (•) and 1 -chloro-2,4-dii-
benzene (a). The absorbance at 280 nm (o) was also measured. The fractions w
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The protein present in the material isolated by anion-exchange chromatography was
treated with ammonium sulphate and the protein precipitated between 30-90% saturation
was collected. Gel filtration, on Sephadex G-100, of the concentrated sample resulted in
the elution of one peak of GST activity.
The active fractions eluted from the gel filtration column were combined and subjected to
hydroxyapatite chromatography. The eluate was monitored for glutathione peroxidase
activity with cumene hydroperoxide as substrate as well as transferase activity (Figure
10.02). A single peak of activity towards 1 -menaphthyl sulphate, that was coincident with
a peak of glutathione peroxidase activity, eluted between 80-120 mM on the sodium
phosphate gradient. Two further peaks of glutathione peroxidase activity, which were not
coincident with activity towards 1-chloro-2,4-dinitrobenzene, were also resolved on the
gradient; one of which possibly represents Se-dependant glutathione peroxidase.
The final chromatofocusing step resolved the 1 -menaphthyl sulphate activity recovered
from hydroxyapatite into three peaks, none of which had detectable activity either towards
1-chloro-2,4-dinitrobenzene or towards cumene hydroperoxide (Figure 10.03a). The
fractions containing each of these three peaks, which eluted at pH's 8.3, 8.15 and 8.0 ,
were combined separately and designated Pool A, Pool B and Pool C respectively.
Electrophoretic analysis revealed that Pool A and Pool B each contained a band of
subunit Mr 25400 (Figure 10.03b). Pool C contained the 25400-M, subunit together with
a polypeptide of Mr 27200. The purification of these 1 -menaphthyl sulphate active GST
pools from mouse liver is shown in Table 10.01.
10.03 Analytical reverse phase h.p.l.c. of mouse Theta-class GST subunits
When murine GST Pools A, B and C were applied to the \i Bondapak C18 column each
resulted in the elution of a peak with a retention time of 52 min (Figure 10.04). Pool C
contained an additional peak which eluted at 24 min.
The three GST pools each appear to contain an identical subunit with respect to mobility
on SDS/PAGE and retention time on h.p.l.c. It is possible, therefore, that they represent
a single homodimeric GST form.
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Figure 10.02 Elution pattern of mouse liver GST from hydroxyapatite
DEAE-cellulose purified material from mouse cytosol was precipitated by ammo
sulphate (section 4.03), and gel-filtered on Sephadex G-100 (section 4.04f) b<
application to a column (1.6 cm x 30 cm) of hydroxyapatite which had been equilibi
with 10 mM sodium phosphate buffer, pH 7.0, containing 1 mM EDTA and 2 m
mercaptoethanol (section 4.04c). The column was developed with a linear 10-250
sodium phosphate gradient (■) in the running buffer. Fractions of 2.3 ml were colle
and the absorbance at 280 nm (o), GST activity with 1-menaphthyl sulphate (•) ar
chloro-2,4-dinitrobenzene (*) as substrates and glutathione peroxidase activity
cumene hydroperoxide (a) as substrate were measured. The horizontal bar indicate-



























































Figure 10.03 Chromatofocusing of murine hepatic Theta-class GST and SDS/P
of pooled fractions
A sample of partially purified murine Theta-class GST, which had been subjecte
chromatography on DEAE-cellulose, Sephadex G-100 and hydroxyapatite, was eluted
a chromatofocusing column in the pH range 9.5-6.5 as described in section 4.04d (p
a). The column (1.6 cm x 30 cm) of polybuffer exchanger PBE 94 was equilibrated'
25 mM ethanolamine/HCI buffer, pH 9.5, containing 2 mM 2-mercaptoethanol. Folio
sample application, a gradient was formed using polybuffer 96 at pH 6.5. GST ac-
towards 1 -menaphthyl sulphate (•) and 1 -chloro-2,4-dinitrobenzene (*), protein conca
tion (o) and the pH at 4 °C (■) were measured in the fractions (3.4) collected. The
peaks of 1-menaphthyl sulphate activity were pooled, as indicated by the horizontal
and analysed by SDS/PAGE (panel b). Tracks 1 and 5 both contained affinity-purifia
liver GST [Ya (Mr 25500), Yb (Mr 26300) and Yc (Mr 27500)]. Tracks 2, 3 and 4
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Recovery
Cytosol(pos -dialysis for24hat4°C) DEAE-cellulosepo l SephadexG-100ool Hydroxyapatitepool Chromatofocusingpo ls: PoolA PoolB PoolC
9520 1359.4 514 23.2 0.129 0.146 0.165
14866.5±204 8054.7±2 0 7567±190 3906±14 211.8±6.7 250.8±19.0 180.5±2.4
1.56±0 02 5.92±0 18 14.7±0.21 168±0.6 1642±51.5 1718±30 1094±75.2
100 54.2 50.9 26.3 1.4 1.7 1.2
Figure 10.04 Analysis of mouse Theta-class GST subunits by reverse-phase h.|
Analytical reverse-phase h.p.l.c. was performed on the murine Theta-class GST which
been purified by sequential DEAE-cellulose chromatography, ammonium sulp
precipitation, gel filtration, hydroxyapatite chromatography and chromatofocusing.
three peaks of GST activity with 1-menaphthyl sulphate as substrate (Pool A, Pool B
Pool C), which were resolved by chromatofocusing in the pH range 9.5-6.5, were
applied to the p. Bondapak C18 column as described in section 4.05b. A 40-70%
acetonitrile gradient in aq. 0.1% (v/v) trifluoroacetic acid was used to develop the co¬
in two linear stages as shown by the straight lines. The A^ of the column eluata





Chapter 11 Characterization of human and murine
Theta-class GST
The only human Theta-class isoenzyme which has been described in the literature was
isolated on the basis of its activity towards the substrate 1,2-epoxy-3-(p-nitrophenoxy)-
propane (Meyer et al., 1991). This hepatic isoenzyme, called GST 8, has been partially
characterized but its quaternary structure remains to be elucidated.
During the present study a human hepatic enzyme, designated GST T2T2, and murine
hepatic GST have been purified by virtue of their catalytic activity towards the substrate
1 -menaphthyl sulphate. The physical, immunochemical, catalytic and structural properties
of human GST T2T2 are presented in this chapter and compared when possible with those
of the murine Theta-class GST.
11.01 Electrophoretic properties of human and murine Theta-class GST
SDS/PAGE analysis of human GST T2T2 and the murine GST present in Pool B, obtained
following chromatofocusing, revealed that the subunit molecular mass values of these
proteins were similar, though not identical (Figure 11.01). Mr values of 25100 and 25400
have been assigned to GST T2T2 and the subunit present in mouse Pool B, respectively.
11.02 Western Blot analysis of human and mouse Theta-class GST
Purified human GST T2T2 and mouse GST Pool B, together with samples taken following
each stage of the purification of the human Theta-class enzyme, were probed with
antisera raised against human Alpha-, Mu- and Pi-class GST (Figure 11.02). GST T2T2
was shown to be immunochemically distinct from other human enzymes of classes Alpha,
Mu and Pi, in that no cross-reactivity was observed between this enzyme and antisera
raised against either GST B^,, GST n or GST ji. This analysis also demonstrated that
the liver cytosol, from which GST T2T2 was isolated, expressed Alpha- and Mu-class GST
which were removed following chromatography on DEAE-cellulose, as well as a very small
quantity of Pi-class GST that was removed following chromatography on Matrex™ Gel
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Figure 11.01 SDS/PAGE analysis of human and murine Theta-class GST
Electrophoresis was performed in a resolving gel which contained 12%
polyacrylamide and 0.32% (w/v) N.N'-methylenebisacrylamide. Human GST su
markers B,B2 (Mr 26000), n (Mr 26700) and n (Mr 24800) were loaded into tracks 1, 2
3 respectively. Purified human GST T2T2 (2 /^g) was loaded into track 4. Tra




Figure 11.02 Cross-reactivity of human and mouse Theta-class GST with ant
raised against Alpha-, Mu- and Pi-class GST
Purified human GST T2T2, mouse GST Pool B and samples obtained following each
of the purification of GST T2T2 were subjected to immunoblot analysis (Towbin etal.,
using antisera raised against human Alpha-class GST B^, (panel a), Mu-class 0
(panel b) and Pi-class GST n (panel c). The SDS/polyacrylamide gel was load*
follows: tracks 1, 2 and 3, human GST BtB,, h and n standards; track 4, humar-
cytosol (30 ng; specimen L5); track 5, DEAE-cellulose pool (30 ng); track 6, hy<
apatite pool (30 //g); track 7, Matrex™ Gel Orange A pool (3 ^g); track 8, purifiec-









Orange A. The mouse GST present in Pool B also did not cross-react with antisera raised
against either human GST or GST \i. However, a feint cross-reaction was observed
with anti-(GST ri) IgG. Whilst this result is surprising it is possible that this represents
trace contamination of the Theta-class GST with murine GST YfYf; the Pi-class enzyme is
abundant in male mouse liver cytosol, and has a pi value (8.5) close to that at which Pool
B eluted from chromatofocusing (McLellan and Hayes, 1987).
The Theta-class GST purified from human and mouse liver were also challenged with an
antiserum, provided by Dr. W.B. Jakoby, raised against rat GST E (Figure 11.03). Also
included on the Western Blot are; human GST B,B2, GST and GST ji, rat liver cytosol,
as well as samples taken at each stage of the purification of GST T2T2. The only GST to
cross-react with this antiserum were the purified human and murine enzymes that were
active towards 1-menaphthyl sulphate. The absence of a cross-reacting polypeptide in
the track which contained rat liver cytosol is probably due to either the low abundance of
this GST (see Meyer et al., 1991) or the low titre of the antiserum.
11.03 Enzymatic properties of human GST T2T2
The specific activity of purified human hepatic GST T2T2 towards a range of substrates is
shown in Table 11.01. This enzyme was found to have no detectable activity towards 1-
chloro-2,4-dinitrobenzene and, unlike GST 6 described by Meyer et al. (1991), it was not
active with 1,2-epoxy-3-(p-nitrophenoxy)propane. GST T2T2 was also inactive with the
substrate para-nitrobenzyl chloride. However, as well as its transferase activity towards
1 -menaphthyl sulphate, GSTT2T2 had considerable glutathione peroxidase activity towards
cumene hydroperoxide.
11.04 Protein sequence analysis of human Theta-class GST
The GST subunit T2 could not be sequenced directly when subjected to automated Edman
degradation and was, therefore, concluded to possess a blocked N-terminus. Following
digestion of the GST T2 subunit with CNBr, the resulting peptides were resolved by
reverse-phase h.p.l.c. (Figure 11.04). Three of the CNBr-derived fragments, represented
by protein-containing peaks a, b and c (which eluted at 21, 24 and 28 min, respectively),
were collected and subjected to automated amino acid sequencing. The peptide present
in peak a was found to possess a blocked N-terminus. Peak b was subjected to 5 cycles
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Figure 11.03 Cross-reactivity of human and mouse Theta-class GST with antisera
raised against rat GST E
Human GST E^B,, n, n, and T2T2, the mouse GST present in Pool B, rat liver cytosol and
samples taken during the purification of GST T2T2 were probed, following SDS/PAGE and
electrophoretic transfer onto nitrocellulose paper, with antisera raised against rat GST E.
Protein was applied to the SDS/polyacrylamide gel as follows: tracks 1, 2 and 3, human
GST BtB,, h and n standards; track 4, rat liver cytosol (30 ^g); track 5, human liver
cytosol (30 ^g; specimen L5); track 6, DEAE-cellulose pool (30 ^g); track 7, hydroxy-
apatite pool (30 ^g); track 8, Matrex™ Gel Orange A pool (3 //g); track 9, purified GST
T2T2 obtained following Mono Q f.p.l.c. (2 fig); track 10 mouse chromatofocusing GST
Pool B (2/yg).
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Table 11.01 Specific activities of human GST T2T2
For experimental details see Chapter 3. Enzyme assays were performed at 37 °C. Results
are expressed as means ± S.D. for three determinations. Abbreviation: N.D., not detected.
Substrate Specific activity of GST T2T2
(i/mol/min per mg)
1-chloro-2,4-dinitrobenzene N.D.




Cumene hydroperoxide 6.9 ± 0.12
of Edman degradation, but unfortunately paucity of material would only permit a very
tentative identification of the amino acid sequence; the following residues were obtained;
leucine, proline, isoleucine, alanine and leucine. The peptide fragment represented by
protein peak c, was subjected to 20 cycles of Edman degradation allowing identification
of residues 1-21. This sequence is shown in Figure 11.05 aligned for comparison with the
homologous N-terminal amino acid sequences of rat YrsYrs (Hiratsuka etal., 1990) as well
as rat GST 5-5 and 12-12 and human GST 8 (Meyer et al., 1991). Five amino acid
differences are apparent between the N-terminal sequence of the T2 subunit and those of
the other Theta-class described in the literature. These changes occur at positions 2, 6,
10, 14 and 17; the amino acid residues are numbered according to the sequence of the
T2 subunit. At position 2 the T2 subunit and subunit 5 both contain valine, whereas,
subunit 12, 8 and the Yrs subunit all contain glycine. At position 6 the T2 subunit
contains a phenylalanine residue, whereas GST 5-5, 12-12 and 8 all contain a tyrosine,
and at position 10 GST T2 possesses a valine whilst the other Theta-class GST contain
leucine. The amino acid residue at position 14 of the GST T2 subunit has been tentatively
identified as serine; GST YrsYrs also contained a serine at this position, whereas, the other
rat GST subunits, 5 and 12, both contain cysteine. At position 17 the T2 subunit, as well
as GST 8 and subunits 12 and Yrs, contains a valine residue, whereas subunit 5 contains
isoleucine.
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Figure 11.04 Preparative peptide map of human GST T2T2
A portion (60 /ig) of GST subunit T2, purified by sequential DEAE-cellulose chro
graphy, hydroxyapatite chromatography, Matrex™ Gel Orange A chromatography,
Q f.p.l.c. and reverse-phase h.p.l.c., was digested with CNBr as described in st
3.04a. The resulting CNBr fragments were dissolved in 0.2 ml of aq. 0.1%
trifluoroacetic acid prior to chromatography on an Aquapore RP 300 column (7//m p
size; 2.1 mm x 30 mm). The column was developed with a linear 0-70% aceto
gradient in aq. 0.1% (v/v) trifluoroacetic acid, formed over 45 min, as indicated t>
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Subunit 5 V L E L Y L D L L S Q P C R A I Y I F A
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Yrs G L E L Y L D L L s Q P s R A V Y I F A
e G L E L Y L D L L s Q P X R A V Y I F A
1 11 21
Figure 11.05 Comparison of the N-terminal amino acid sequence of the T2 subunit
with those of other Theta-class GST
The N-terminal amino acid sequence of subunit T2 was obtained following automated
Edman degradation of a CNBr-derived peptide (peak c). This sequence is shown aligned
for comparison with the N-terminal amino acid sequences of Theta-class GST 5-5,12-12,
and 6 (Meyer et al., 1991) and GST YrsYrs (Hiratsuka et al„ 1990). The putative
methionine residue is in parentheses. Where assignments were tentative the residues are






Chapter 12 Mu-class and Theta-class GST isoenzymes
In this thesis purification schemes have been devised for the isolation of human and
murine isoenzymes which belong to the Mu- and Theta-classes of cytosolic GST. The
present investigation has shown that the human Mu-class GST are represented by a large
number of distinct, but closely related, isoenzymes which are subject to both inter-
individual and inter-organ differences in their patterns of expression. The existence of
unique GST forms in murine and human liver, which belong to the recently assigned
Theta-class, has also been demonstrated.
A number of homodimeric human Mu-class GST are described in the literature which have
been named either using the Greek symbols n, y and <f> (Warholm et ah, 1983; Singh et
ah, 1987a; Stockman and Hayes, 1987; Hayes, 1989) or according to their gene loci as
GST1 (type 1 and 2), GST4, GST5 and GST6 (Suzuki et ah, 1987, 1991; Board et ah,
1988). The Mu-class enzymes isolated from human tissues during this project comprise
four distinct subunits which may combine to form both homodimeric and heterodimeric
proteins. The Mu, or neutral-type subunits, have been designated N,8, N,b, N2 and N3,
according to the decreasing pi values of the corresponding homodimeric enzymes. This
designation permits the use of a more systematic system of nomenclature for the human
Mu-class GST which reflects their quaternary structures.
A total of eight separate Mu-class GST have been purified from human tissues during this
thesis. Four Mu-class enzymes and one Pi-class enzyme were isolated from skeletal
muscle (see Chapter 5). The Mu-class GST are described, in terms of their subunit
composition, as N,bN2, N2N2 and N2N3. The Nrtype subunits were found in only
some of the muscle specimens examined, whereas N2 and N3 were present in all
specimens. One homodimeric Mu-class GST, called N3N3, and an Alpha-class GST were
purified from human testicular tissue (see Chapter 6). Several other GST were also
present in this specimen, including the Mu-class enzymes N,N2, N2N2 and N2N3, and a Pi-
class GST. In addition to these forms, three separate Mu-class isoenzymes, which all
comprise Nrtype subunits, were isolated from a single human liver specimen (see Chapter
7).
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Recently, isoenzymes which belong to a new class of cytosolic GST have been observed
in rat and human liver (Hiratsuka et al., 1990; Meyer et al., 1991). During the present
investigation a human hepatic Theta-class GST, which catalyses the conjugation of 1-
menaphthyl sulphate (1-MS) with GSH, has been purified and is described by its
quaternary structure as T2T2. Theta-class GST forms have also been isolated from mouse
liver and shown to have similar properties to those of human GST T2T2.
A unifying nomenclature for the human GST has recently been proposed by a number of
investigators working in this field (Mannervik et al., 1992). This revised nomenclature
which provides a designation for each individual subunit, groups the cytosolic enzymes
into the four currently recognised classes; Alpha (A), Mu (M), Pi (P) and Theta (T). Arabic
numerals may then be assigned to each of the subunits, in the order that they have been
described. It is important that isoenzymes are only included formally in the new
nomenclature once their entire primary structures are known. Following these guidelines,
the Mu-class GST purified during this thesis may be given alternative names using the
revised nomenclature of Mannervik et al. (1992) (Table 12.01). Although only the N-
terminal amino acid sequences of the human Theta-class GST are available at present,
these isoenzymes are included in Table 12.01 with an asterix, to indicate a provisional
designation.
12.01 Mu-class and Theta-class GST present in human liver
The purification of three separate Mu-class GST from one human liver specimen is
described in Chapter 7. This specimen contained two homodimeric enzymes, designated
N,aN,a and N^N,", and a heterodimeric GST called N^N,". Although these isoenzymes
possess subunits which have a similar electrophoretic mobility upon SDS/polyacrylamide-
gel electrophoresis (N,a, Mr 27700; N,", Mr 27600), they may be distinguished by their
isoelectric points. GST N,aN,a is the most basic of these enzymes, with a pi of 6.1, GST
N^N,6 is the most acidic enzyme, possessing a pi of 5.5, and GST N^N," has an
intermediate pi of 5.9. The isoelectric points of the homodimeric GST N,aN,a and
indicate that these enzymes correspond to GST p and GST xp, isoenzymes which have
been described previously in the literature (Warholm et al., 1983; Singh et al., 1987a;
Hayes, 1989). The purification and characterization of the heterodimeric enzyme, GST
N^N,", formed by the combination of "ji-type" (or N,a) and "y-type" (or N,b) subunits
represents additional information on the human hepatic GST.
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Table 12.01 Revised nomenclature for human Mu- and Theta-class GST
Designation used Class Previous 1992 nomenclature8
in this thesis designation1"7
Mu H, GST1,type 2 GST M1a-1a
n^n," Mu n.i. GST M1a-1b
NX" Mu y, GST1 ,type 1 GST M1b-1b
N.H Mu n.i. GST M1a-2
nx Mu n.i. GST M1b-2
n2n2 Mu GST4 GST M2-2
n2n3 Mu n.i. GST M2-3
n3n3 Mu Brain/Testis p. GST M3-3
Theta e GST T1*-1* or
t2t2 Theta n.i. GST T2-2"
References:
1. Warholm ef a/., 1983
2. Singh ef a/., 1987
3. Suzuki ef a/., 1987
4. Board ef a/., 1988
5. Campbell ef a/., 1990
6. Vorachek ef a/., 1991
7. Meyer ef a/., 1991
8. Mannervik ef a/., 1992
Abbreviation: N.I., not included
The polymorphism which occurs at the genetic locus encoding the hepatic Mu-class
isoenzymes results in the expression of four different phenotypes in human liver. The
genetic model proposed by Board (1981) and Strange ef al. (1984), in order to account
for these inter-individual differences, postulated the existence of a heterodimeric protein
encoded at this GST1 locus. In a subsequent investigation, which involved chromato-
focusing together with hybridization experiments, Faulder ef al. (1987) demonstrated the
presence of such a hybrid enzyme in human liver cytosol. The expected occurrence, in
a Caucasian population, of this GST1 2-1 phenotype, which results in the expression of
at least three Mu-class GST in liver, was estimated by these investigators at approx. 6%.
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Recently, Van Ommen et al. (1990) quantified the human hepatic GST subunits from a
number of individuals, using a reverse-phase h.p.l.c. method. These workers confirmed
the genetic polymorphism of subunits n and y, and demonstrated that the combination
of both n and y was present in only one of 20 human liver specimens examined.
The current investigation has shown that GST N^N,®, N^N,", and N^N,6, the three
products of the GST1 locus, possess indistinguishable catalytic properties when examined
with a range of compounds (see Table 8.02, Chapter 8). The substrate specificities of the
hepatic Mu-class GST isolated during this project are closely similar, with all three
isoenzymes containing N,-type subunits having high activity towards frans-4-phenyl-3-
buten-2-one, para-nitrobenzyl chloride and 1-chloro-2,4-dinitrobenzene, as well as
moderate activity towards 4-hydroxnonenal, 4-hydroxydecinal and cumene hydroperoxide.
The Nrtype subunits, however, were found to have no detectable activity towards the
compound 1,2-dichloro-4-nitrobenzene. Hayes (1989) purified both GST n and GST y,
from two different liver specimens, and also demonstrated that the allelic variants of the
human hepatic Mu-class GST are catalytically indistinguishable. The present study
confirms several earlier investigations which describe the substrate specificity of GST |x.
Others have also observed the high activity of this enzyme towards frans-4-phenyl-3-
buten-2-one, cumene hydroperoxide and 4-hydroxyalkenals (Warholm et al., 1983;
Danielson et al., 1987).
During this thesis it has been shown that, in addition to transferase activity towards CDNB,
human liver cytosol contains activity towards the compound 1-menaphthyl sulphate (1-
MS). Using GST activity towards this sulphate esterto monitor purification, a homodimeric
GST has been isolated from human liver and designated GST T2T2 (see Chapter 9). This
transferase, which has structural homology with the Theta-class GST described by Meyer
et a/.(1991), does not appear to have been purified previously. Other workers have
isolated several GST forms from rat liver cytosol which are active towards 1-MS (Gillham,
1973; Hiratsuka etal., 1991) but, to date, the existence of a human GST which can utilize
1-MS as a substrate has not been documented.
Recently, Meyer etal. (1991) have isolated a human hepatic Theta-class GST and called
it GST 6. A comparison of the physical, catalytic and structural properties of GST T2T2
with those of GST d indicates that these two proteins represent distinct isoenzymes. GST
T2T2 contains two subunits which co-migrate during SDS/polyacrylamide-gel electrophore¬
sis and have a Mr value of 25100; this represents an electrophoretic mobility which is in
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between that of the human Alpha-class GST (Mr 26000) and that of the Pi-class GST
tc (Mr 24800). By contrast, electrophoresis of GST 9 gave two bands with mobilities in
between those of human Alpha- and Pi-class GST subunits. A comparison of the
chromatographic properties of GST T2T2 with those of GST 6 indicates that these proteins
have different charges. GST T2T2 was retained by Mono Q f.p.l.c. at pH 8.0 (see Chapter
9), whereas, a higher pH (9.55) was necessary to retain GST 6. GST T2T2 and GST 6 also
show significant differences in their substrate specificities. GST T2T2 not only exhibits
activity towards 1 -MS, but also has a high glutathione peroxidase activity towards cumene
hydroperoxide. Of equal importance is the observation that GST T2T2 was found to have
no detectable activity towards either 1,2-epoxy-3-(p-nitrophenoxy)propane or 1 -chloro-2,4-
dinitrobenzene. By contrast, purified GST 9 was reported to have a low, but detectable,
activity towards the epoxide substrate and no detectable activity towards cumene
hydroperoxide. Unfortunately, the activity of GST 9 towards 1-menaphthyl sulphate was
not documented.
The hypothesis that GST T2T2 and GST 9 are distinct proteins is supported by the fact that
the T2 subunit appeared to possess a blocked N-terminus, whereas, GST 9 is amenable
to direct sequence analysis (Meyer eta!., 1991). Amino acid sequence analysis of the N-
terminal portion of the T2 subunit was achieved by automated Edman degradation
following CNBr cleavage of the protein. A plausible reason why the T2 subunit has a
blocked N-terminus is that the initiator methionine amino acid remains attached to the
protein and is acetylated by a post-translational event. It is of interest that the chemical
nature of the blocked group at the N-terminus of rat GST subunit 8 (or Yk) has recently
been identified as an acetylmethionine structure (Alin et al. 1989). The amino acid
sequence of the N-terminal region of the GST T2 subunit was found to be closely similar
to the published N-termini of other Theta-class GST (Hiratsuka et al., 1990; Meyer et al.,
1991); no apparent homology was noted between T2 and other GST isoenzymes which
belong to classes Alpha, Mu or Pi. Although the T2 subunit and GST 9 have similar N-
terminal amino acid sequences, three conservative amino acid substitutions are present
in the first 20 residues (see Figure 11.05). At positions 2, 6 and 10 the T, subunit contains
valine, phenylalanine and valine, whereas the GST 9 subunit contains glycine, tyrosine
and leucine, respectively.
The immunochemical data presented in this thesis supports the assignment of GST T2T2
to the Theta-class; no immunological cross-reactivity was observed between GST T2T2 and
antisera raised against human Alpha-, Mu- and Pi-class GST. By contrast, the GST T2
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subunit was found to be related immunochemically to antisera raised against the original
GST E preparation obtained from rat liver described by Fjellstedt et al. (1973).
The precise relationship between the homodimeric Theta-class GST isolated during this
project and the hepatic enzyme identified by Meyer et al. (1991) is unclear. Whilst the
data presented in this thesis indicate that GST T2T2 and GST 6 represent separate
isoenzymes, the electrophoretic data reported by Meyer et al. (1991) indicate that GST 6
may be a heterodimeric protein. Therefore the possibility that the two enzymes share a
common subunit cannot be excluded.
12.02 Extra-hepatic expression of human GST isoenzymes
This thesis describes the purification of a total of five separate Mu-class GST from human
extra-hepatic tissues. The skeletal muscle and testis forms isolated during this
investigation comprise both homo- and heterodimeric proteins formed by the combination
of four different N-type subunits. Previously, several other groups of workers have
identified a number of extra-hepatic human GST (Laisney etal., 1984; Suzuki ef al., 1987;
Board et al., 1988; Singh etal., 1988; Campbell etal., 1990; Singhal et al., 1991). The
relationships between the transferases isolated during this project and those described
elsewhere will be discussed.
12.02a Characterization of the N-type GST subunits
The skeletal muscle GST N1bN2, N2N2, N2N3 and a homodimeric GST N3N3 isolated from a
human testis sample possess distinct catalytic properties. The substrate specificities of
these isoenzymes are also clearly distinct from those of the hepatic Mu-class GST (see
Table 8.01). The N,bN2 heterodimer, together with the hepatic Mu-class isoenzymes
(N^N,8, N^N^, and IVN,") all possess a high activity towards frans-4-phenyl-3-buten-2-
one and para-nitrobenzyl chloride. This is an indication that the N,-type subunits are
responsible for catalysing the conjugation of GSH to these compounds. All of the Mu-
class GST purified from skeletal muscle were active towards 1,2-dichloro-4-nitrobenzene.
By contrast, the hepatic isoenzymes were inactive towards this compound. The N2
subunit is, therefore, strongly implicated in the metabolism of 1,2-dichloro-4-nitrobenzene.
The Nrtype, N2 and N3 subunits were all found to possess a high transferase activity
towards 4-hydroxynonenal and 4-hydroxydecinal. Other workers have also noted the high
activity of the hepatic enzyme GST n towards 4-hydroxyalkenals (Danielson etal., 1987).
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Unfortunately, no substrate was identified that could serve as a marker for the N3 subunit.
However, the testis enzyme GST N3N3 was distinguished by a significantly lower activity
towards 1-chloro-2,4-dinitrobenzene than that observed for other human Mu-class GST.
With the exception of GST N2N3 and N3N3, the human Mu-class GST purified during this
investigation have different isoelectric points (see Figure 8.01 and Table 8.01). However,
the pi values of these enzymes fall within a close range (between 6.1 and 5.0), therefore,
it is unwise to identify the GST solely on the basis of their isoelectric points. The subunit
types that the Mu-class GST comprise can be resolved conveniently and identified by
SDS/PAGE. With this method the Nrtype, N2 and N3 subunits have estimated Mr values
of 26700, 26000 and 26300 respectively. It is important to recognise that the N2 subunit
and the Alpha-class subunits co-migrate during SDS/PAGE and that immuno¬
chemical methods are required to help discriminate between these subunits.
Subunits N,a, N,b, N2 and N3 showed no cross-reactivity towards antibodies raised against
either human Alpha-class GST B^, or the Pi-class GST n. All of the N-type subunits were
found to cross-react with antisera raised against hepatic GST p (or N^N,") and, therefore,
although the N2 and B,/B2 subunits co-migrate during SDS/PAGE, they can be
discriminated immunochemically. The data also suggest that the individual N-type
subunits can be distinguished by immunochemistry, but that to achieve identification the
choice of antiserum is important (Table 12.02).
Table 12.02 Immunochemical properties of human N-type subunits
Subunit Cross-reactivity with antisera against human GST:
B.B, n N,aN,a N2N2 N3N3
N,a - - + + + + + + + +
N," - - + + + + + + + +
N2 - - ++ + + + +
N3 - - + - + + + +
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The degree of cross-reactivity towards antibodies against GST |i (or N^N,") was found to
vary from subunit to subunit. As expected, the N,-type subunits cross-reacted strongly
with this antiserum, whereas the N2 and the N3 subunits both showed a weaker reactivity.
Antibodies raised against the N2 subunit were found to cross-react with the N, subunit, but
not with the N3 subunit. By contrast, anti-(N3N3) antibodies only cross-reacted with the N3
subunit and, therefore, clearly distinguish this subunit from other human Mu-class GST.
N-terminal amino acid sequencing suggests that the N^type, N2 and N3 subunits are
genetically separate (see Figure 8.05). It was possible to analyze the purified N2 and N3
subunits directly. However, the constituent subunits of GST N,aN2 were not resolved by
reverse-phase h.p.l.c. and, therefore, the sequence data presented for subunit N,a were
derived from the analysis of the N^N., heterodimer. Comparison between N,a and N2
showed differences at residues 3, 8 and 15; at these positions subunit N,a appeared to
contain isoleucine, aspartic acid and alanine, whereas subunit N2 was found to contain
threonine, asparagine and serine. Comparison of the N-terminal sequence data for
skeletal muscle subunit N,a with the primary structure of the subunits of hepatic GST p.
suggest that they are identical. This conclusion is supported by the immunochemical
results, the observation that the N,-type subunit has a high activity for frans-4-phenyl-3-
buten-2-one and the inter-individual variability in the expression of the N,-type subunits.
In contrast to the N,a and the N2 subunits, the N3 subunit was found to possess a blocked
N-terminus. Recently, Campbell et al. (1990) have purified a Mu-class GST from human
testis, which they have called brain/testis n. It is of interest to note that this isoenzyme
was reported to have a pi of 5.2 which is similar to that of GST N3N3 purified during this
study, and to possess a blocked N-terminus.
Inspection of the sequence data for the N2 subunit compared with the cDNA clone
encoding GST n (DeJong ef al., 1988) shows that they are genetically distinct (see Figure
8.06); differences in primary structure were noted at residues 3, 8, 15, 66, 77, 133, 139,
144, 148 and 150. Moreover, comparison of these data for the N2 subunit with the N-
terminal sequence forthe skeletal muscle GST4 described by Board etal. (1988) suggests
that subunits N2 and GST4 are probably the same. The amino acid sequence analysis of
subunit N2 also allowed comparison with the genomic human Mu-class GST clones of
Taylor ef al. (1990,1991). This indicated that N2 probably represents the subunit encoded
by clone GST mu3. Recently, Vorachek et al. (1991) have isolated a cDNA clone (called
GTHMUS) encoding a GST expressed in human myoblasts. Protein sequence data
obtained by these workers indicates that this skeletal muscle GST is equivalent to the
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protein encoded by the GST4 locus described by Board et al. (1988). A comparison of
the amino acid sequence of the N2 subunit with the deduced amino acid sequence of the
human muscle cDNA clone GTHMUS indicates that they are identical, with the exception
of one amino acid residue. At position 209 the N2 subunit contains a serine residue,
whereas the protein encoded by GTHMUS contains threonine. It is possible that this
single conservative amino acid substitution is a result of allelic variation.
The N3 GST subunit, which is expressed in both skeletal muscle and testis tissue, was
found to possess a blocked N-terminus. A preparative CNBr digest of the N3 subunit
purified from human testicular tissue, however, enabled a small region of the protein,
between residues 188-208, to be sequenced. The 14 amino acids identified in this region
were found to be identical to the corresponding amino acids encoded by a human cDNA
clone HTGT-6 isolated from a human testis library (Campbell et al., 1990). These data are
further confirmation of the identity of GST N3N3 with the brain/testis n isoenzyme described
by Campbell et al. (1990).
Others have studied the GST isoenzyme content of human skeletal muscle. Awasthi and
co-workers isolated a number of GST from muscle which have N-terminal sequences
either identical to or closely related those of the N,a or the N2 subunit (Singh et al., 1988;
Singhal et al., 1991). The major muscle isoenzyme which was described by these
workers, however, had a blocked N-terminus. This transferase, called GST £, had an
acidic pi (5.2) and did not cross-react with antibodies raised against either human Alpha-,
Mu- or Pi-class GST. Although the N3 subunit is not an abundant protein in the muscle
specimens analysed during this project, it is a possibility, given the similarities in structural
and immunochemical properties between the two proteins, that GST N3N3 is related to GST
£ observed by Singhal etal. (1991). It is also worth noting that the Mu-class homodimer
GST <p, which Stockman and Hayes (1987) found in only one of 20 human liver
specimens, may also represent GST N3N3 as it also possessed a blocked N-terminus.
12.02b Variation in the expression of N,-tvpe GST subunits in extra-hepatic tissues
Each of four skeletal muscle specimens (M1, M2, M3 and M4; see Table 4.01) included
in this study had a different Mu-class GST isoenzyme content. These differences were
due to a variation in the expression of the N,-type subunits. All of the muscle specimens
examined contained GST N2N2 and GST N2N3. However, specimens M2, M3 and M4
expressed additional heterodimeric enzymes. Muscle specimen M2 contained GST N,aN2,
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specimen M3 contained GST N,bN2 (see Chapter 5), and muscle specimen M4 expressed
both of these GST forms (see Chapter 7).
In order to establish the relationship between the expression of N,-type GST subunits in
human liver and the presence of these subunits in extra-hepatic tissues, the isoenzyme
profiles from several different tissue samples obtained from the same individual were
analysed (see Chapter 7). A liver specimen obtained from this individual expressed
subunits N,a and N,b, two of the allelic variants encoded by the hepatic Mu-class GST
locus. Analysis of the GST content of skeletal muscle and cerebrum indicated that the
extra-hepatic tissues both expressed two chromatographically distinct heterodimeric
proteins which contained an N,-type subunit together with an N2 subunit. Therefore, the
hepatic Mu-class GST phenotype of this individual influenced the Mu-class GST subunits
expressed in skeletal muscle and cerebrum. Others have observed a direct relationship
between the expression of GST n in liver its presence in mononuclear leukocytes
(Seidegard etal., 1987).
The work presented in this thesis clearly demonstrates the ability of the skeletal muscle
N2 subunit to hybridize with other Mu-class subunits. The existence of a heterodimeric
protein formed by the combination of the subunits encoded by the GST1 locus (i.e. N,a
and N,b) and the GST4 locus (i.e. N2) was first predicted, by using zymogram analysis, by
Laisney etal. (1984). This finding, however, was not confirmed when similar studies were
performed by Suzuki etal. (1987). The isolation and characterization, described in this
thesis, of the N,aN2 and N,bN2 heterodimeric GST, therefore, supports the earlier work of
Laisney et al. (1984). The purification of the N2N3 heterodimer from skeletal muscle
represents new information on the multiplicity of the human Mu-class GST family. During
the present study a heterodimer was not recovered from either skeletal muscle or
testis and although its existence seems probable there is no obvious explanation for its
absence. Campbell et al. (1990) have also noted the absence of a natural heterodimer
formed by the combination of Mu-class GST subunits obtained from human liver and
testis.
12.03 The existence of multiple human Mu-class GST
The purification and characterization, described in this thesis, of three genetically distinct
N-type subunits supports the view that the human Mu-class GST are members of a
multigene family. Others have also described extra-hepatic Mu-class isoenzymes which
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appear to exhibit a degree of tissue-specific expression. A brain form, termed GST5, has
been identified and purified and shown to be related to the GST1 (or N,-type) isoenzymes
(Laisney et al., 1984; Suzuki et at., 1987). This GST was reported to have a pi of 5.9,
which falls between N^N,® and N^N,", and an identical subunit Mr to that of the product
of the GST1 locus. In addition, this GST cross-reacted readily with antisera raised against
GST1 isoenzymes. An acidic GST with a pi of 4.25, called GST6, has also been observed
in human tissues (Suzuki etal., 1987). The purification of this form from human brain and
its subsequent characterization has revealed that it has an identical N-terminal amino acid
sequence to that of GST4 (Board et at., 1988; Suzuki et at., 1991). GST6 cross-reacted
with antisera raised against GST4, but not with antisera raised against either GST1, GST2
or GST3. Furthermore, this GST has an electrophoretic mobility on SDS/PAGE that is
distinct from those of GST1 and GST4.
Recently, Tsuchida et al. (1990), have isolated five Mu-class subunits from human heart
and aorta. These subunits were shown to form a combination of homo- and heterodimeric
proteins. The three isoenzymes isolated from human heart, by these workers, could be
identified as GST N^N,®, N^NL, and N2N2 on the basis of their isoelectric points and N-
terminal amino acid sequences. However, two of the three subunits which comprise the
two proteins purified from aorta had distinct amino acid substitutions within their amino
terminal sequence. Therefore, in addition to the N-type subunits described in the present
study, there is evidence in the literature for the existence of multiple Mu-class GST which
are subject to tissue specific expression and may be the products of additional Mu-class
genes.
A total of four full-length cDNA clones which encode four separate Mu-class GST subunits
have been isolated by different workers. The Mu-class isoenzyme forms which these
cDNA represent have all been purified and characterised. Two of these cDNA encode the
hepatic isoenzymes GST ^ (or N^N,®) and GST tp (or N^N,") which differ by a single
amino acid at position 172 (DeJong etal., 1988; Seidegard etal., 1988; Widersten etal.,
1991). A third human Mu-class cDNA has a mostly divergent 3' non-coding region and
encodes a protein expressed in testicular and brain tissue. The GST encoded by this
cDNA clone (called testis/brain jx) shares approx. 68% protein sequence homology with
the hepatic enzymes (Campbell et al., 1990). Recently, Vorachek et al. (1991) have
isolated a fourth cDNA clone which encodes a skeletal muscle Mu-class enzyme. This
cDNA clone has a high homology in the 3' non-coding region with that of the hepatic
cDNA clones identified earlier. In addition, the protein encoded by the skeletal muscle
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cDNA clone shares approx. 85% homology with the GST1 isoenzymes. A comparison of
the N-terminal amino acid sequence of the protein encoded by the muscle cDNA with that
of GST4, described by Board etal. (1988), indicates that these proteins may be identical.
This view is further supported by a comparison of the physical properties of the purified
enzymes.
A recent study has indicated that the human Mu-class GST may be encoded by a
dispersed gene family (DeJong et al., 1991). The genomic organization of four human
Mu-class genes, with related 3' non-coding sequences, was investigated by these workers
using a panel of mouse-human somatic cell hybrids. The hybridization analysis revealed
that the four DNA fragments segregated with three different human chromosomes. An 8
kb EcoR1 fragment, which appeared to represent the polymorphic hepatic Mu-class
subunit genes, segregated with chromosome 13. Two fragments of 5.1 kb and 4.3 kb co-
segregated with chromosome 1, consistent with earlier in situ hybridization results
obtained using a GST ji cDNA probe (DeJong et al., 1988). A further 10 kb DNA fragment
segregated with chromosome 6. In this context it is worth noting that a cosmid clone
analysis by Taylor et al. (1991) indicated that at least two of the Mu-class genes (called
mu2 and mu3) are closely linked.
The evolutionary origin of the multiple human Mu-class GST has been the subject of
speculation in the literature. A number of workers have proposed that gene conversion
events are responsible for the high degree of homology seen in the coding and non-
coding regions of some of the human Mu-class genes (Taylor et al., 1991; Vorachekefa/.,
1991). A more recent proposal, which may account for the observation that the human
Mu-class gene family is dispersed, is that the polymorphic GST p/y> gene was created by
a transposition or recombination event during evolution (DeJong et al., 1991).
12.04 Inter-species relationships between Mu-class and Theta-class GST
The multiplicity observed in the human cytosolic GST is also apparent in other mammalian
species. For example, both rat and murine Mu-class GST are represented by multiple
isoenzymes which, although related, are catalytically and structurally distinct (Hayes, 1984;
Tu and Reddy, 1985; Ishikawa et al., 1988; Hayes et al., 1991b). To date, only three rat
Theta-class GST have been described (Hiratsuka et al., 1990; Meyer et al., 1991; Harris
et al., 1991), therefore, information on the complexity of a possible fourth GST multigene
family has yet to be obtained.
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12.04a A comparison of human and rat Mu-class GST isoenzymes
In the rat multiple Mu-class Yb-type and Yn-type GST subunits have been identified
(Hayes, 1984; Ishikawa etal., 1988). The dimeric enzymes which are composed of these
subunits, together with an additional subunit type, named Yo (Hayes, 1988; Kispert et
a/.,1989), are subject to a marked tissue specific expression. Rat liver cytosol contains
at least two Yb-type subunits (called Yb, and Yb2) which can combine to form a
homodimeric and two heterodimeric proteins (Hayes, 1983; Tu and Reddy, 1985).
Furthermore, the presence in rat liver of a Yn-type subunit which may form heterodimeric
proteins with both the Yb, and the Yb2 subunits has also been demonstrated (Hayes,
1984). More recently, Ishikawa et al. (1988) have shown that rat testis contains two
distinct Yn-type subunits. The major GST form isolated from this tissue was a hetero¬
dimeric protein comprising Yn, and Yn2 subunits. A Yn,Yn, homodimer was not purified
from rat testis by these workers, however, it was found in rat brain. These investigators
also demonstrated that subunits Yn, and Yb2 can combine to form a heterodimer which
is detectable not only in rat testis but also in heart kidney and lung. Others have
described an additional Mu-class GST, called YoYo (or 11-11), which is also expressed
in rat testis (Hayes, 1988; Kispert etal., 1989).
A variation in the GST isoenzyme content of different human tissues was also clearly
evident during the present study. The GST subunits N2 and N3 were found to be absent
from human liver, however, both of these proteins were expressed in skeletal muscle and
testis. The N2 subunit was a major form in skeletal muscle, as were the heterodimeric
proteins formed by the combination of the N2 subunit with either N,-type, when present,
or N3 subunits. In addition to GST N,N2 and N2N2, the homodimeric GST N3N3 was found
to be a major form present in the human testis sample analysed. The N3 subunit is
distinct from the N,-type and N2 subunits in that it possesses a blocked N-terminus. This
is an interesting observation, as in the rat the only Mu-class GST subunit that has a
blocked N-terminus is Yo (Hayes, 1988; Kispert et al., 1989), the Yb,, Yb2, Yn, and Yn2
subunits having N-termini that are amenable to direct sequencing analysis. It is, therefore,
possible that the human subunit N3 is the homologue of the rat Yo subunit.
It is worth noting the relationships between the substrate specificities of the human N-type
subunits and those of rat Mu-class isoenzymes (Table 12.03). Each of the rat GST
subunits has characteristic specific activities for certain substrates. The compounds trans-
4-phenyl-3-buten-2-one (f-PBO), 1,2-dichloro-4-nitrobenzene (DCNB), bromosulpho-
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phthalein (BSP) and para-nitrobenzyl chloride (p-NBC) may be used to distinguish
between the rat Yb,, Yb2 and Yn, subunits (Mannervik and Jenssen, 1982; Hayes, 1986).
For example, the rat GST Yb2Yb2 has a high specific activity for f-PBO and a relatively low
activity for DCNB, whereas the converse is true for both rat GST Yb,Yb, and Yn,Yn,. The
latter enzymes may be distinguished by their respective activities towards the compounds
p-NBC and BSP. These four substrates may also be used to discriminate between the
human N-type subunits. If one examines the catalytic activities of the human isoenzymes
it is apparent that GST N2N2 has a similar substrate specificity to that of the rat enzyme
Y^Yn,, whereas the substrate preferences of the homodimeric enzymes containing Nrtype
subunits are more closely similar to that of rat GST Yb2Yb2. The catalytic activities of the
human and rat Mu-class isoenzymes towards 1 -chloro-2,4-dinitrobenzene (CDNB) are also
of interest. Human GST N2N2 and rat GST Yn,Yn, both have a characteristically high
activity towards this substrate. By contrast, CDNB was found to be a relatively poor
substrate for both human GST N3N3 and rat GST YoYo.
Other investigators have also noted similarities between the substrate preferences of
certain human Mu-class GST and those of rat Mu-class GST. Tsuchida etal. (1990) have
purified three isoenzymes from human heart which appear to be identical to the GST
N^N,8, N,ttN2 and N2N2 described in this thesis. These workers concluded, using the
activities of the different enzymes towards DCNB to distinguish between GST forms, that
GST N2N2 is equivalent to rat GST Yn,Yn,, and proposed that the human enzyme GST
N,aN2 may correspond to GST Yb2Yn, which others have detected in rat heart and testis
(Ishikawa et at., 1988). Vorachek et at. (1991) found that activity towards f-PBO may be
used to discriminate between the muscle enzyme GST4 (or N2N2) and the hepatic GST y
(or N^N,"). This investigation demonstrated that human GSTy and rat GST Yb2Yb2 share
a high specific activity towards f-PBO, whereas human GST4 and rat Yn,Yn, have a low
activity towards this compound. Following a comparison of the amino acid sequences of
GST y and GST4 with those of the rat Yb2 and Yn, subunits, these workers have identified
a region between residues 158-168 which, they believe, may be involved in the catalysis
of f-PBO. In this region the amino acid sequence of Yb2 is identical to that of GST y,
whereas that of GST4 differs from the rat Yb2 subunit at 7 of the 11 residues.
Western blot analysis has revealed that the N^type, N2 and N3 subunits are immuno-
chemically related to a number of rat Mu-class GST, however, the degree of cross-

















































1.Hayesetl.(1986) 2.Danielsonetal.(1987) 3.Kispertetal.(1989) Abbreviations:CDNB,1-chloro-2,4-dinitrobenzene;f-PBO,frans-4-phenyl-3-buten-2-one;DCNB,1,2-dichloro-4-nitrob zeSP, bromosulphophthalein;p-NBC,para-nitrobenzylchl rid4-HNE,4-hydroxynon al;N.D.n tdetect d.
Figure 8.04; Chapters). The N,-type subunits cross-reacted strongly with antisera raised
against rat GST Y^Yb,, Yn,Yn, and YoYo, whereas a strong cross-reactivity with the N3
subunit was only evident using antisera raised against either rat GST Yb,Yb, or GST YoYo.
By contrast, a weak cross-reactivity was observed between the N2 subunit and all three
rat Mu-class GST antisera. Tsuchida et al. (1990) have examined the relationships
between human and rat Mu-class GST using immunodiffusion. These workers have
reported that immunochemical relationships exist between the human GST which
corresponds to N^N,8 and rat GST Yb2Yb2, and between the human enzyme which
represents GST N2N2 and rat Y^Yn,.
The analysis of genomic DNA using Southern blotting experiments has indicated that a
multigene family encode the rat Mu-class GST (Lai et al., 1986). In agreement with this
observation a number of cDNA clones which encode separate Mu-class GST subunits
expressed in rat liver (Ding et al., 1986) and testis (Abramowitz and Listowsky, 1987) have
been isolated. In addition, the structural genes which encode three rat liver Yb-type
subunits have been isolated and characterized (Lai et al., 1988; Morton etal., 1990). Two
of these genes encode the rat Yb, and Yb2 subunits, however, the third gene encodes a
subunit, designated Yb4, which has not been purified to date from any rat tissue. A
comparison of the nucleotide sequences of genes encoding the Yb, and Yb2 subunits
reveals that all of the exons and some of the introns share significant identity (Morton et
al., 1990). Tu and co-workers have also reported a conservation of the introns in the
genes encoding subunits Yb, and Yb4 (Lai etal., 1988). Therefore, as with the human Mu-
class genes, there is evidence for gene conversion in the evolution of the rat Mu-class
multigene family. The recent analysis of the human genomic Mu-class genes by Taylor
et al. (1991) has indicated that the exon-intron boundaries are conserved between man
and rat. This study also demonstrated that there is a high degree of nucleotide sequence
homology in both the exons and some of the introns between sequences of the human
mu2 and mu3 genes and the rat Yb2 subunit gene. These workers proposed that the
conservation of introns between human and rat Mu-class genes was possibly due to the
presence of regulatory sequences.
190
12.04b Theta-class GST present in human, murine and rat liver
An investigation into hepatic GST which catalyse the conjugation of GSH to 1-menaphthyl
sulphate has been undertaken during this thesis. This has led to the isolation and
characterization of a homodimeric human isoenzyme and the identification of related
murine GST forms.
The earliest reports on the chromatographic purification of GST employed either 1-
menaphthyl sulphate (1 -MS) or 1,2-epoxy-3-(p-nitrophenoxy)propane (EPNP) as substrates
for these enzymes (Gillham, 1971,1973; Fjellstedt et al., 1973). With the development of
a general purification scheme it was found that most of the rat liver GST catalyse the
conjugation of GSH to 1 -chloro-2,4-dinitrobenzene (CDNB) and, therefore, this compound
was adopted as the substrate of choice to monitor purification (Habig etal., 1974a, 1976).
The widespread, almost exclusive use of CDNB as a GST substrate, however, has resulted
in the GST which metabolise 1-MS and EPNP being ignored until relatively recently. In
rat liver cytosol separate GST isoenzymes are responsible for metabolising 1-MS and
EPNP. GST YrsYrs, described by Hiratsuka etal. (1990), was shown to be active with 1-
MS but not EPNP. Three Theta-class GST (referred to as 5-5,12-12 and 13-13) have been
isolated by Ketterer and co-workers, and it appears that only one of these transferases,
possibly 12-12, is active with 1-MS (Harris et al., 1991; Meyer et al., 1991).
The current investigation has indicated that human liver also contains separate GST which
are responsible for the metabolism of 1-MS and EPNP. GST T2T2, purified during this
study, catalyses the conjugation of GSH to 1-MS. However, unlike the human GST 6
described by Meyer et al. (1991), this isoenzyme is not active towards the epoxide
substrate EPNP. This study has also shown that male mouse liver contains GST forms
that metabolise 1-MS. Unfortunately, due to paucity of material, the activity of a purified
murine enzyme towards EPNP has not been established. However, it is worth noting that
murine fraction obtained following hydroxyapatite chromatography that was active with 1 -
MS did not possess EPNP activity. In addition to the GST activity towards 1-MS, the
human GST T2T2 exhibited a high peroxidase activity towards cumene hydroperoxide.
Interestingly, peroxidase activity, with cumene hydroperoxide as a substrate, was also
attributed to rat GST YrsYrs (Hiratsuka et al., 1990) and rat GST 5-5 (Meyer et al., 1991).
Comparisons between the physical properties of the human, murine and rat GST which
metabolise 1-MS reveals a number of similarities. The GST T2 subunit present in the
human enzyme had a similar, but not identical, electrophoretic mobility on SDS/PAGE to
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that of the subunit present in the murine 1-MS active GST. GST T2T2 has a subunit Mr of
25100, whereas the mouse enzyme has a subunit Mr of 25400. The murine GST forms
have pi values, which may be estimated from chromatofocusing, in the region of 8.3-8.0.
It is noteworthy that GST YrsYrs described by Hiratsuka et al. (1990) also eluted from
chromatofocusing columns between pH 8.2-8.0.
The subunits present in the human GST T2T2 and the mouse 1 -MS metabolising GST are
both immunochemically related to a preparation of rat liver GST E, which catalyses the
conjugation of GSH to EPNP. In addition, the human enzyme shares N-terminal amino
acid sequence homology with the rat liver GST which metabolise either 1-MS or EPNP.
Therefore, the immunochemical and the sequence data are a clear indication that the
human and the murine isoenzymes, described in this study are novel members of the
Theta-class of GST. The entire coding sequence of the rat Yrs subunit was revealed
recently following the isolation of a rat liver cDNA (Ogura et al., 1991). This cDNA
encoded a polypeptide which contained 244 amino acid residues, the sequence of which
showed very little homology (19-23%) with those of rat liver isoenzymes belonging to
classes Alpha, Mu and Pi.
Recently, a rat liver mitochondrial matrix GST has been purified and shown to have a
structural similarity to the rat cytosolic Theta-class enzymes (Harris et al., 1991). A
comparison of the N-terminal amino acid sequence of mitochondrial GST 13-13 with that
of human GST T2T2 reveals that 8 of the first 15 residues present in the T2 subunit are
identical to those found in subunit 13. One of these residues, namely phenylalanine at
position 6, is not found in the corresponding position in any of the other known cytosolic
Theta-class GST.
Subunit T2 (M)v LELFLDLVSQPsr
Subunit 13 CPAPRVLELFYDVLSPYSX
1 15
Harris et al. (1991) have also noted structural similarities between GST 13-13 and the
dichloromethane dehalogenase of Methylobacterium sp. (La Roche and Leisinger, 1990).
Therefore, it is possible that an evolutionary relationship exists between the bacterial,
mitochondrial and Theta-class cytosolic GST of eukaryotes.
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12.05 Biological consequences of variation in GST isoenzyme expression
The GST isoenzymes clearly play an important role in cellular defence mechanisms which
exist to combat the cytotoxic and genotoxic effects of both endogenous and xenobiotic
electrophiles. Although these enzymes display a broad and overlapping range of
substrate specificities, each of the separate classes of GST show a characteristic substrate
preference. For example, Mu-class GST are efficient in the detoxification of mutagens
such as styrene oxide and frans-stilbene oxide, and carcinogenic epoxides such as
benzo(a)pyrene-7,8-diol-9,10-epoxide (Seidegard eta!., 1987; Ketterer, 1988, Mannervik
and Danielson, 1988). Whereas, Theta-class GST have been shown to catalyse the
conjugation of GSH to a number of highly reactive sulphate esters formed from the
corresponding hydroxymethylarenes (Hiratsuka ef a/., 1990).
The work presented in this thesis has shown that within a class the individual subunits,
which comprise the human enzymes, display distinctive activities towards certain
substrates. The GST isoenzyme pattern present in a particular tissue may, therefore, have
both toxicological and pharmacological implications. In man, the GST are subject to both
inter-individual and tissue specific expression. The variations observed in isoenzyme
profiles are thought to be influenced by a number of factors; these include genetic
deficiencies, developmental changes, hormonal influences, as well as the sensitivity of the
individual GST forms towards inhibitors and inducers.
The genetic polymorphism associated with the human hepatic Mu-class GST has received
a great deal of attention by workers in this field. However, whether the variations
observed in the expression of these forms leads to changes in the susceptibility of an
individual to cellular and genetic damage caused by electrophilic compounds is as yet
unclear. There are reports which indicate that a lack of expression of the hepatic Mu-class
GST increases an individuals sensitivity to the cancer-inducing or cancer-promoting
compounds in tobacco smoke (Seidegard etal., 1986, 1991) and may cause an increase
susceptibility to adenocarcinomas of the colon and stomach (Strange ef a/., 1991).
However, by contrast, others have reported a similar distribution of GST ply in a large
number of carcinoma patients compared to that found in a control population (Peters ef
a/., 1990). In addition, Zhong etal. (1991) have observed a positive correlation between
the expression of Mu-class GST in patients with adenocarcinoma of the lung.
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Several groups of workers have studied the influence that the GST Mu polymorphism has
on the induction of cytogenetic damage. One such investigation demonstrated that
lymphocytes obtained from GST ^ deficient individuals are more sensitive to the induction
of sister chromatid exchanges produced by trans-stilbene oxide than those obtained from
individuals who expressed GST \i (Wiencke et al., 1990). In another study, designed to
investigate the consequences of the GST Mu polymorphism, Lui et al. (1991) attempted
to determine the role of GST \i in modulating the formation of benzo(a)pyrene- and
aflatoxin B,-derived DNA adducts. Interestingly, although the presence of GST p in
hepatic cytosol did not reduce the formation of benzo(a)pyrene-derived adducts, aflatoxin
B,-DNA binding was inhibited to a greater extent by the presence of cytosol which
contained this GST. These workers have, therefore, suggested that the hepatic Mu-class
enzymes may be a susceptibility marker for aflatoxin B,-related liver cancer.
The data presented in this thesis has shown that, in addition to the hepatic Mu-class GST
subunits, at least two structurally and immunologically related Mu-class subunits are
expressed in human skeletal muscle and testicular tissue. In order to establish the nature
of the protective roles that these distinct Mu-class GST forms may perform a number of
factors need to be determined. For example, it would be important to establish the
catalytic activities of these GST towards a range of potentially harmful endogenous and
xenobiotic electrophilic compounds. The work presented here has indicated that these
enzymes may be involved in the detoxification of certain by-products of lipid peroxidation,
in that they possess a high GSH conjugating activity towards 4-hydroxyalkenals, together
with a relitively high peroxidase activity towards cumene hydroperoxide. However, it
would also be of interest to determine the catalytic efficiency of these Mu-class subunits
towards known mutagenic and carcinogenic compounds, such as the epoxides trans-
stilbene oxide and benzo(a)pyrene-7,8-diol-9,10-epoxide. Furthermore, factors which
influence the levels of expression of these Mu-class forms in particular tissues need to be
considered. Throughout this project no evidence of genetic polymorphism in the
expression of either the N2 or the N3 subunit in human skeletal muscle was observed.
Other investigators have also reported no evidence of polymorphism in the expression of
the extra-hepatic Mu-class isoenzymes GST4 (Suzuki et al., 1987) and brain/testis p.
(Campbell et al., 1990). However, it is worth noting that inter-individual variations were
observed in the levels of expression of the N2 and the N3 subunits in muscle specimens.
Unfortunately, relitively little is known about the factors which control the differential
expression of GST genes. It is of interest, however, that the 5' flanking regions of the rat
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Yb, and Yb2 subunit genes are quite distinct, which suggests that unique mechanisms
may regulate the expression of the individual Mu-class GST genes (Morton etal., 1990).
The Theta-class GST which catalyse the conjugation of GSH to reactive sulphate esters
formed from hydroxymethylarenes, such as 5-hydroxymethylchrysene, appear to play an
important role in the prevention of carcinogenesis caused by these environmental
pollutants. The fact that GST activity provides protection against this class of compound
was first demonstrated when it was shown that GSH conjugation, mediated by GST
present in rat hepatic cytosol, inactivates both 5-hydroxymethylchrysene sulphate and
7,12-dihydroxymethylbenz(a)anthracene sulphate and inhibits the formation of DNA
adducts (Okuda ef a/., 1986; Watabe et al., 1987). Hiratsuka et al. (1990) subsequently
purified a GST from rat liver which possesses catalytic activity towards a range of sulphate
esters, including 1-menaphthyl sulphate. It is important to note that the level of
hydroxysteroid sulphotransferase activity may also influence whether a particular tissue
is target for carcinogenicity caused by hydroxymethylarenes. For example, rat liver which
has a high level of hydroxysteroid sulphotransferase activity (Singer, 1985; Okuda etal.,
1989) is not a target for hydroxymethylarenes, whereas these compound show potent
carcinogenicity to rat skin (Cavalieri et al., 1979).
The work undertaken in this thesis has shown that human liver also possesses at least
one GST isoenzyme with GSH conjugating activity towards reactive sulphate esters. An
important area of further investigation would be to determine the tissue specificity and
levels of expression of this novel human GST. It would also be of value to establish
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Variation in the expression of Mu-class glutathione ^-transferase
isoenzymes from human skeletal muscle
Evidence for the existence of heterodimers
Amanda J. HUSSEY,*§ Linda A. KERR,| Andrew D. CRONSHAW,| David J. HARRISONJ
and John D. HAYES*
*University of Edinburgh Department of Clinical Chemistry, The Royal Infirmary, Edinburgh EH3 9YW,
tWELMET Protein Sequencing Laboratory, University of Edinburgh Department of Biochemistry, George Square,
Edinburgh EH8 9XD, and {University of Edinburgh Department of Pathology, Medical Building, Teviot Place,
Edinburgh EH8 9AG, Scotland, U.K.
The cytosolic glutathione S-transferases (GST) from human skeletal muscle were purified by a combination of affinity
chromatography and anion-exchange chromatography followed by either chromatofocusing or hydroxyapatite
chromatography. Pi-class and Mu-class GST, but not Alpha-class GST, were isolated from muscle. In addition to a Pi-
class GST subunit, which exists as a homodimer, this tissue also contains a total of three distinct neutral-type Mu-class
GST subunits, which hybridize to form homodimers or heterodimers. The neutral-type subunits are referred to as Nj-Ns
and are defined by the decreasing isoelectric points of the homodimers; GST N4Nj, N2N2 and N3N3 have estimated pi
values of 6.1, 5.3 and < 5.0 respectively. SDS/PAGE showed that N1; N2 and N3 have Mv values of 26700, 26000 and
26300 respectively. The Np N2 and N3 subunits are catalytically distinct, with N: possessing a high activity for trans-4-
phenylbut-3-en-2-one and N2 having high activity with 1,2-dichloro-4-nitrobenzene. In skeletal muscle the expression of
the Nj subunit, but not ofN2 and N3 subunits, was found to differ from specimen to specimen. The Nt subunit was absent
from about 50% of samples examined, and the purification results from two different specimens are presented to illustrate
this inter-individual variation. Skeletal muscle from one individual (Ml), which did not express Nl; contained only GST
N2N2, N2N3 and n, whereas the second sample examined (M2) contained GST NjN2, N2N2 and N2N3 as well as GST n.
TV-Terminal amino acid sequence analysis supported the electrophoretic evidence that the N2 subunit in GST N,N2, N2N2
and N2N3 represents the same polypeptide. The peptides obtained from CNBr digests of N2 were subjected separately to
automated amino acid sequencing, and the results indicate that N2 is distinct but closely related to the protein encoded
by the human Mu-class cDNA clone GTH4 [DeJong, Chang, Whang-Peng, Knutsen & Tu (1988) Nucleic Acids Res. 16,
8541-8554], GST N2N2 is probably identical with GST 4 [Board, Suzuki & Shaw (1988) Biochim. Biophys. Acta 953,
214—217], as over the 24 TV-terminal residues of GST 4 there is complete identity between the two enzymes. Our data
suggest that the GST 1 and GST 4 loci are part of the same multi-gene family.
INTRODUCTION
The glutathione ^-transferases (GST), a complex group of
isoenzymes, function as a part of the phase II drug metabolism
response, which provides protection against xenobiotics (Chas-
seaud, 1979; Ketterer, 1988; Pickett & Lu, 1989). The mammalian
cytosolic enzymes are dimeric and can be divided into three
classes, which are distinguishable by their physical, structural,
catalytic and immunological characteristics (Mannervik, 1985;
Hayes & Mantle, 1986a). In man these classes were originally
described as the basic, near-neutral and acidic forms on the basis
of the isoelectric points of the enzymes, but recently these have
become more commonly referred to as Alpha-class, Mu-class
and Pi-class GST respectively (Alin et al., 1985). Other workers,
who have taken a genetic approach to the classification of these
enzymes, have numbered the human GST according to their gene
loci, using evidence obtained from zymogram analysis (Board,
1981; Strange et al., 1984). This approach has given rise to the
designation GST 1, GST 2 and GST 3, which are the loci that
encode enzymes of the Mu-class, Alpha-class and Pi-class GST
respectively.
In man, as in other species, the GST in liver have been the
most extensively studied. Three hepatic Alpha-class enzymes
formed by the combination of two structurally and immuno¬
logically distinct subunits termed B4 and B2 have been identified
(Stockman et al., 1985, 1987; Hayes et al., 1989). The B4 and B2
subunits are the products of two independent genes (Rhoads
et al., 1987) encoded by the GST 2-1 and GST 2-2 loci (Board,
1981, 1990) respectively. Kamisaka et al. (1975) originally
described five cationic forms of GST (a, p, y, S and e) in human
liver. Subsequent studies (Stockman et al., 1985) have shown
that the homodimcric enzyme B.Bj represents GST e and the
heterodimer BjB2 is equivalent to GST S. The relationship of
B„B, to these enzymes is less clear; this homodimer probably
represents a, fi and y, three GST forms that may have arisen,
during purification, from autoxidation of a single gene product
(for further discussion see Hayes et al., 1989).
The Mu-class GST in human liver are represented by two well-
characterized enzymes termed n (Warholm et al., 1983) and ijs
(Hussey et al., 1986; Singh et al., 1987; Hayes, 1989). These
homodimeric proteins are highly homologous (Hayes, 1989), and
it has been suggested that they represent allelic variants encoded
by the GST 1 locus, which was earlier identified by Board (1981)
and Strange et al. (1984). The existence of a heterodimeric form
Abbreviation used: GST, glutathione S-transferase(s).
§ To whom correspondence should be addressed.
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of these enzymes has been described (Faulder et al., 1987);
however, so far it has not been purified from human tissue.
Between 40 and 45 % of individuals fail to express either of these
Mu-class GST (Strange et al., 1984; Hussey et al., 1987), and it
has been suggested that those lacking /< or \j/, which are the most
efficient GST in the detoxification ofmutagenic epoxides, may be
more susceptible to lung cancer (Seidegard et al., 1986, 1990).
The Pi-class GST isolated from placenta (Howie et al., 1988)
is the most thoroughly characterized extrahepatic enzyme. This
enzyme is not expressed in hepatocytes, but is found in biliary
epithelium, lung and erythrocytes. The available evidence sug¬
gests that these Pi-class enzymes, usually termed tt, are the
products of a single gene (Cowell et al., 1988; Morrow et al.,
1989) encoded at the GST 3 locus.
The existence of further extrahepatic GST was first revealed
by means of zymogram analysis (Laisney et al., 1984). These
enzymes, predominantly expressed in skeletal muscle, heart and
brain, which were thought to be the products of additional gene
loci termed GST 4, GST 5 and GST 6 (Suzuki et al., 1987), are
poorly characterized, and the molecular basis for the existence of
these further enzyme forms (i.e. GST 4-6) is unclear. Board et al.
(1988) have purified an enzyme from human skeletal muscle,
called GST 4, that is immunologically related to GST p and has
A-terminal amino acid sequence homology with GST p. Others
(Singh et al., 1988) have isolated novel GST from skeletal muscle
with TV-terminal sequences cither identical with or closely related
to those of GST p or GST 4.
In the present study we have purified skeletal-muscle GST
from several individuals to permit the isoenzymes present to be




Chemicals used were all of analytical grade and were readily
available commercially. The h.p.l.c. solvents were obtained from
Rathburn Chemicals, Walkerburn, Peeblesshire, Scotland, U.K.
Buffers
The pH values quoted are those determined at the temperature
at which the buffers were used.
Tissues
Human skeletal-muscle specimens Ml and M2 were obtained
less than 16 h post mortem from an 84-year-old female and a
60-year-old male respectively. A macroscopic examination at
autopsy indicated that there was no evidence of any musculo¬
skeletal abnormality in these individuals. Tissue was obtained
from both right and left psoas muscles and stored at — 70 °C
until used.
Analytical methods
Protein concentrations were determined by the method of
Bradford (1976) with the use of a centrifugal fast analyser.
SDS/PAGE was carried out by the method of Laemmli (1970) as
described elsewhere (Hayes & Mantle, 19866)- The resolving gel
contained 12% (w/v) polyacrylamide and 0.32% (w/v) NN'-
methylenebisacrylamide.
Isoelectric focusing was performed in an LKB Multiphor
apparatus, as described by the manufacturer (LKB Produkter,
Bromma, Sweden), with a broad-range gel (pH 3.5-9.5) in thin-
layer 5 % (w/v) polyacrylamide. The gel was calibrated with
protein pi standards obtained from Pharmacia, Milton Keynes,
Bucks., U.K. The method of Habig & Jakoby (1981) was
employed for all substrates studied with the exception of cumene
hydroperoxide. Peroxidase activity was measured by an ad¬
aptation of the method of Wendel (1981) at pH 7.6 with final
concentrations of GSH, NADPH and glutathione reductase at
1.0 mM, 0.25 mM and I unit/ml respectively.
Enzyme purification
Portions of frozen skeletal-muscle specimen Ml (375 g) and
M2 (247 g) were allowed to thaw at room temperature, and 25 %
(w/v) homogenates were prepared in ice-cold 20 mM-Tris/HCl
buffer, pH 7.8, containing 200 mM-NaCl and 0.5 mM-dithio-
threitol (buffer A). Unless otherwise stated all subsequent steps
were performed at 4 °C. The supernatants at 100 000 g, referred
to as cytosol, were passed through plugs of glass-wool before
dialysis for 24 h against two changes, each of 5 litres, of buffer A.
M1 and M2 cytosols were then subjected to affinity chromato¬
graphy on columns (1.6 cm x 30 cm) of S-hexylglutathione-
Sepharose 6B equilibrated in buffer A. After a washing, with
about 800 ml ofbuffer A, and elution by 5 mM-S-hexylglutathione
in the same buffer, the bound material was dialysed for 24 h
against two changes, each of 2 litres, of 20 mM-Tris/HCl buffer,
pH 8.4, containing 0.5 mM-dithiothreitol (buffer B).
Partial resolution of the GST isoenzymes present in the affinity-
purified material was achieved by the use of anion-exchange
chromatography on Mono Q HR 5/5 with the integrated
Pharmacia f.p.l.c. system. This procedure was carried out at
room temperature. The Mono Q columns were equilibrated with
buffer B (pH 8.0 at 20 °C) at 0.75 ml/min and developed in two
stages with linear salt gradients of 0-0.15 M-NaCl in buffer B
followed immediately by 0.15-1.0 M-NaCl in buffer B. Fractions
eluted from the Mono Q column that contained protein were
combined, seven peaks from M1 (P1-P7) and five peaks from M2
(PI, P3 and P5-P7), and analysed by SDS/PAGE before further
purification.
The material designated PI, obtained from M2, was dialysed
against two changes, each of 2 litres, of 25 mM-Bistris/
iminodiacetic acid buffer, pH 7.1, before being chromatofocused,
at 20 °C, in the pH range 7-4 on a Mono P HR 5/20 f.p.l.c.
column (Pharmacia). Four protein-containing peaks were re¬
solved by this method (Pl-A, Pl-B, Pl-C and Pl-D).
The GST activity present in peak P3 from Mono Q, purified
from Ml and M2, was resolved into two peaks (P3-A and P3-B)
by hydroxyapatite chromatography with a Waters h.p.l.c. system
(Waters Associates, Northwich, Cheshire, U.K.). The material
present in peak P3 was first dialysed against two changes, each of
2 litres, of 10 mM-sodium phosphate buffer, pH 7.0, containing
0.5 mM-dithiothreitol before application at room temperature to
a Bio-Gel HPHT column (Bio-Rad Laboratories, Hemel Hemp¬
stead, Herts., U.K.). A 10-350 mM-sodium phosphate gradient,
at pH 7.0, was employed to develop the column at a flow rate of
0.5 ml/min.
Immunoblotting
Antisera against purified human GST were raised in New
Zealand White rabbits as described previously (Hayes & Mantle,
1986a). Western blotting was performed by the method of
Towbin et al. (1979).
Reverse-phase h.p.l.c.
This was carried out as described previously (Hayes et al.,
1989), with a Waters h.p.l.c. system with a //Bondapak C18
column (Millipore, Harrow, Middx., U.K.). Purified skeletal-
muscle GST subunits were resolved with linear gradients of
40-55% (v/v) acetonitrile in aq. 0.1 % (v/v) trifluoroacetic acid.
CNBr cleavage
A portion (1.0 mg) of GST isoenzyme P3-B, purified under
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reducing conditions, was dialysed extensively against 10mM-
ammonium acetate buffer, pH 7.0, before being freeze-dried. The
freeze-dried protein was then subjected to CNBr cleavage as
described elsewhere (Hayes et al., 1989). The freeze-dried peptides
were redissolved in 1.5 ml of aq. 0.1 % (v/v) trifluoroacetic acid
and resolved by reverse-phase h.p.l.c. on the /tBondapak C18
column with a 0-70% (v/v) acetonitrile gradient in aq. 0.1 %
(v/v) trifluoroacetic acid.
Amino acid sequencing
Purified skeletal-muscle subunits and the fragments obtained
from CNBr cleavage of isoenzyme P3-B were checked for purity
on an Applied Biosystems 130 A Microbore Separation System
(Applied Biosystems, Warrington, Cheshire, U.K.) before being
subjected to automated sequencing on an Applied Biosystems
477A instrument with a 120A on-line phenylthiohydantoin
analyser. For a complete description of these methods see Hayes
et al. (1989).
RESULTS
Variability in the expression of GST isoenzymes in human
skeletal muscle
Analyses of affinity-purified muscle GST by anion-exchange
chromatography yielded profiles that differed from specimen to
specimen (see Figs. 1 a and lc). Material from skeletal-muscle
specimen Ml was resolved by Mono Q into seven protein-
containing pools, two of which (P3 and P6) contained the major
GST forms. SDS/PAGE showed that peaks PI and P2, which
did not have GST activity with i-chloro-2,4-dinitrobenzene as
substrate, both contained a single band with a subunit A/r of
28 500 (Fig. 1 b). P3, the first major peak, contained the 28 500-A/,,
polypeptide together with bands that co-migrated with the human
placental 24800-Mr GST n standard and with a 26000-Mr
standard. The minor peaks P4 and P5 contained polypeptides of
the same electrophoretic mobility as that of peak P3; however,
peak P5 contained an additional band with an estimated subunit
Mr of 22500, which probably represents glyoxylase I (Hayes,
1988). The second major peak (P6) yielded two electrophoretic
bands, one of which co-migrated with the 26000-Mr standard
and a second diffuse band with a subunit Mr of 26300. This
26300-Mr band was also observed in peak P7, as was the
22500-Mr polypeptide tentatively identified as glyoxylase I.
By contrast, when the affinity-purified GST pool from skeletal-
muscle specimen M2 was subjected to the same anion-exchange
chromatography step only five peaks were resolved by Mono Q
(Fig. lc). The most significant difference between the elution
profile of specimen M2 and that obtained from specimen Ml was
the increased size of the first peak, PI, and the fact that, unlike
peak PI from the M1 specimen, this pool contained GST activity.




















Resolution of human skeletal-muscle GST by anion-exchange chromatography and SDS/PAGE analysis of individual peaks
S-Hexylglutathione-affinity-purified GST were resolved by anion-exchange chromatography on Mono Q as described in the text. A 0-1.0 M-NaCl
gradient was established in two steps as shown by the straight lines. Transferase activity with I-chloro-2,4-dinitrobenzene (CDNB) (A) and protein
concentration (O) were measured. Panels (a) and (c) show elution profiles obtained from material purified from specimens Ml and M2
respectively. The pooled fractions, indicated by the horizontal bars, were combined and subjected to electrophoretic analysis as shown in panels
(b) and (d). SDS/PAGE was performed in a 12 % (w/v) resolving gel. The positions of the human GST markers // (Mr 26700) and n (Mt 24800),
which were run in parallel, are indicated. The first lanes were loaded with total S-hexylglutathione-affinity-purified material (T; 6 /tg). The
following seven lanes in panel (b) and five lanes in panel (d) contained the combined fractions from Mono Q (4 /<g).
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Fig. 2. Chromatofocusing of partially purified skeletal-muscle GST and SDS/PAGE analysis of pooled fractions
Skeletal-muscle GST activity, from specimen M2, purified by S-hexylglutathione affinity chromatography and anion-exchange chromatography
on Mono Q (PI), was resolved by chromatofocusing on Mono P as described in the text (panel a). Transferase activity with l-chloro-2,4-
dinitrobenzene (CDNB) as substrate (A) and protein concentration (O) were measured, and the pH was monitored ( ). Fractions were
combined, as indicated by the horizontal bars, and the subunit composition was analysed by SDS/PAGE (panel b). The first lane was loaded with
the material applied to the chromatofocusing column (PI; 4 /rg). The following lanes contained the pools obtained from Mono P. Pl-A (4 /<g),
Pl-B (1.5 //g), Pl-C (4 /tg) and Pl-D (3 //,g), as shown. The mobility of the human GST marker n (A/r 26700), which was run in parallel, is indicated.
When examined by SDS/PAGE (Fig. 1 d), three subunit bands
were observed; the largest was the 28 500-AFr polypeptide, the
second band co-migrated with the human hepatic GST /t standard
(Mr 26700) and a third subunit co-migrated with the 26000-Mr
standard. Apart from the absence of the polypeptide ofMr 28 500,
peaks P3, P5, P6 and P7 appeared to have the same subunit
compositions as the corresponding peaks on the elution profile
obtained from specimen Ml. The additional subunit, present
only in specimen M2, that co-migrated with GST /i (Mr 26700)
was also clearly visible when the affinity-purified total GST pool
from specimen M2 was analysed by SDS/PAGE (T in Fig. 1 d).
Hence specimen Ml expressed GST subunits ofMr 24800, 26000
and 26300 whereas specimen M2 expressed not only these three
polypeptides but also a GST subunit of Mr 26700.
The GST in muscle specimen M2 that was eluted from Mono Q
in peak PI were purified further by chromatofocusing on
Mono P. This column resolved the material recovered in peak PI
into one major peak, Pl-A, and three minor peaks, Pl-B, Pl-C
and Pl-D (Fig. 2a). The protein-containing fractions were com¬
bined and their subunit compositions examined by SDS/PAGE
(Fig. 2b). Peak Pl-A, which was eluted from the chromato¬
focusing column at pH 5.9, contained the two subunits that co-
migrated during SDS/PAGE with the liver GST standards of
Mr 26000 and 26 700. Electrophoresis showed that peak PI-B
also contained these two subunits ofMr 26000 and 26700 as well
as the polypeptide with Mr 28500. Pl-C, the only peak that did
not have GST activity, contained the contaminant polypeptide
of Mr28500. Peak Pl-D contained trace amounts of the con¬
taminant and the GST subunit with Mr 26000.
Hydroxyapatite h.p.l.c., a technique that separates the human
hepatic GST according to their class (Hussey et al., 1986), was
employed to resolve the different subunit forms present in peak
P3 from both muscle specimens. The profile obtained when
material from specimen M2 was applied to this column is shown
in Fig. 3(a). The first peak, which was eluted on the early part of
the phosphate gradient, indicated the presence of Pi-class GST,
and the second peak, which was eluted half-way along the
gradient, indicated the presence of Mu-class subunits. Analysis
by SDS/PAGE (Fig. 3b) confirmed that the first peak (P3-A)
contained the subunit with the same mobility as GST n, whereas
the second peak (P3-B) contained the subunit with an estimated
Mr of 26000. Peak P3-B possibly, therefore, contains Mu-class
subunits with a greater anodal mobility during SDS/PAGE
(Mr 26000) than that of the Mu-class GST /r/^ isoenzymes of
human liver (Mr 26700). The results of the purification of the
GST isoenzymes of skeletal muscle are summarized in Table 1.
Identification and characterization of three Mu-class isoenzymes
and a Pi-class isoenzyme from human skeletal muscle
Upon analytical isoelectric focusing the GST pools Pl-A,
P3-A, P3-B and P6 focused into single bands, thereby confirming
their purity. Electrophoretic analysis therefore indicates that
peaks P3-A and P3-B probably contain homodimeric GST
whereas peaks Pl-A and P6 contain heterodimeric proteins.
Western-blot analysis revealed that the components of peaks
Pl-A, P3-B and P6 cross-reacted with antisera raised against
GST // but not with antisera raised against either Alpha-class or
Pi-class GST. By contrast, the component of peak P3-A was
found to cross-react with antibodies to Pi-class GST but not with
other antibodies against other GST. These immunochemical
data suggest that peaks Pl-A, P3-B and P6 contain Mu-class
subunits and that peak P3-A contains Pi-class subunits. Together
the immunochemical and electrophoretic data suggested the
presence of three neutral-type Mu-class GST subunits in human
muscle. By designating these as Nj, N2 and N3 (according to their
apparent pi values) we were able to use a more systematic
designation for the muscle enzymes that reflects their quaternary
structures. Table 2 summarizes the physical and immunological
characteristics of the skeletal-muscle GST; the hepatic GST ji is
also included for comparison.
The specific activities of the muscle isoenzymes with a range of
substrates are shown in Table 3. All of the enzymes purified from
skeletal muscle have high activity with l-chloro-2,4-dinitro-
benzene as a substrate. However, when l,2-dichloro-4-nitro-
benzene or rra«s-4-phenylbut-3-en-2-one was employed con¬
siderably different patterns of activity were observed for the
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Fig. 3. Hydroxyapatite chromatography of partially purified skeletal-muscle GST isoenzymes and SDS/PAGE of resulting peaks
Enzymes purified from skeletal-muscle specimen MI by S-hexylglutathione affinity chromatography and anion-exchange chromatography on
Mono Q (P3) were further resolved by chromatography on Bio-Gel HPHT as described in the text (panel a). The column was developed with a
linear 10-350 mM-sodium phosphate gradient, indicated by the straight line, and the A2S0 was monitored ( ). SDS/PAGE analysis of the
combined fractions, indicated by the horizontal bars, is shown in panel (b). The mobilities of the human GST markers n (Mr26700) and
n (Mr 24800) are indicated. The first lane contained the material applied to the hydroxyapatite h.p.l.c. column (P3; 4//,g). The following lanes
were loaded with the combined fractions, P3-A (4 fig) and P3-B (4 /zg), as shown.
skeletal-muscle enzymes. The homodimeric Mu-class GST N2N2
(peak P3-B) and the heterodimeric Mu-class GST N2N3 (peak
P6) both had activity with l,2-dichloro-4-nitrobenzene but no
detectable activity with fra«j-4-phenylbut-3-en-2-one, unlike the
liver enzyme GST /i, where the converse is true. The heterodimeric
Mu-class GST N,N2 (peak PI-A), however, had activity with
both of these substrates. GST ji and GST NtN2 were the only
Mu-class enzymes to have activity with cumene hydroperoxide.
The Pi-class skeletal-muscle enzyme (peak P3-A), like the pla¬
cental enzyme GST n, had a relatively high activity with
ethacrynic acid, but neither GST NjNj nor GST N2N2 nor
GST N2N3 was as active with this substrate.
Subunit separation and /V-terminal sequence analysis
Before sequence analysis, reverse-phase h.p.l.c. was employed
in an attempt to prepare separately the individual subunits
present in the skeletal-muscle GST isoenzymes. Unfortunately,
the Nj and N2 subunits could not be resolved on the //Bondapak
Clg column, but the N;) subunit was resolved from these two Mu-
class polypeptides by reverse-phase h.p.l.c. This technique was
also used to purify further GST N2N2 (peak P3-B) by removing
small residual quantities of the 28500-ATr polypeptide that
contaminated certain preparations (Fig. 4). The elution of the two
subunits present in GST N2N3 (peak P6) from the /zBondapak
Table 1. Purification of human skeletal-muscle GST isoenzymes
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Table 2. Physical and immunochemical properties of skeletal-muscle GST isoenzymes
Preparations of antisera were as described in Hayes el al. (1983) (GST B,Bj), Hayes (1989) (subunit Nj or GST /j) and Howie et al. (1988)
(GST n). Anti-(subunit N2) IgG was prepared as described in the Experimental section using N2 subunits, purified by reverse-phase h.p.l.c.,
as immunogen.
Cross-reactivity with antisera against:
Preparation
Enzyme designation Subunit Mr pi value BjB, Nt N2 n
NjNJ O)* - 26700 6.10 - + + + + + +
NN Pl-A / 26 700 \ , /— + + + + + +12 \ 26000/ 5'65 ++ + + +
N.,N2 P3-B 26000 5.30 - ++ + + +
N,N. P6 {*«»} 5.00 {; % :
n P3-A 24700 4.70 - - + + +
* Data from Hayes (1989)
Table 3. Specific activities of skeletal-muscle GST isoenzymes
For experimental details see the text. Abbreviations: CDNB. l-chloro-2,4-dinitrobenzene; DCNB. l,2-dichloro-4-nitrobenzene; tPBO, trans-4-
phenylbut-3-en-2-one; EA, ethacrynic acid; CuOOH, cumene hydroperoxide.
Specific activity (/<mol/min per mg at 37 °C)
Preparation
Enzyme designation CDNB DCNB tPBO EA CuOOH
N,N, (jj)* - 261 0 0.22 0.08 0.22
NjN2 Pl-A 136 + 3 2.67 ±0.04 0.26 + 0.04 0.41 ±0.13 0.17±0.01
N,N2 P3-B 171 ±7 1.91 ±0.32 0 0.33±0.04 0
N2N3 P6 92 + 3 1.61 ±0.2 0 0.27 ±0.01 0
n~ ' P3-A 113± 1 0.25±0.06 0 0.78±0.01 0
* Data from Hayes (1989).
C18 column is also shown in Fig. 4. The major peak, which was
eluted at between 37 and 41 min, contained a polypeptide of
A/r 26000, whereas the two minor peaks, which were eluted at
50 min and 56 min, both contained subunits of Mr 26300.
SDS/PAGE analysis of the GST subunits that were isolated by
this technique is shown in Fig. 5.
TV-Terminal sequence analysis was undertaken to help establish
the relationship between the muscle GST and provide evidence
that the polypeptide of Mr 26000 that was found in the different
Mu-class enzymes, and that we have designated N,, is indeed a
common subunit. The results of these analyses are shown in Fig.
6. The subunits ofMr 26000 present in the GST N2N2 homodimer
Fig. 4. Reverse-phase h.p.l.c. of human skeletal-muscle GST subunits
Skeletal-muscle GST pools P3-B (a) and P6 (b) were subjected to reverse-phase h.p.l.c. on a Waters //Bondapak C18 column (10 /(m particle size;
0.39 cm x 30 cm). The column was developed with a 40-70% (v/v) acetonitrile gradient in aq. 0.1 % (v/v) trifluoroacetic acid in two stages as
shown by the straight lines. The A220 of the eluate was monitored continuously ( ).
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Fig. 5. SDS/PAGE analysis of Mu-Class subunits isolated from human
skeletal muscle
SDS/PAGE was performed by using the method of Laemmli (1970).
The resolving gel contained 12% (w/v) polyacrylamide and 0.32%
(w/v) AW'-methylenebisacrylamide. The GST subunits purified on
reverse-phase h.p.l.c. were analysed as follows. Lane 1 contained the
subunit marker B,B2 (Mr 26000) and lane 2 contained the subunit
marker /i (Mr 26700). Lane 3 was loaded with pool P3 obtained
after anion-exchange chromatography on Mono Q of affinity-
purified material (4 fig). Lane 4 contained pool P3-B purified on
hydroxyapatite h.p.l.c. (4 fig). Lane 5 contained the GST subunit N2
isolated from pool P3-B after reverse-phase h.p.l.c. Lane 6 was
loaded with pool P6 purified by affinity chromatography and anion-
exchange chromatography on Mono Q (4 fig), lane 7 contained the
GST subunit N2 isolated from P6, and lanes 8 and 9 contained the
N3 subunits resolved on reverse-phase h.p.l.c. from P6.
and the GST N2N3 heterodimer were shown to have identical
TV-terminal sequences over the first ten residues. Although the
subunits in GST NtN2 could not be separated on the //Bondapak
C18 column it was possible to interpret the sequence data obtained
from the heterodimeric protein over most of the residues ana¬
lysed. The direct sequencing of GST N4N2 yielded unambiguous
assignments from cycles 1, 2, 4, 5, 6, 7, 9, 10, 11, 12, 13 and 14,
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but at residues 3, 8 and 15 the Sequenator found two amino
acids, namely threonine or isoleucine, asparagine or aspartic acid
and serine or alanine. When these sequences were compared with
those of human Mu-class enzymes described in the literature, it
was apparent that one sequence could be attributed to that of
human liver GST fi or GST ij/ (Alin et al., 1985; Hayes, 1989)
and the other was identical with the 24 residues published for the
skeletal-muscle enzyme GST 4 (Board et al., 1988). These data
suggest that the subunit of Mr 26000, designated N2, in
GST NjN2, N2N2 and N2N3 represents the same polypeptide.
The N3 subunit that was purified by reverse-phase h.p.l.c. was
found to possess a blocked TV-terminus and could not be
sequenced directly.
Comparison of the amino acid sequences of human Mu-class
GST isoenzymes
The protein sequence information obtained from the muscle
Mu-class enzyme GST N2N2 has enabled the comparison of
52% of its primary structure with that of other human Mu-class
enzymes reported in the literature. Four of the peptides,
CNBr-2, CNBr-5, CNBr-6 and CNBr-7, were subjected to auto¬
mated amino acid sequencing. In Fig. 7 the amino acid sequences
obtained from these fragments, together with the TV-terminal
sequence of subunit N2 (peptide CNBr-1), are shown aligned
with the homologous sequences deduced from the human hepatic
cDNA clone GTH4, reported by DeJong et al. (1988), and the
sequences deduced from the human Mu-class genomic clones,
GST mu2 and GST mu3, described by Taylor et al. (1990).
Comparison of the TV-terminal sequence ofGST N,N2 (peptide
CNBr-1) with that of the GTH4 clone reveals the three amino
acid differences found at positions 3, 8 and 15 predicted from the
TV-terminal sequence analysis of GST /i and GST \Jr discussed
above. This is followed by a region of complete identity between
the two sequences from residue 16 to residue 38. The peptide
CNBr-2, which was elutcd from the //Bondapak C18 column at
44.5 min, was subjected to 45 automated Edman degradation
cycles, allowing identification of residues 34—78. Over this region
Enzyme Pool Subunit(s) Residue
examined 15 10 15 20
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Fig. 6. TV-Terminal amino acid sequences of GST from human skeletal muscle
Purified skeletal-muscle GST enzymes N4N2, N2N2 and N2N3 were subjected to automated TV-terminal amino acid sequencing as described in the
text. *Data from Hayes (1989). tTV-Terminus blocked. JData from Board et al. (1988).
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Fig. 7. Comparison of the primary structure of the N2 subunit with other human Mu-class GST
The A-terminal amino acid sequence (CNBr-I) and the sequences of the CNBr-derived peptides from subunit N2 are aligned for comparison with
the homologous sequences deduced from the cDNA GTH4 (DeJong el al„ 1988) and the available homologous sequences deduced from the
genomic clones GST mu2 and GST mu3 (Taylor et al., 1990). Putative methionine residues are in parentheses and a dash indicates where no residue
could be identified with confidence. An asterisk (*) indicates amino acid residues that differ between the sequences.
of the protein amino acid sequence information on the genomic
clones GST mu2 and GST mu3 is available for comparison with
subunit N2. Amino acid differences were apparent between the
sequence of the N,-subunit peptide CNBr-2 and those of the
proteins encoded by clones GTH4 and GST mu2. At position 66
the N2 subunit contains threonine whereas the proteins encoded
by clones GTH4 and GST mu2 contain alanine, and at position
77 the N2 subunit possesses arginine whereas the proteins encoded
by clones GTH4 and GST mu2 both contain cysteine. However,
when the sequence of N2-subunit peptide CNBr-2 is compared
with that of the protein encoded by clone GST mu3 it is apparent
that the two sequences correspond exactly over the region where
sequence data on this genomic clone are available (i.e. residues
37-78).
Residues 133-153 of subunit N2 were identified by sequencing
the peptide, CNBr-5, that was eluted at 51 min from the
//Bondapak C18 column. Five amino acid substitutions were
present between the sequence of N,-subunit peptide CNBr-5 and
that of the protein encoded by clone GTH4. At position 133 a
methionine residue, which has provided a CNBr-cleavage site,
can be assigned to subunit N2, whereas the protein encoded by
clone GTH4 contains a lysine residue. The other four amino acid
changes between N2-subunit peptide CNBr-5 and the protein
encoded by clone GTH4, at positions 139, 144, 148 and 150, were
as follows: glutamine to glutamic acid, glutamine to arginine,
leucine to alanine and aspartic acid to asparagine respectively.
N2-subunit peptides CNBr-6 and CNBr-7, which were eluted at
30 min and 23 min from the reverse-phase column, contained
residues 198-210 and residues 212-217 respectively. No differ¬
ences were apparent between this C-terminal region of the N2
subunit and the homologous region of the protein encoded by
clone GTH4.
DISCUSSION
This paper describes the purification of a total of four GST
isoenzymes from human skeletal muscle. Three of these were
Mu-class GST and the remaining enzyme was a Pi-class GST.
No Alpha-class enzymes were isolated from any of the specimens
of human muscle. The Mu-class, or neutral, enzymes were shown
to comprise three distinct subunits, which we have designated
N1( N2 and N3 according to their decreasing pi values. These
subunits can hybridize, and we have described the muscle GST
by their quaternary structure as N4N2, N2N2 and N2N3. During
the present study a N4N3 heterodimer has not been recovered,
and although its existence seems probable we can offer no
explanation for its absence from human muscle. The N4 subunit
was found in only about half of the muscle specimens examined,
whereas N2 and N3 were recovered in all specimens. Because of
the variation in the expression of N4, the N4N2 heterodimer was
absent from some of the enzyme preparations.
GST NjN2, N2N2 and N2N3 possess distinct catalytic proper¬
ties. The NjN2 heterodimer was found to possess the greatest
activity of all the muscle GST for /ra/w-4-phenylbut-3-en-2-one,
indicating that the N4 subunit is responsible for catalysing its
conjugation with GSH. All these GST were active with 1,2-
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dichloro-4-nitrobenzene, which strongly implicates the N2 sub-
unit in the metabolism of this compound. No substrate was
identified that could serve as a marker for the N3 subunit. It may
be noted that the substrate-specificities of the b^N,,, N2N2 and
N2N3 muscle enzymes are significantly different from the well-
characterized hepatic Mu-class enzyme, GST /t (Table 3). When
one examines the activities of these enzymes for l,2-dichloro-4-
nitrobenzene and /ra«.y-4-phenylbut-3-en-2-one, both diagnostic
substrates for the Yb-type subunits in the rat, it is apparent that
GST N2N2 has a similar substrate-specificity to that of the rat
enzymes YbjYbj and YnYn, whereas the substrate preference of
GST ft, is more closely similar to that of rat GST Yb„Yb2 (Hayes,
1986).
A modest decrease in the specific activity of the purified GST
isoenzymes, with l-chloro-2,4-dinitrobenzene as substrate, is
apparent towards the end of the purification procedure (Table 1).
Having examined the data from five skeletal-muscle preparations,
we have observed a relatively large amount of variability in the
specific activities obtained for the purified Mu-class isoenzymes
GST NjN2 and GST N2N2, whereas the Pi-class enzyme has a
specific activity that varies little from preparation to preparation.
The basis for this observation is uncertain, but it does not appear
to be due to proteolysis, as neither the A/r nor the immuno¬
chemical properties of GST NtN2 or GST N.2N2 change during
the purification. It therefore seems probable that either an aging
effect or the removal of an activator during purification is
causing a loss in the enzymic activity of these Mu-class GST in
certain preparations. In this context it is noteworthy that certain
rat Mu-class GST are labile, and Kispert et al. (1989) have
proposed that the thiol status of the cysteine residue at position
184 in rat subunit 11 (Yo) is responsible for this property in this
particular GST.
The muscle Mu-class GST have different isoelectric points,
and their pi values are helpful aids to the identification of the
various isoenzymes; GST N,N2, N2N2 and N2N3 have isoelectric
points of 5.65, 5.30 and 5.00 respectively. However, because of
the closeness of these pi values it is unwise to identify GST solely
on the basis of isoelectric-focusing results. The subunits that
the Mu-class GST comprise can be resolved conveniently, and
identified, by SDS/PAGE. With this method the N15 N2 and N3
subunits have estimated Mr values of 26700, 26000 and 26300
respectively. It is important to recognize that the N2 subunit and
the Alpha-class Bj/B2 subunits co-migrate during SDS/PAGE
and that it is therefore essential to use immunochemical methods
to help discriminate between these subunits.
No cross-reactivity was observed between subunits Nt, N2 and
N3 and antibodies against either the Alpha-class GST BjB., or the
Pi-class GST rr. All the N-type subunits were found to cross-react
with antiserum raised against hepatic GST /<, and therefore,
although the N2 and Bj/B., subunits co-migrate during SDS/
PAGE, they can be discriminated by Western-blot analysis.
However, our data also suggest that the individual N-type
subunits can be distinguished by immunochemistry, but that to
achieve identification the choice of antiserum is important. The
degree of cross-reactivity towards GST /t antibodies was found
to vary from subunit to subunit. Whereas the NL subunit cross-
reacted strongly with this antiserum, the N2 subunit showed
a significantly weaker reactivity, giving a moderate signal in
the Western-blot assay and less than 10% cross-reactivity in
the GST [i radioimmunoassay (A. F. Howie, A. J. Hussey, J. D.
Hayes & G. J. Beckett, unpublished work). By contrast, the N3
subunit was even less reactive than the N., subunit towards anti-
(GST /1) antibodies, yielding only a weak signal in the Western-
blot assay. We have also raised antibodies against the N2 subunit
and found that, although these cross-react with the Nt subunit,
they do not exhibit reactivity with the N3 subunit.
TV-Terminal amino acid sequencing suggested that subunits
N1S N2 and N., are genetically separate. Although we were able to
analyse the purified N2 and N3 subunits directly, we were unable
to resolve by reverse-phase h.p.l.c. the constituent subunits of
GST NtN2 and therefore the sequence data for subunit N( were
derived from the direct analysis of the NjN2 heterodimer.
Comparison between subunits N2 and N2 showed differences at
residues 3, 8 and 15; at these positions subunit Nt appeared to
contain isoleucine, aspartic acid and alanine whereas subunit
N, was found to contain threonine, asparagine and serine. By
contrast, the N3 subunit possesses a blocked TV-terminus, but
unfortunately paucity of material prevented us from undertaking
a preparative CNBr digest that could have allowed us to obtain
sequence data.
Comparison of the TV-terminal sequence data for subunit Nj
with the primary structure of the subunits of hepatic GST /t
suggests that they are identical. This conclusion is supported by
the immunochemical results, the observation that subunit Nj has
a high activity for tra«i-4-phenylbut-3-en-2-one and the inter-
individual variability in the expression of the Nt subunit.
Inspection of the sequence data for the N2 subunit compared
with the cDNA clone encoding GST fi (i.e. NjNJ shows that
they are genetically distinct; differences in primary structure
were noted at residues 3, 8, 15, 66, 77, 133, 139, 144, 148 and 150.
Moreover, comparison of these data for the N2 subunit with the
TV-terminal sequence for GST-4 (Board et al., 1988) suggests that
subunits N2 and GST-4 are probably the same. The amino acid
sequence analysis of subunit N2 also allowed comparison with
the genomic human Mu-class clones of Taylor et al. (1990). This
indicated that N2 represents the subunit encoded by clone
GST mu3. The fact that the N3 subunit possesses a blocked TV-
terminus is itself an interesting observation, as in the rat the only
Mu-class GST subunit that has a blocked A-terminus is Yo
(Hayes, 1988; Kispert et al., 1989), the Ybr Yb2, Yn3 and Yn2
subunits having A-termini that are amenable to direct sequence
analysis. It is therefore possible that subunit N3 is the homologue
of the rat Yo subunit. It is also worth noting that the Mu-class
homodimer GST (j> of pi 4.6, which Stockman & Hayes (1987)
found in only one of 20 human liver specimens, may represent
N3N3 as it also possessed a blocked A-terminus.
We have demonstrated the ability of the N2 subunit to hybridize
with other Mu-class subunits. The existence of a heterodimeric
protein formed by the combination of the subunits encoded by
the GST 1 locus (i.e.NJ and the GST 4 locus (i.e. N2) was first
predicted, by using zymogram analysis, by Laisney et al. (1984).
This finding, however, was not confirmed when similar studies
were performed by Suzuki et al. (1987). The isolation and
characterization, described in the present paper, of the NjN,,
heterodimer supports the earlier work of Laisney et al. (1984),
and the purification of the N.,N3 heterodimer represents new
information abut the multiplicity of the human Mu-class GST
family. 11 is of interest that the chromosome mapping experiments
performed by several workers have located human Mu-class
genes on both chromosome 1 (DeJong et al., 1988) and chromo¬
some 3 (Islam et al., 1989).
Two hepatic human Mu-class homodimers, GST/i and GST ijr,
have been described (Hussey et al., 1986; Hayes, 1989). These
enzymes represent allelic variants and possess closely similar
catalytic activities and identical A-terminal amino acid sequences
(up to 50 residues), but differ in their isoelectric points, with
GST /i and GST ]r having pi values of 6.1 and 5.5 respectively.
As GST /i/x/r appear to comprise Nj-type subunits, we propose
that GST [i be designated N/'Nj" and GST ^ be designated
N/'N/'. On the basis of respective pi values of 6.1, 5.5 and 5.3 for
N/Nj", N/'N/' and N2N2, it is probable that the NjN2 hetero¬
dimer of pi 5.65 described in the present study represents
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N,"N2; it is expected that the isoelectric point of the N^N,
heterodimer would be approx. 5.4. This difference in the pi value
of the allelic variants of is an important reason why extreme
caution should be exercised in identifying these enzymes solely
by isoelectric focusing.
The acidic enzyme, peak 3-A, which was present in large
quantities in skeletal muscle of all individuals included in the
study, has similar physical and catalytic properties to those of the
Pi-class enzyme found in human placenta. Other workers have
also observed an enzyme, or enzymes, similar to the placental
GST 7t in skeletal muscle (Board et al., 1988; Singh et al., 1988).
Awasthi and co-workers (Singh et al., 1988) found two acidic
GST isoenzymes, termed GST 4.8 and GST 4.5, that have
identical A-terminal amino acid sequences to each other and to
that of human placental GST ft. One of these enzymes, GST 4.5,
was present in only two of six skeletal muscles studied, and these
workers therefore proposed the existence of a polymorphism at
the GST 3 locus. Although we have not observed any difference
in the Pi-class GST from different specimens of skeletal muscle,
it should be recognized that hybridization in situ has localized the
gene encoding Pi-class GST in man to both chromosomes 11 and
12 (Board et al., 1989). The possibility therefore remains that two
GST 7t isoenzymes exist, but this question remains to be resolved.
In this context, it is interesting that the amino acid sequence of
fatty acid ethyl ester synthetase from human myocardium has
been reported to be highly similar to, but not identical with, that
of the placental GST tt (Bora et al., 1989). On the basis of the
data of Alin et al. (1985) and Bora et al. (1989) it is apparent that
over the 23 IV-terminal residues of fatty acid ethyl ester synthetase
and placental GST n two amino acid differences exist at residues
1 (alanine->proline) and 15 (lysine-^alanine). There is therefore
evidence that two separate Pi-class GST are expressed in man,
but it is unclear how these relate to the GST 4.5 and GST 4.8
forms described by Singh et al. (1988).
From the results presented here it is clear that there are at least
one Pi-class and three Mu-class subunits expressed in skeletal
muscle. Evidence has been provided that the three Mu-class
subunits combine to form homodimeric or heterodimeric proteins
and that one of these subunits is absent from the muscle of
certain individuals. The characterization of the N15 N2 and N3
subunits has provided a valuable insight to the molecular basis
for the multiplicity of Mu-class GST in man.
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